BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Celli BR, Cote CG, Marin JM, Casanova C, Montes de Oca M, Mendez RA, Pinto Plata V, Cabral HJ. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med. 2004;350:1005-1012. [PMID: 14999112 DOI: 10.1056/nejmoa021322] [Cited by in Crossref: 2192] [Cited by in F6Publishing: 832] [Article Influence: 121.8] [Reference Citation Analysis]
Number Citing Articles
1 Fossati L, Müller-Mottet S, Hasler E, Speich R, Bloch KE, Huber LC, Ulrich Somaini S. Long-term effect of vasodilator therapy in pulmonary hypertension due to COPD: a retrospective analysis. Lung 2014;192:987-95. [PMID: 25348430 DOI: 10.1007/s00408-014-9650-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
2 de Bisschop C, Caron F, Ingrand P, Bretonneau Q, Dupuy O, Meurice JC. Does branched-chain amino acid supplementation improve pulmonary rehabilitation effect in COPD? Respir Med 2021;189:106642. [PMID: 34678585 DOI: 10.1016/j.rmed.2021.106642] [Reference Citation Analysis]
3 Boer LM, Asijee GM, van Schayck OC, Schermer TR. How do dyspnoea scales compare with measurement of functional capacity in patients with COPD and at risk of COPD? Prim Care Respir J 2012;21:202-7. [PMID: 22453664 DOI: 10.4104/pcrj.2012.00031] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
4 Zinellu A, Collu C, Nasser M, Paliogiannis P, Mellino S, Zinellu E, Traclet J, Ahmad K, Mangoni AA, Carru C, Pirina P, Fois AG, Cottin V. The Aggregate Index of Systemic Inflammation (AISI): A Novel Prognostic Biomarker in Idiopathic Pulmonary Fibrosis. J Clin Med 2021;10:4134. [PMID: 34575245 DOI: 10.3390/jcm10184134] [Reference Citation Analysis]
5 Glaab T, Vogelmeier C, Buhl R. Outcome measures in chronic obstructive pulmonary disease (COPD): strengths and limitations. Respir Res 2010;11:79. [PMID: 20565728 DOI: 10.1186/1465-9921-11-79] [Cited by in Crossref: 61] [Cited by in F6Publishing: 73] [Article Influence: 5.1] [Reference Citation Analysis]
6 Boes JL, Hoff BA, Bule M, Johnson TD, Rehemtulla A, Chamberlain R, Hoffman EA, Kazerooni EA, Martinez FJ, Han MK, Ross BD, Galbán CJ. Parametric response mapping monitors temporal changes on lung CT scans in the subpopulations and intermediate outcome measures in COPD Study (SPIROMICS). Acad Radiol 2015;22:186-94. [PMID: 25442794 DOI: 10.1016/j.acra.2014.08.015] [Cited by in Crossref: 52] [Cited by in F6Publishing: 53] [Article Influence: 6.5] [Reference Citation Analysis]
7 Puhan MA, Hansel NN, Sobradillo P, Enright P, Lange P, Hickson D, Menezes AM, ter Riet G, Held U, Domingo-Salvany A, Mosenifar Z, Antó JM, Moons KG, Kessels A, Garcia-Aymerich J; International COPD Cohorts Collaboration Working Group. Large-scale international validation of the ADO index in subjects with COPD: an individual subject data analysis of 10 cohorts. BMJ Open 2012;2:e002152. [PMID: 23242246 DOI: 10.1136/bmjopen-2012-002152] [Cited by in Crossref: 48] [Cited by in F6Publishing: 50] [Article Influence: 4.8] [Reference Citation Analysis]
8 Doyle TJ, Patel AS, Hatabu H, Nishino M, Wu G, Osorio JC, Golzarri MF, Traslosheros A, Chu SG, Frits ML, Iannaccone CK, Koontz D, Fuhrman C, Weinblatt ME, El-Chemaly SY, Washko GR, Hunninghake GM, Choi AM, Dellaripa PF, Oddis CV, Shadick NA, Ascherman DP, Rosas IO. Detection of Rheumatoid Arthritis-Interstitial Lung Disease Is Enhanced by Serum Biomarkers. Am J Respir Crit Care Med 2015;191:1403-12. [PMID: 25822095 DOI: 10.1164/rccm.201411-1950OC] [Cited by in Crossref: 75] [Cited by in F6Publishing: 45] [Article Influence: 10.7] [Reference Citation Analysis]
9 Smith LJ, Ali I, Stone P, Smeeth L, Quint JK. Prognostic variables and scores identifying the last year of life in COPD: a systematic review protocol. BMJ Open 2016;6:e011677. [PMID: 27633634 DOI: 10.1136/bmjopen-2016-011677] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
10 Corlateanu A, Siafakas N, Botnaru V. Defining COPD: from simplistic approach to multilateral assessment of COPD. Curr Respir Care Rep 2012;1:177-82. [DOI: 10.1007/s13665-012-0023-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
11 de Torres JP, Casanova C, Pinto-Plata V, Varo N, Restituto P, Cordoba-Lanus E, Baz-Dávila R, Aguirre-Jaime A, Celli BR. Gender differences in plasma biomarker levels in a cohort of COPD patients: a pilot study. PLoS One 2011;6:e16021. [PMID: 21267454 DOI: 10.1371/journal.pone.0016021] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 3.2] [Reference Citation Analysis]
12 Politis J, Eastman P, Le B, Furler J, Irving L, Smallwood N. Managing Severe Chronic Breathlessness in Chronic Obstructive Pulmonary Disease Is Challenging for General Practitioners. Am J Hosp Palliat Care 2021;38:472-9. [PMID: 32940530 DOI: 10.1177/1049909120959061] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
13 Sepúlveda-Loyola W, Osadnik C, Phu S, Morita AA, Duque G, Probst VS. Diagnosis, prevalence, and clinical impact of sarcopenia in COPD: a systematic review and meta-analysis. J Cachexia Sarcopenia Muscle 2020;11:1164-76. [PMID: 32862514 DOI: 10.1002/jcsm.12600] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
14 Xi F, Wang Z, Qi Y, Brightwell R, Roberts P, Stewart A, Sim M, Wang W. Long-term effect of respiratory training for chronic obstructive pulmonary disease patients at an outpatient clinic: a randomised controlled trial. Clin Transl Med 2015;4:31. [PMID: 26458936 DOI: 10.1186/s40169-015-0073-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
15 Ho SC, Hsu MF, Kuo HP, Wang JY, Chen LF, Lee KY, Chuang HC. The relationship between anthropometric indicators and walking distance in patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 2015;10:1857-62. [PMID: 26392760 DOI: 10.2147/COPD.S87714] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
16 Wan ES, Cho MH, Boutaoui N, Klanderman BJ, Sylvia JS, Ziniti JP, Won S, Lange C, Pillai SG, Anderson WH, Kong X, Lomas DA, Bakke PS, Gulsvik A, Regan EA, Murphy JR, Make BJ, Crapo JD, Wouters EF, Celli BR, Silverman EK, DeMeo DL; Evaluation of Chronic Obstructive Pulmonary Disease Longitudinally to Identify Predictive Surrogate End-Points (ECLIPSE)., Norway-Bergen cohort., National Emphysema Treatment Trial., COPD Gene investigators. Genome-wide association analysis of body mass in chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 2011;45:304-10. [PMID: 21037115 DOI: 10.1165/rcmb.2010-0294OC] [Cited by in Crossref: 36] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
17 Silverman EK. Exacerbations in chronic obstructive pulmonary disease: do they contribute to disease progression? Proc Am Thorac Soc 2007;4:586-90. [PMID: 18073387 DOI: 10.1513/pats.200706-068TH] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
18 Kim HC, Kim TH, Rhee CK, Han M, Oh YM. Effects of inhaler therapy on mortality in patients with tuberculous destroyed lung and airflow limitation. Ther Clin Risk Manag 2019;15:377-87. [PMID: 30881003 DOI: 10.2147/TCRM.S194324] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
19 Riesco-Miranda JA, Solano-Reina S, Rábade-Castedo C, de Granda-Orive JI, Pastor-Esplá E, García-Rueda M, Callejas-Gonzalez FJ, Azpeitia-Anadón Á, Mas S, Jiménez-Ruiz CA. Certified Smoking Cessation Units in Spain: High Potential for Detection of Undiagnosed Chronic Obstructive Pulmonary Disease and Profile of Newly Diagnosed Cases. Int J Chron Obstruct Pulmon Dis 2021;16:443-50. [PMID: 33658774 DOI: 10.2147/COPD.S289097] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Chakrabarti B, Purkait S, Gun P, Moore VC, Choudhuri S, Zaman MJ, Warburton CJ, Calverley PM, Mukherjee R. Chronic airflow limitation in a rural Indian population: etiology and relationship to body mass index. Int J Chron Obstruct Pulmon Dis 2011;6:543-9. [PMID: 22069366 DOI: 10.2147/COPD.S24113] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
21 Gu W, Yuan Y, Yang H, Qi G, Jin X, Yan J. A bibliometric analysis of the 100 most influential papers on COPD. Int J Chron Obstruct Pulmon Dis 2015;10:667-76. [PMID: 25848243 DOI: 10.2147/COPD.S74911] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
22 Zieliński J. Six minute walking test: an old tool with new applications. Multidiscip Respir Med 2010;5:241-2. [PMID: 22958496 DOI: 10.1186/2049-6958-5-4-241] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
23 Budweiser S, Hitzl AP, Jörres RA, Schmidbauer K, Heinemann F, Pfeifer M. Health-related quality of life and long-term prognosis in chronic hypercapnic respiratory failure: a prospective survival analysis. Respir Res 2007;8:92. [PMID: 18086309 DOI: 10.1186/1465-9921-8-92] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 2.5] [Reference Citation Analysis]
24 Shavelle RM, Paculdo DR, Kush SJ, Mannino DM, Strauss DJ. Life expectancy and years of life lost in chronic obstructive pulmonary disease: findings from the NHANES III Follow-up Study. Int J Chron Obstruct Pulmon Dis 2009;4:137-48. [PMID: 19436692 DOI: 10.2147/copd.s5237] [Cited by in Crossref: 74] [Cited by in F6Publishing: 46] [Article Influence: 5.7] [Reference Citation Analysis]
25 Dal Negro RW. The socioeconomic status of subjects: a prominent feature contributing to the phenotypical approach to COPD. Respiration 2011;82:400-1. [PMID: 21849770 DOI: 10.1159/000330839] [Reference Citation Analysis]
26 Li SY, Li JS, Wang MH, Xie Y, Yu XQ, Sun ZK, Ma LJ, Zhang W, Zhang HL, Cao F, Pan YC. Effects of comprehensive therapy based on traditional Chinese medicine patterns in stable chronic obstructive pulmonary disease: a four-center, open-label, randomized, controlled study. BMC Complement Altern Med 2012;12:197. [PMID: 23107470 DOI: 10.1186/1472-6882-12-197] [Cited by in Crossref: 56] [Cited by in F6Publishing: 60] [Article Influence: 5.6] [Reference Citation Analysis]
27 Tomohara-Ichishima H, Wakabayashi H, Maeda K, Nishioka S, Momosaki R. Relationship of body mass index on activities of daily living in hospitalized patients with chronic obstructive pulmonary disease. Respir Med Res 2022;81:100899. [PMID: 35523042 DOI: 10.1016/j.resmer.2022.100899] [Reference Citation Analysis]
28 Oh EG, Yoo JY. Progression of erectile function in men with chronic obstructive pulmonary disease: a cohort study. BMC Pulm Med 2019;19:139. [PMID: 31474221 DOI: 10.1186/s12890-019-0902-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
29 Kim SJ, Lee J, Park YS, Lee CH, Lee SM, Yim JJ, Kim YW, Han SK, Yoo CG. Effect of airflow limitation on acute exacerbations in patients with destroyed lungs by tuberculosis. J Korean Med Sci 2015;30:737-42. [PMID: 26028926 DOI: 10.3346/jkms.2015.30.6.737] [Cited by in Crossref: 3] [Cited by in F6Publishing: 10] [Article Influence: 0.4] [Reference Citation Analysis]
30 Regueiro EM, Di Lorenzo VA, Basso RP, Pessoa BV, Jamami M, Costa D. Relationship of BODE Index to functional tests in chronic obstructive pulmonary disease. Clinics (Sao Paulo) 2009;64:983-8. [PMID: 19841705 DOI: 10.1590/S1807-59322009001000008] [Cited by in Crossref: 19] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
31 Papadimos TJ, Maldonado Y, Tripathi RS, Kothari DS, Rosenberg AL. An overview of end-of-life issues in the intensive care unit. Int J Crit Illn Inj Sci 2011;1:138-46. [PMID: 22229139 DOI: 10.4103/2229-5151.84801] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
32 Conte ME, Pedone C, Forastiere F, Bellia V, Antonelli-Incalzi R. Discriminative and predictive properties of disease-specific and generic health status indexes in elderly COPD patients. BMC Pulm Med 2008;8:14. [PMID: 18700955 DOI: 10.1186/1471-2466-8-14] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
33 Omachi TA, Katz PP, Yelin EH, Gregorich SE, Iribarren C, Blanc PD, Eisner MD. Depression and health-related quality of life in chronic obstructive pulmonary disease. Am J Med 2009;122:778.e9-15. [PMID: 19635280 DOI: 10.1016/j.amjmed.2009.01.036] [Cited by in Crossref: 63] [Cited by in F6Publishing: 72] [Article Influence: 4.8] [Reference Citation Analysis]
34 Córdoba-Lanús E, Baz-Dávila R, de-Torres JP, Rodríguez-Pérez MC, Maca-Meyer N, Varo N, Medina-Coello C, Aguirre-Jaime A, Casanova C. TNFA-863 polymorphism is associated with a reduced risk of chronic obstructive pulmonary disease: a replication study. BMC Med Genet 2011;12:132. [PMID: 21985478 DOI: 10.1186/1471-2350-12-132] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
35 Pfeifer M. [New therapeutic approaches to COPD]. Internist (Berl) 2004;45:1395-401. [PMID: 15517127 DOI: 10.1007/s00108-004-1293-5] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
36 Wada H, Ikeda A, Maruyama K, Yamagishi K, Barnes PJ, Tanigawa T, Tamakoshi A, Iso H. Low BMI and weight loss aggravate COPD mortality in men, findings from a large prospective cohort: the JACC study. Sci Rep 2021;11:1531. [PMID: 33452329 DOI: 10.1038/s41598-020-79860-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
37 de-Torres JP, Marín JM, Pinto-Plata V, Divo M, Sanchez-Salcedo P, Zagaceta J, Zulueta JJ, Berto J, Cabrera C, Celli BR, Casanova C. Is COPD a Progressive Disease? A Long Term Bode Cohort Observation. PLoS One 2016;11:e0151856. [PMID: 27100872 DOI: 10.1371/journal.pone.0151856] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
38 Witt LJ, Spacht WA, Carey KA, Arora VM, White SR, Huisingh-Scheetz M, Press VG. Weak Handgrip at Index Admission for Acute Exacerbation of COPD Predicts All-Cause 30-Day Readmission. Front Med (Lausanne) 2021;8:611989. [PMID: 33898475 DOI: 10.3389/fmed.2021.611989] [Reference Citation Analysis]
39 Wu SM, Sun WL, Lee KY, Lin CW, Feng PH, Chuang HC, Ho SC, Chen KY, Chen TT, Liu WT, Tseng CH, Bamodu OA. Determinants of Pulmonary Emphysema Severity in Taiwanese Patients with Chronic Obstructive Pulmonary Disease: An Integrated Epigenomic and Air Pollutant Analysis. Biomedicines 2021;9:1833. [PMID: 34944649 DOI: 10.3390/biomedicines9121833] [Reference Citation Analysis]
40 Chuang C. Transition of patients with COPD across different care settings: challenges and opportunities for hospitalists. Hosp Pract (1995) 2012;40:176-85. [PMID: 22406893 DOI: 10.3810/hp.2012.02.958] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
41 Ozsoy I, Ozcan Kahraman B, Ozsoy G, Ilcin N, Kahraman T, Acar S, Tekin N, Savci S. Determinants of the 6-minute pegboard and ring test as an unsupported upper-extremity exercise capacity measure in older adults with chronic obstructive pulmonary disease. Eur Geriatr Med 2018;9:863-70. [PMID: 34674474 DOI: 10.1007/s41999-018-0111-x] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
42 Agustí A, Antó JM, Auffray C, Barbé F, Barreiro E, Dorca J, Escarrabill J, Faner R, Furlong LI, Garcia-Aymerich J, Gea J, Lindmark B, Monsó E, Plaza V, Puhan MA, Roca J, Ruiz-Manzano J, Sampietro-Colom L, Sanz F, Serrano L, Sharpe J, Sibila O, Silverman EK, Sterk PJ, Sznajder JI. Personalized respiratory medicine: exploring the horizon, addressing the issues. Summary of a BRN-AJRCCM workshop held in Barcelona on June 12, 2014. Am J Respir Crit Care Med 2015;191:391-401. [PMID: 25531178 DOI: 10.1164/rccm.201410-1935PP] [Cited by in Crossref: 43] [Cited by in F6Publishing: 19] [Article Influence: 6.1] [Reference Citation Analysis]
43 Raju SV, Jackson PL, Courville CA, McNicholas CM, Sloane PA, Sabbatini G, Tidwell S, Tang LP, Liu B, Fortenberry JA, Jones CW, Boydston JA, Clancy JP, Bowen LE, Accurso FJ, Blalock JE, Dransfield MT, Rowe SM. Cigarette smoke induces systemic defects in cystic fibrosis transmembrane conductance regulator function. Am J Respir Crit Care Med 2013;188:1321-30. [PMID: 24040746 DOI: 10.1164/rccm.201304-0733OC] [Cited by in Crossref: 108] [Cited by in F6Publishing: 74] [Article Influence: 13.5] [Reference Citation Analysis]
44 Chen Y, Li T, Li C, Lin S, Fu P. Statins Associated with Better Long-Term Outcomes in Aged Hospitalized Patients with COPD: A Real-World Experience from Pay-for-Performance Program. JPM 2022;12:299. [DOI: 10.3390/jpm12020299] [Reference Citation Analysis]
45 Yan X, Xu L, Shi B, Wang H, Xu X, Xu G. Epidemiology and risk factors of chronic obstructive pulmonary disease in Suzhou: a population-based cross-sectional study. J Thorac Dis 2020;12:5347-56. [PMID: 33209368 DOI: 10.21037/jtd-20-1616] [Reference Citation Analysis]
46 Zemans RL, Jacobson S, Keene J, Kechris K, Miller BE, Tal-Singer R, Bowler RP. Multiple biomarkers predict disease severity, progression and mortality in COPD. Respir Res 2017;18:117. [PMID: 28610627 DOI: 10.1186/s12931-017-0597-7] [Cited by in Crossref: 44] [Cited by in F6Publishing: 44] [Article Influence: 8.8] [Reference Citation Analysis]
47 Kocks JW, Kerstjens HA, Snijders SL, de Vos B, Biermann JJ, van Hengel P, Strijbos JH, Bosveld HE, van der Molen T. Health status in routine clinical practice: validity of the clinical COPD questionnaire at the individual patient level. Health Qual Life Outcomes 2010;8:135. [PMID: 21080960 DOI: 10.1186/1477-7525-8-135] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 2.2] [Reference Citation Analysis]
48 Mohan A, Sharma M, Uniyal A, Borah R, Luthra K, Pandey RM, Madan K, Hadda V, Guleria R. Variability in proteinase-antiproteinase balance, nutritional status, and quality of life in stable chronic obstructive pulmonary disease due to tobacco and nontobacco etiology. Lung India 2016;33:605-10. [PMID: 27890988 DOI: 10.4103/0970-2113.192859] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
49 Alameri HF, Sanai FM, Al Dukhayil M, Azzam NA, Al-Swat KA, Hersi AS, Abdo AA. Six Minute Walk Test to assess functional capacity in chronic liver disease patients. World J Gastroenterol 2007; 13(29): 3996-4001 [PMID: 17663517 DOI: 10.3748/wjg.v13.i29.3996] [Cited by in CrossRef: 60] [Cited by in F6Publishing: 53] [Article Influence: 4.0] [Reference Citation Analysis]
50 Chu CM, Chan VL, Lin AW, Wong IW, Leung WS, Lai CK. Readmission rates and life threatening events in COPD survivors treated with non-invasive ventilation for acute hypercapnic respiratory failure. Thorax 2004;59:1020-5. [PMID: 15563699 DOI: 10.1136/thx.2004.024307] [Cited by in Crossref: 123] [Cited by in F6Publishing: 110] [Article Influence: 6.8] [Reference Citation Analysis]
51 Han MK, Agusti A, Calverley PM, Celli BR, Criner G, Curtis JL, Fabbri LM, Goldin JG, Jones PW, Macnee W, Make BJ, Rabe KF, Rennard SI, Sciurba FC, Silverman EK, Vestbo J, Washko GR, Wouters EF, Martinez FJ. Chronic obstructive pulmonary disease phenotypes: the future of COPD. Am J Respir Crit Care Med 2010;182:598-604. [PMID: 20522794 DOI: 10.1164/rccm.200912-1843CC] [Cited by in Crossref: 586] [Cited by in F6Publishing: 297] [Article Influence: 48.8] [Reference Citation Analysis]
52 Deng D, Zhou A, Chen P, Shuang Q. CODEXS: A New Multidimensional Index to Better Predict Frequent COPD Exacerbators with Inclusion of Depression Score. Int J Chron Obstruct Pulmon Dis 2020;15:249-59. [PMID: 32099350 DOI: 10.2147/COPD.S237545] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
53 Liu SF, Chin CH, Tseng CW, Chen YC, Kuo HC. Exertional Desaturation Has Higher Mortality Than Non-Desaturation in COPD. Medicina (Kaunas) 2021;57:1110. [PMID: 34684147 DOI: 10.3390/medicina57101110] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
54 Tannus-Silva DG, Masson-Silva JB, Ribeiro LS, Conde MB, Rabahi MF. Myocardial performance index correlates with the BODE index and affects quality of life in COPD patients. Int J Chron Obstruct Pulmon Dis 2016;11:2261-8. [PMID: 27695314 DOI: 10.2147/COPD.S110779] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
55 Boeck L, Soriano JB, Brusse-Keizer M, Blasi F, Kostikas K, Boersma W, Milenkovic B, Louis R, Lacoma A, Djamin R, Aerts J, Torres A, Rohde G, Welte T, Martinez-Camblor P, Rakic J, Scherr A, Koller M, van der Palen J, Marin JM, Alfageme I, Almagro P, Casanova C, Esteban C, Soler-Cataluña JJ, de-Torres JP, Miravitlles M, Celli BR, Tamm M, Stolz D. Prognostic assessment in COPD without lung function: the B-AE-D indices. Eur Respir J 2016;47:1635-44. [PMID: 27103389 DOI: 10.1183/13993003.01485-2015] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 4.0] [Reference Citation Analysis]
56 Guerra B, Haile SR, Lamprecht B, Ramírez AS, Martinez-Camblor P, Kaiser B, Alfageme I, Almagro P, Casanova C, Esteban-González C, Soler-Cataluña JJ, de-Torres JP, Miravitlles M, Celli BR, Marin JM, Ter Riet G, Sobradillo P, Lange P, Garcia-Aymerich J, Antó JM, Turner AM, Han MK, Langhammer A, Leivseth L, Bakke P, Johannessen A, Oga T, Cosio B, Ancochea-Bermúdez J, Echazarreta A, Roche N, Burgel PR, Sin DD, Soriano JB, Puhan MA; 3CIA collaboration. Large-scale external validation and comparison of prognostic models: an application to chronic obstructive pulmonary disease. BMC Med 2018;16:33. [PMID: 29495970 DOI: 10.1186/s12916-018-1013-y] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
57 Vaz Fragoso CA, Concato J, McAvay G, Van Ness PH, Rochester CL, Yaggi HK, Gill TM. Chronic obstructive pulmonary disease in older persons: A comparison of two spirometric definitions. Respir Med 2010;104:1189-96. [PMID: 20199857 DOI: 10.1016/j.rmed.2009.10.030] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 2.9] [Reference Citation Analysis]
58 De Ramón Fernández A, Ruiz Fernández D, Marcos-Jorquera D, Gilart Iglesias V. Support System for Early Diagnosis of Chronic Obstructive Pulmonary Disease Based on the Service-Oriented Architecture Paradigm and Business Process Management Strategy: Development and Usability Survey Among Patients and Health Care Providers. J Med Internet Res 2020;22:e17161. [PMID: 32181744 DOI: 10.2196/17161] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
59 Pedone C, Scarlata S, Sorino C, Forastiere F, Bellia V, Antonelli Incalzi R. Does mild COPD affect prognosis in the elderly? BMC Pulm Med 2010;10:35. [PMID: 20529281 DOI: 10.1186/1471-2466-10-35] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
60 Dávalos-Yerovi V, Marco E, Sánchez-Rodríguez D, Duran X, Meza-Valderrama D, Rodríguez DA, Muñoz E, Tejero-Sánchez M, Muns MD, Guillén-Solà A, Duarte E. Malnutrition According to GLIM Criteria Is Associated with Mortality and Hospitalizations in Rehabilitation Patients with Stable Chronic Obstructive Pulmonary Disease. Nutrients 2021;13:369. [PMID: 33530364 DOI: 10.3390/nu13020369] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
61 Silva DR, Gazzana MB, Knorst MM. C-reactive protein levels in stable COPD patients: a case-control study. Int J Chron Obstruct Pulmon Dis 2015;10:1719-25. [PMID: 26357470 DOI: 10.2147/COPD.S87015] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 0.9] [Reference Citation Analysis]
62 Mueller JA, Martini K, Eberhard M, Mueller MA, De Silvestro AA, Breiding P, Frauenfelder T. Diagnostic Performance of Dual-Energy Subtraction Radiography for the Detection of Pulmonary Emphysema: An Intra-Individual Comparison. Diagnostics (Basel) 2021;11:1849. [PMID: 34679547 DOI: 10.3390/diagnostics11101849] [Reference Citation Analysis]
63 Nathan S. Lung transplant candidate selection and clinical outcomes: strategies for improvement in prioritization: . Current Opinion in Organ Transplantation 2005;10:216-20. [DOI: 10.1097/01.mot.0000169367.38261.34] [Reference Citation Analysis]
64 Marron RM, Zheng M, Fernandez Romero G, Zhao H, Patel R, Leopold I, Thomas A, Standiford T, Kumaran M, Patlakh N, Stewart J, Criner GJ; and the Temple University COVID-19 Research Group. Impact of Chronic Obstructive Pulmonary Disease and Emphysema on Outcomes of Hospitalized Patients with Coronavirus Disease 2019 Pneumonia. Chronic Obstr Pulm Dis 2021;8:255-68. [PMID: 33780602 DOI: 10.15326/jcopdf.2020.0200] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
65 Trudzinski FC, Jörres RA, Alter P, Kahnert K, Waschki B, Herr C, Kellerer C, Omlor A, Vogelmeier CF, Fähndrich S, Watz H, Welte T, Jany B, Söhler S, Biertz F, Herth F, Kauczor HU, Bals R; COSYCONET consortium. Associations of oxygenated hemoglobin with disease burden and prognosis in stable COPD: Results from COSYCONET. Sci Rep 2020;10:10544. [PMID: 32601330 DOI: 10.1038/s41598-020-67197-x] [Reference Citation Analysis]
66 da Silva SM, Paschoal IA, De Capitani EM, Moreira MM, Palhares LC, Pereira MC. COPD phenotypes on computed tomography and its correlation with selected lung function variables in severe patients. Int J Chron Obstruct Pulmon Dis. 2016;11:503-513. [PMID: 27042039 DOI: 10.2147/copd.s90638] [Cited by in Crossref: 19] [Cited by in F6Publishing: 11] [Article Influence: 3.2] [Reference Citation Analysis]
67 McDonald MN, Wouters EFM, Rutten E, Casaburi R, Rennard SI, Lomas DA, Bamman M, Celli B, Agusti A, Tal-Singer R, Hersh CP, Dransfield M, Silverman EK. It's more than low BMI: prevalence of cachexia and associated mortality in COPD. Respir Res 2019;20:100. [PMID: 31118043 DOI: 10.1186/s12931-019-1073-3] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 9.0] [Reference Citation Analysis]
68 Holmedahl NH, Øverland B, Fondenes O, Ellingsen I, Hardie JA. Sleep hypoventilation and daytime hypercapnia in stable chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 2014;9:265-75. [PMID: 24600219 DOI: 10.2147/COPD.S57576] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 1.9] [Reference Citation Analysis]
69 Roca B, Almagro P, López F, Cabrera FJ, Montero L, Morchón D, Díez J, de la Iglesia F, Fernández M, Castiella J, Zubillaga E, Recio J, Soriano JB; ECCO Working Group on COPD., Spanish Society of Internal Medicine. Factors associated with mortality in patients with exacerbation of chronic obstructive pulmonary disease hospitalized in General Medicine departments. Intern Emerg Med 2011;6:47-54. [PMID: 20886377 DOI: 10.1007/s11739-010-0465-7] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
70 Sharp C, Adamali HI, Millar AB. A comparison of published multidimensional indices to predict outcome in idiopathic pulmonary fibrosis. ERJ Open Res 2017;3:00096-2016. [PMID: 28326312 DOI: 10.1183/23120541.00096-2016] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
71 Kesten S, Celli B, Decramer M, Liu D, Tashkin D. Adverse health consequences in COPD patients with rapid decline in FEV1--evidence from the UPLIFT trial. Respir Res 2011;12:129. [PMID: 21955733 DOI: 10.1186/1465-9921-12-129] [Cited by in Crossref: 14] [Cited by in F6Publishing: 18] [Article Influence: 1.3] [Reference Citation Analysis]
72 Omachi TA, Katz PP, Yelin EH, Iribarren C, Knight SJ, Blanc PD, Eisner MD. The COPD Helplessness Index: a new tool to measure factors affecting patient self-management. Chest 2010;137:823-30. [PMID: 19837823 DOI: 10.1378/chest.09-0764] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
73 Kim DK, Jacobson FL, Washko GR, Casaburi R, Make BJ, Crapo JD, Silverman EK, Hersh CP. Clinical and radiographic correlates of hypoxemia and oxygen therapy in the COPDGene study. Respir Med 2011;105:1211-21. [PMID: 21396809 DOI: 10.1016/j.rmed.2011.02.015] [Cited by in Crossref: 21] [Cited by in F6Publishing: 27] [Article Influence: 1.9] [Reference Citation Analysis]
74 Koo HK, Park JH, Park HK, Jung H, Lee SS. Conflicting role of sarcopenia and obesity in male patients with chronic obstructive pulmonary disease: Korean National Health and Nutrition Examination Survey. PLoS One 2014;9:e110448. [PMID: 25353344 DOI: 10.1371/journal.pone.0110448] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.8] [Reference Citation Analysis]
75 Maury J, Gouzi F, De Rigal P, Heraud N, Pincemail J, Molinari N, Pomiès P, Laoudj-Chenivesse D, Mercier J, Préfaut C, Hayot M. Heterogeneity of Systemic Oxidative Stress Profiles in COPD: A Potential Role of Gender. Oxid Med Cell Longev 2015;2015:201843. [PMID: 26167238 DOI: 10.1155/2015/201843] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
76 Tousignant M, Marquis N, Pagé C, Imukuze N, Métivier A, St-Onge V, Tremblay A. In-home Telerehabilitation for Older Persons with Chronic Obstructive Pulmonary Disease: A Pilot Study. Int J Telerehabil 2012;4:7-14. [PMID: 25945192 DOI: 10.5195/ijt.2012.6083] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
77 Bulcun E, Ekici M, Ekici A. Assessment of patients' preferences regarding the characteristics associated with the treatment of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 2014;9:363-8. [PMID: 24790426 DOI: 10.2147/COPD.S56229] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
78 Lamprecht B, Mahringer A, Soriano JB, Kaiser B, Buist AS, Studnicka M. Is spirometry properly used to diagnose COPD? Results from the BOLD study in Salzburg, Austria: a population-based analytical study. Prim Care Respir J 2013;22:195-200. [PMID: 23538703 DOI: 10.4104/pcrj.2013.00032] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
79 Kalaycıoğlu E, Gökdeniz T, Aykan AÇ, Hatem E, Gürsoy MO, Toksoy F, Dursun I, Çelik S. Evaluation of Left Ventricular Function and its Relationship With Multidimensional Grading System (BODE Index) in Patients With COPD. COPD 2015;12:568-74. [PMID: 26457459 DOI: 10.3109/15412555.2015.1008692] [Cited by in Crossref: 3] [Article Influence: 0.4] [Reference Citation Analysis]
80 Kamath S, Kumar A, Panda SK, Samanta RP. Correlation of BODE index with quality of life in stable Chronic Obstructive Pulmonary Disease (COPD) patients - A prospective study. J Family Med Prim Care 2020;9:5606-13. [PMID: 33532403 DOI: 10.4103/jfmpc.jfmpc_735_20] [Reference Citation Analysis]
81 Cosentino ER, Landolfo M, Bentivenga C, Spinardi L, Esposti DD, Cicero AF, Miceli R, Bui V, Berardi E, Borghi C. Morbidity and mortality in a population of patients affected by heart failure and chronic obstructive pulmonary disease: an observational study. BMC Cardiovasc Disord 2019;19:20. [PMID: 30651063 DOI: 10.1186/s12872-018-0986-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
82 Tabberer M, Benson VS, Gelhorn H, Wilson H, Karlsson N, Müllerova H, Menjoge S, Rennard SI, Tal-Singer R, Merrill D, Jones PW. The COPD Biomarkers Qualification Consortium Database: Baseline Characteristics of the St George's Respiratory Questionnaire Dataset. Chronic Obstr Pulm Dis 2017;4:112-23. [PMID: 28848920 DOI: 10.15326/jcopdf.4.2.2017.0128] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
83 Cutaia M, Brehm R, Cohen M. The relationship of the BODE index to oxygen saturation during daily activities in patients with chronic obstructive pulmonary disease. Lung 2011;189:269-77. [PMID: 21701832 DOI: 10.1007/s00408-011-9308-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
84 Kumar I, Verma A, Jain A, Agarwal SK. Performance of quantitative CT parameters in assessment of disease severity in COPD: A prospective study. Indian J Radiol Imaging 2018;28:99-106. [PMID: 29692536 DOI: 10.4103/ijri.IJRI_296_17] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
85 Serban KA, Pratte KA, Bowler RP. Protein Biomarkers for COPD Outcomes. Chest 2021;159:2244-53. [PMID: 33434499 DOI: 10.1016/j.chest.2021.01.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
86 de Carvalho Junior LCS, Trimer R, Zangrando KL, Arêas GPT, Caruso FR, Bonjorno Junior JC, Oliveira CR, Mendes R, Borghi-Silva A. Overlap syndrome: the coexistence of OSA further impairs cardiorespiratory fitness in COPD. Sleep Breath 2020;24:1451-62. [PMID: 31898188 DOI: 10.1007/s11325-019-02002-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
87 Labaki WW, Martinez CH, Martinez FJ, Galbán CJ, Ross BD, Washko GR, Barr RG, Regan EA, Coxson HO, Hoffman EA, Newell JD Jr, Curran-Everett D, Hogg JC, Crapo JD, Lynch DA, Kazerooni EA, Han MK. The Role of Chest Computed Tomography in the Evaluation and Management of the Patient with Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med 2017;196:1372-9. [PMID: 28661698 DOI: 10.1164/rccm.201703-0451PP] [Cited by in Crossref: 53] [Cited by in F6Publishing: 26] [Article Influence: 10.6] [Reference Citation Analysis]
88 McDonald VM, Higgins I, Gibson PG. Managing older patients with coexistent asthma and chronic obstructive pulmonary disease: diagnostic and therapeutic challenges. Drugs Aging 2013;30:1-17. [PMID: 23229768 DOI: 10.1007/s40266-012-0042-z] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 2.8] [Reference Citation Analysis]
89 Roche O, Deguiz ML, Tiana M, Galiana-Ribote C, Martinez-Alcazar D, Rey-Serra C, Ranz-Ribeiro B, Casitas R, Galera R, Fernández-Navarro I, Sánchez-Cuéllar S, Bernard V, Ancochea J, Wasserman WW, García-Rio F, Jimenez B, Del Peso L. Identification of non-coding genetic variants in samples from hypoxemic respiratory disease patients that affect the transcriptional response to hypoxia. Nucleic Acids Res 2016;44:9315-30. [PMID: 27625398 DOI: 10.1093/nar/gkw811] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
90 Han MK, Muellerova H, Curran-Everett D, Dransfield MT, Washko GR, Regan EA, Bowler RP, Beaty TH, Hokanson JE, Lynch DA, Jones PW, Anzueto A, Martinez FJ, Crapo JD, Silverman EK, Make BJ. GOLD 2011 disease severity classification in COPDGene: a prospective cohort study. Lancet Respir Med 2013;1:43-50. [PMID: 24321803 DOI: 10.1016/S2213-2600(12)70044-9] [Cited by in Crossref: 129] [Cited by in F6Publishing: 90] [Article Influence: 12.9] [Reference Citation Analysis]
91 Rahaghi FF, Monk R, Ramakrishnan V, Beiko T, Strange C. Alpha-1 Antitrypsin Augmentation Therapy Improves Survival in Severely Deficient Patients with Predicted FEV1 Between 10% and 60%: A Retrospective Analysis of the NHLBI Alpha-1 Antitrypsin Deficiency Registry. Int J Chron Obstruct Pulmon Dis 2020;15:3193-9. [PMID: 33299307 DOI: 10.2147/COPD.S263725] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
92 Stringer WW, Porszasz J, Bhatt SP, McCormack MC, Make BJ, Casaburi R. Physiologic Insights from the COPD Genetic Epidemiology Study. Chronic Obstr Pulm Dis 2019;6:256-66. [PMID: 31342731 DOI: 10.15326/jcopdf.6.3.2019.0128] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
93 Nápolis LM, Dal Corso S, Neder JA, Malaguti C, Gimenes AC, Nery LE. Neuromuscular electrical stimulation improves exercise tolerance in chronic obstructive pulmonary disease patients with better preserved fat-free mass. Clinics (Sao Paulo) 2011;66:401-6. [PMID: 21552662 DOI: 10.1590/s1807-59322011000300006] [Cited by in Crossref: 21] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
94 Al-Mudares F, Reddick S, Ren J, Venkatesh A, Zhao C, Lingappan K. Role of Growth Differentiation Factor 15 in Lung Disease and Senescence: Potential Role Across the Lifespan. Front Med (Lausanne) 2020;7:594137. [PMID: 33344478 DOI: 10.3389/fmed.2020.594137] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
95 Crisafulli E, Venturelli E, Biscione G, Vagheggini G, Iattoni A, Lucic S, Ambrosino N, Pasqua F, Cesario A, Clini EM. Exercise performance after standard rehabilitation in COPD patients with lung hyperinflation. Intern Emerg Med 2014;9:23-31. [PMID: 22113504 DOI: 10.1007/s11739-011-0727-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
96 Chin AT, Rylance J, Makumbirofa S, Meffert S, Vu T, Clayton J, Mason P, Woodruff P, Metcalfe J. Chronic lung disease in adult recurrent tuberculosis survivors in Zimbabwe: a cohort study. Int J Tuberc Lung Dis 2019;23:203-11. [PMID: 30808453 DOI: 10.5588/ijtld.18.0313] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
97 Mani S, Norel X, Varret M, Bchir S, Ben Anes A, Garrouch A, Tabka Z, Longrois D, Chahed K. Polymorphisms rs2745557 in PTGS2 and rs2075797 in PTGER2 are associated with the risk of chronic obstructive pulmonary disease development in a Tunisian cohort. Prostaglandins Leukot Essent Fatty Acids 2021;166:102252. [PMID: 33545665 DOI: 10.1016/j.plefa.2021.102252] [Reference Citation Analysis]
98 Blervaque L, Préfaut C, Forthin H, Maffre F, Bourrelier M, Héraud N, Catteau M, Pomiès P, Jaffuel D, Molinari N, Hayot M, Gouzi F. Efficacy of a long-term pulmonary rehabilitation maintenance program for COPD patients in a real-life setting: a 5-year cohort study. Respir Res 2021;22:79. [PMID: 33691702 DOI: 10.1186/s12931-021-01674-3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
99 Pirard L, Marchand E. Reassessing the BODE score as a criterion for listing COPD patients for lung transplantation. Int J Chron Obstruct Pulmon Dis 2018;13:3963-70. [PMID: 30573956 DOI: 10.2147/COPD.S182483] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
100 Klein SR, Gulart AA, Venâncio RS, Munari AB, Gavenda SG, Martins ACB, Mayer AF. Performance difference on the six-minute walk test on tracks of 20 and 30 meters for patients with chronic obstructive pulmonary disease: validity and reliability. Braz J Phys Ther 2021;25:40-7. [PMID: 32007324 DOI: 10.1016/j.bjpt.2020.01.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
101 Gudmundsson G, Gislason T, Lindberg E, Hallin R, Ulrik CS, Brøndum E, Nieminen MM, Aine T, Bakke P, Janson C. Mortality in COPD patients discharged from hospital: the role of treatment and co-morbidity. Respir Res 2006;7:109. [PMID: 16914029 DOI: 10.1186/1465-9921-7-109] [Cited by in Crossref: 75] [Cited by in F6Publishing: 70] [Article Influence: 4.7] [Reference Citation Analysis]
102 Moberg M, Vestbo J, Martinez G, Lange P, Ringbaek T. Prognostic value of C-reactive protein, leukocytes, and vitamin d in severe chronic obstructive pulmonary disease. ScientificWorldJournal 2014;2014:140736. [PMID: 24587707 DOI: 10.1155/2014/140736] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
103 Nowak C, Sievi NA, Clarenbach CF, Schwarz EI, Schlatzer C, Brack T, Brutsche M, Frey M, Irani S, Leuppi JD, Rüdiger J, Thurnheer R, Kohler M. Accuracy of the Hospital Anxiety and Depression Scale for identifying depression in chronic obstructive pulmonary disease patients. Pulm Med 2014;2014:973858. [PMID: 25548667 DOI: 10.1155/2014/973858] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
104 Esteban C, Moraza J, Iriberri M, Aguirre U, Goiria B, Quintana JM, Aburto M, Capelastegui A. Outcomes of a telemonitoring-based program (telEPOC) in frequently hospitalized COPD patients. Int J Chron Obstruct Pulmon Dis 2016;11:2919-30. [PMID: 27920519 DOI: 10.2147/COPD.S115350] [Cited by in Crossref: 16] [Cited by in F6Publishing: 4] [Article Influence: 2.7] [Reference Citation Analysis]
105 Espantoso-Romero M, Román Rodríguez M, Duarte-Pérez A, Gonzálvez-Rey J, Callejas-Cabanillas PA, Lazic DK, Anta-Agudo B, Torán Monserrat P, Magallon-Botaya R, Gerasimovska Kitanovska B, Lingner H, Assenova RS, Iftode C, Gude-Sampedro F, Clavería A; PROEPOC/COPD study group. External validation of multidimensional prognostic indices (ADO, BODEx and DOSE) in a primary care international cohort (PROEPOC/COPD cohort). BMC Pulm Med 2016;16:143. [PMID: 27835945 DOI: 10.1186/s12890-016-0305-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
106 Balasubramanian A, Kolb TM, Damico RL, Hassoun PM, McCormack MC, Mathai SC. Diffusing Capacity Is an Independent Predictor of Outcomes in Pulmonary Hypertension Associated With COPD. Chest 2020;158:722-34. [PMID: 32184109 DOI: 10.1016/j.chest.2020.02.047] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
107 Slok AH, in 't Veen JC, Chavannes NH, van der Molen T, Rutten-van Mölken MP, Kerstjens HA, Salomé PL, Holverda S, Dekhuijzen PN, Schuiten D, Asijee GM, van Schayck OC. Development of the Assessment of Burden of COPD tool: an integrated tool to measure the burden of COPD. NPJ Prim Care Respir Med 2014;24:14021. [PMID: 25010353 DOI: 10.1038/npjpcrm.2014.21] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
108 Vestbo J. Editorial: Risk Prediction in Smokers. Chronic Obstr Pulm Dis 2020;7:297-9. [PMID: 33108108 DOI: 10.15326/jcopdf.7.4.2020.0174] [Reference Citation Analysis]
109 Sava F, Laviolette L, Bernard S, Breton MJ, Bourbeau J, Maltais F. The impact of obesity on walking and cycling performance and response to pulmonary rehabilitation in COPD. BMC Pulm Med 2010;10:55. [PMID: 21054892 DOI: 10.1186/1471-2466-10-55] [Cited by in Crossref: 52] [Cited by in F6Publishing: 49] [Article Influence: 4.3] [Reference Citation Analysis]
110 Zhou Y, Bruijnzeel PL, McCrae C, Zheng J, Nihlen U, Zhou R, Van Geest M, Nilsson A, Hadzovic S, Huhn M, Taib Z, Gu Y, Xie J, Ran P, Chen R, Zhong N. Study on risk factors and phenotypes of acute exacerbations of chronic obstructive pulmonary disease in Guangzhou, China-design and baseline characteristics. J Thorac Dis 2015;7:720-33. [PMID: 25973239 DOI: 10.3978/j.issn.2072-1439.2015.04.14] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
111 Veljanovski J, Ouellette DR. Risk factors for respiratory hospitalizations in a population of patients with a clinical diagnosis of COPD. Int J Chron Obstruct Pulmon Dis 2018;13:1061-9. [PMID: 29681729 DOI: 10.2147/COPD.S157230] [Reference Citation Analysis]
112 Weill D. Lung transplantation: indications and contraindications. J Thorac Dis 2018;10:4574-87. [PMID: 30174910 DOI: 10.21037/jtd.2018.06.141] [Cited by in Crossref: 26] [Cited by in F6Publishing: 17] [Article Influence: 6.5] [Reference Citation Analysis]
113 Mirrakhimov AE. Chronic obstructive pulmonary disease and glucose metabolism: a bitter sweet symphony. Cardiovasc Diabetol 2012;11:132. [PMID: 23101436 DOI: 10.1186/1475-2840-11-132] [Cited by in Crossref: 70] [Cited by in F6Publishing: 60] [Article Influence: 7.0] [Reference Citation Analysis]
114 Gainza-Miranda D, Sanz-Peces EM, Alonso-Babarro A, Varela-Cerdeira M, Prados-Sánchez C, Vega-Aleman G, Rodriguez-Barrientos R, Polentinos-Castro E. Breaking Barriers: Prospective Study of a Cohort of Advanced Chronic Obstructive Pulmonary Disease Patients To Describe Their Survival and End-of-Life Palliative Care Requirements. J Palliat Med 2019;22:290-6. [PMID: 30388050 DOI: 10.1089/jpm.2018.0363] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
115 Verberkt CA, van den Beuken-van Everdingen MHJ, Schols JMGA, Hameleers N, Wouters EFM, Janssen DJA. Effect of Sustained-Release Morphine for Refractory Breathlessness in Chronic Obstructive Pulmonary Disease on Health Status: A Randomized Clinical Trial. JAMA Intern Med 2020;180:1306-14. [PMID: 32804188 DOI: 10.1001/jamainternmed.2020.3134] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 12.0] [Reference Citation Analysis]
116 Cabrera C, Casanova C, Martín Y, Mirabal V, Sánchez Mdel C, Álvarez F, Juliá G, Cabrera-Navarro P, García-Bello MÁ, Marín JM, de-Torres JP, Divo M, Celli B. Agreement between a simple dyspnea-guided treatment algorithm for stable COPD and the GOLD guidelines: a pilot study. Int J Chron Obstruct Pulmon Dis 2016;11:1217-22. [PMID: 27354780 DOI: 10.2147/COPD.S100853] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
117 Katz P, Iribarren C, Sanchez G, Blanc PD. Obesity and Functioning Among Individuals with Chronic Obstructive Pulmonary Disease (COPD). COPD 2016;13:352-9. [PMID: 26683222 DOI: 10.3109/15412555.2015.1087991] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
118 Eisner MD, Blanc PD, Omachi TA, Yelin EH, Sidney S, Katz PP, Ackerson LM, Sanchez G, Tolstykh I, Iribarren C. Socioeconomic status, race and COPD health outcomes. J Epidemiol Community Health 2011;65:26-34. [PMID: 19854747 DOI: 10.1136/jech.2009.089722] [Cited by in Crossref: 117] [Cited by in F6Publishing: 117] [Article Influence: 9.0] [Reference Citation Analysis]
119 Zagaceta J, Bastarrika G, Zulueta JJ, Colina I, Alcaide AB, Campo A, Divo M, Casanova C, Marin JM, Pinto-Plata VM, Celli BR, de-Torres JP. Prospective comparison of non-invasive risk markers of major cardiovascular events in COPD patients. Respir Res 2017;18:175. [PMID: 28962654 DOI: 10.1186/s12931-017-0658-y] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
120 Rea H, Kenealy T, Adair J, Robinson E, Sheridan N. Spirometry for patients in hospital and one month after admission with an acute exacerbation of COPD. Int J Chron Obstruct Pulmon Dis 2011;6:527-32. [PMID: 22069364 DOI: 10.2147/COPD.S24133] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 0.1] [Reference Citation Analysis]
121 Turino GM. Emphysema in COPD: consequences and causes. Thorax 2006;61:1031-2. [PMID: 17114369 DOI: 10.1136/thx.2006.066308] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
122 Au DH, Udris EM, Engelberg RA, Diehr PH, Bryson CL, Reinke LF, Curtis JR. A randomized trial to improve communication about end-of-life care among patients with COPD. Chest 2012;141:726-35. [PMID: 21940765 DOI: 10.1378/chest.11-0362] [Cited by in Crossref: 95] [Cited by in F6Publishing: 90] [Article Influence: 8.6] [Reference Citation Analysis]
123 Timofte I, Wijesinha M, Vesselinov R, Kim J, Reed R, Sanchez PG, Ladikos N, Pham S, Kon Z, Rajagopal K, Scharf SM, Wise R, Sternberg AL, Kaczorowski D, Griffith B, Terrin M, Iacono A. Survival benefit of lung transplantation compared with medical management and pulmonary rehabilitation for patients with end-stage COPD. ERJ Open Res 2020;6:00177-2019. [PMID: 32363207 DOI: 10.1183/23120541.00177-2019] [Reference Citation Analysis]
124 Kovarik M, Joskova V, Patkova A, Koblizek V, Zadak Z, Hronek M. Hand grip endurance test relates to clinical state and prognosis in COPD patients better than 6-minute walk test distance. Int J Chron Obstruct Pulmon Dis 2017;12:3429-35. [PMID: 29238187 DOI: 10.2147/COPD.S144566] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 2.2] [Reference Citation Analysis]
125 Dubé BP, Laveneziana P. Effects of aging and comorbidities on nutritional status and muscle dysfunction in patients with COPD. J Thorac Dis 2018;10:S1355-66. [PMID: 29928518 DOI: 10.21037/jtd.2018.02.20] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
126 de-Torres JP, Ezponda A, Alcaide AB, Campo A, Berto J, Gonzalez J, Zulueta JJ, Casanova C, Rodriguez-Delgado LE, Celli BR, Bastarrika G. Pulmonary arterial enlargement predicts long-term survival in COPD patients. PLoS One 2018;13:e0195640. [PMID: 29694376 DOI: 10.1371/journal.pone.0195640] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
127 Clarke H, Voss M. The role of a multidisciplinary student team in the community management of chronic obstructive pulmonary disease. Prim Health Care Res Dev 2016;17:415-20. [PMID: 26960978 DOI: 10.1017/S1463423616000013] [Reference Citation Analysis]
128 Huchon G. [Follow-up criteria for community acquired pneumonias and acute exacerbations of chronic obstructive pulmonary disease]. Med Mal Infect 2006;36:636-49. [PMID: 17137739 DOI: 10.1016/j.medmal.2006.10.005] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
129 Nguyen HQ, Donesky-Cuenco D, Wolpin S, Reinke LF, Benditt JO, Paul SM, Carrieri-Kohlman V. Randomized controlled trial of an internet-based versus face-to-face dyspnea self-management program for patients with chronic obstructive pulmonary disease: pilot study. J Med Internet Res 2008;10:e9. [PMID: 18417444 DOI: 10.2196/jmir.990] [Cited by in Crossref: 99] [Cited by in F6Publishing: 90] [Article Influence: 7.1] [Reference Citation Analysis]
130 Hook JL, Lederer DJ. Selecting lung transplant candidates: where do current guidelines fall short? Expert Rev Respir Med 2012;6:51-61. [PMID: 22283579 DOI: 10.1586/ers.11.83] [Cited by in Crossref: 49] [Cited by in F6Publishing: 47] [Article Influence: 4.9] [Reference Citation Analysis]
131 Klooster K, Hartman JE, Ten Hacken NH, Slebos DJ. One-Year Follow-Up after Endobronchial Valve Treatment in Patients with Emphysema without Collateral Ventilation Treated in the STELVIO Trial. Respiration 2017;93:112-21. [PMID: 27974713 DOI: 10.1159/000453529] [Cited by in Crossref: 20] [Cited by in F6Publishing: 28] [Article Influence: 3.3] [Reference Citation Analysis]
132 Ashmore J, Russo R, Peoples J, Sloan J, Jackson BE, Bae S, Singh KP, Blair SN, Coultas D. Chronic obstructive pulmonary disease self-management activation research trial (COPD-SMART): design and methods. Contemp Clin Trials 2013;35:77-86. [PMID: 23680985 DOI: 10.1016/j.cct.2013.05.004] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
133 Lee JH, Rhee CK, Kim K, Kim JA, Kim SH, Yoo KH, Kim WJ, Park YB, Park HY, Jung KS. Identification of subtypes in subjects with mild-to-moderate airflow limitation and its clinical and socioeconomic implications. Int J Chron Obstruct Pulmon Dis 2017;12:1135-44. [PMID: 28442900 DOI: 10.2147/COPD.S130140] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
134 Piper A, Song Y, Eves ND, Maher TM. Year in review 2013: Acute lung injury, interstitial lung diseases, sleep and physiology. Respirology 2014;19:428-37. [PMID: 24708032 DOI: 10.1111/resp.12254] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
135 Makita H, Suzuki M, Konno S, Shimizu K, Nasuhara Y, Nagai K, Akiyama Y, Fuke S, Saito H, Igarashi T, Takeyabu K, Nishimura M. Unique Mortality Profile in Japanese Patients with COPD: An Analysis from the Hokkaido COPD Cohort Study. Int J Chron Obstruct Pulmon Dis 2020;15:2081-90. [PMID: 32943861 DOI: 10.2147/COPD.S264437] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
136 Burkes RM, Gassett AJ, Ceppe AS, Anderson W, O'Neal WK, Woodruff PG, Krishnan JA, Barr RG, Han MK, Martinez FJ, Comellas AP, Lambert AA, Kaufman JD, Dransfield MT, Wells JM, Kanner RE, Paine R 3rd, Bleecker ER, Paulin LM, Hansel NN, Drummond MB; Current and former investigators of the SPIROMICS sites and reading centers. Rural Residence and Chronic Obstructive Pulmonary Disease Exacerbations. Analysis of the SPIROMICS Cohort. Ann Am Thorac Soc 2018;15:808-16. [PMID: 29584453 DOI: 10.1513/AnnalsATS.201710-837OC] [Cited by in Crossref: 14] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
137 Kapoor A, Matheos T, Walz M, McDonough C, Maheswaran A, Ruppell E, Mohamud D, Shaffer N, Zhou Y, Kaur S, Heard S, Crawford S, Cabral H, White DK, Santry H, Jette A, Fielding R, Silliman RA, Gurwitz J. Self-Reported Function More Informative than Frailty Phenotype in Predicting Adverse Postoperative Course in Older Adults. J Am Geriatr Soc 2017;65:2522-8. [PMID: 28926087 DOI: 10.1111/jgs.15108] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
138 Benzo R, Kelley GA, Recchi L, Hofman A, Sciurba F. Complications of lung resection and exercise capacity: a meta-analysis.Respir Med. 2007;101:1790-1797. [PMID: 17408941 DOI: 10.1016/j.rmed.2007.02.012] [Cited by in Crossref: 105] [Cited by in F6Publishing: 82] [Article Influence: 7.0] [Reference Citation Analysis]
139 Jaitovich A, Angulo M, Lecuona E, Dada LA, Welch LC, Cheng Y, Gusarova G, Ceco E, Liu C, Shigemura M, Barreiro E, Patterson C, Nader GA, Sznajder JI. High CO2 levels cause skeletal muscle atrophy via AMP-activated kinase (AMPK), FoxO3a protein, and muscle-specific Ring finger protein 1 (MuRF1). J Biol Chem 2015;290:9183-94. [PMID: 25691571 DOI: 10.1074/jbc.M114.625715] [Cited by in Crossref: 71] [Cited by in F6Publishing: 45] [Article Influence: 10.1] [Reference Citation Analysis]
140 Santambrogio L, Tarsia P, Mendogni P, Tosi D. Transplant options for end stage chronic obstructive pulmonary disease in the context of multidisciplinary treatments. J Thorac Dis 2018;10:S3356-65. [PMID: 30450242 DOI: 10.21037/jtd.2018.04.166] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
141 Geidl W, Semrau J, Streber R, Lehbert N, Wingart S, Tallner A, Wittmann M, Wagner R, Schultz K, Pfeifer K. Effects of a brief, pedometer-based behavioral intervention for individuals with COPD during inpatient pulmonary rehabilitation on 6-week and 6-month objectively measured physical activity: study protocol for a randomized controlled trial. Trials 2017;18:396. [PMID: 28851462 DOI: 10.1186/s13063-017-2124-z] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 3.4] [Reference Citation Analysis]
142 Singh S, Daga MK, Hira HS, Kumar L, Mawari G. Correlation of chronic obstructive pulmonary disease assessment test and clinical chronic obstructive pulmonary disease questionnaire score with BODE index in patients of stable chronic obstructive pulmonary disease. Lung India 2018;35:494-8. [PMID: 30381559 DOI: 10.4103/lungindia.lungindia_93_18] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
143 Hu G, Zhou Y, Wu Y, Yu Y, Liang W, Ran P. The Pneumonia Severity Index as a Predictor of In-Hospital Mortality in Acute Exacerbation of Chronic Obstructive Pulmonary Disease. PLoS One 2015;10:e0133160. [PMID: 26186637 DOI: 10.1371/journal.pone.0133160] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
144 Case AH, Hellkamp AS, Neely ML, Bender S, Dilling DF, Gulati M, Hotchkin DL, Huie TJ, Lancaster L, Snyder LD, Conoscenti CS, Palmer SM. Associations between Patient-reported Outcomes and Death or Lung Transplant in Idiopathic Pulmonary Fibrosis. Data from the Idiopathic Pulmonary Fibrosis Prospective Outcomes Registry. Ann Am Thorac Soc 2020;17:699-705. [PMID: 32040340 DOI: 10.1513/AnnalsATS.201906-437OC] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
145 Villar Balboa I, Carrillo Muñoz R, Regí Bosque M, Marzo Castillejo M, Arcusa Villacampa N, Segundo Yagüe M. [Factors associated with the quality of life in patients with chronic obstructive pulmonary disease]. Aten Primaria 2014;46:179-87. [PMID: 24262284 DOI: 10.1016/j.aprim.2013.09.004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
146 Moon SM, Lim JH, Hong YS, Shin KC, Lee CY, Kim DJ, Lee SH, Jung KS, Lee CH, Yoo KH, Lee H, Park HY. Clinical impact of forced vital capacity on exercise performance in patients with chronic obstructive pulmonary disease. J Thorac Dis 2021;13:837-46. [PMID: 33717557 DOI: 10.21037/jtd-20-1098a] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
147 García Río F. [Daily living activity in COPD: a new parameter to be evaluated?]. Med Clin (Barc) 2007;129:337-8. [PMID: 17910849 DOI: 10.1157/13109553] [Reference Citation Analysis]
148 Rivero González G. Estratificación pronóstica en los pacientes con EPOC agudizada que requieren hospitalización. Más humo que señales. Archivos de Bronconeumología 2007;43:640. [DOI: 10.1157/13111353] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
149 Mannino DM, Davis KJ. Lung function decline and outcomes in an elderly population. Thorax 2006;61:472-7. [PMID: 16517577 DOI: 10.1136/thx.2005.052449] [Cited by in Crossref: 99] [Cited by in F6Publishing: 91] [Article Influence: 6.2] [Reference Citation Analysis]
150 Blanco-Aparicio M, Vázquez MI, Romero-Frais E, Seoane G, Verea-Hernando H. Validation of a Spanish version of the Airways Questionnaire 20: a short and simple instrument. Qual Life Res 2010;19:1235-40. [PMID: 20556659 DOI: 10.1007/s11136-010-9683-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
151 Ergün P, Kaymaz D, Günay E, Erdoğan Y, Turay UY, Demir N, Canak E, Sengül F, Egesel N, Köse SK. Comprehensive out-patient pulmonary rehabilitation: Treatment outcomes in early and late stages of chronic obstructive pulmonary disease. Ann Thorac Med 2011;6:70-6. [PMID: 21572695 DOI: 10.4103/1817-1737.78420] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
152 Martínez González C, González Barcala FJ, Belda Ramírez J, González Ros I, Alfageme Michavila I, Orejas Martínez C, González Rodríguez-Moro JM, Rodríguez Portal JA, Fernández Álvarez R; Spanish Society of Pulmonology and Thoracic Surgery (SEPAR). Recommendations for fitness for work medical evaluations in chronic respiratory patients. Spanish Society of Pulmonology and Thoracic Surgery (SEPAR). Arch Bronconeumol 2013;49:480-90. [PMID: 24120308 DOI: 10.1016/j.arbres.2013.06.004] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
153 Brat K, Svoboda M, Zatloukal J, Plutinsky M, Volakova E, Popelkova P, Novotna B, Dvorak T, Koblizek V. The Relation Between Clinical Phenotypes, GOLD Groups/Stages and Mortality in COPD Patients - A Prospective Multicenter Study. Int J Chron Obstruct Pulmon Dis 2021;16:1171-82. [PMID: 33953554 DOI: 10.2147/COPD.S297087] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
154 Almagro P, Yun S, Sangil A, Rodríguez-Carballeira M, Marine M, Landete P, Soler-Cataluña JJ, Soriano JB, Miravitlles M. Palliative care and prognosis in COPD: a systematic review with a validation cohort. Int J Chron Obstruct Pulmon Dis 2017;12:1721-9. [PMID: 28652724 DOI: 10.2147/COPD.S135657] [Cited by in Crossref: 25] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
155 Hersh CP, DeMeo DL, Silverman EK. National Emphysema Treatment Trial state of the art: genetics of emphysema. Proc Am Thorac Soc 2008;5:486-93. [PMID: 18453360 DOI: 10.1513/pats.200706-078ET] [Cited by in Crossref: 21] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
156 Rieger-reyes C, García-tirado FJ, Rubio-galán FJ, Marín-trigo JM. Classification of Chronic Obstructive Pulmonary Disease Severity According to the New Global Initiative for Chronic Obstructive Lung Disease 2011 Guidelines: COPD Assessment Test Versus Modified Medical Research Council Scale. Archivos de Bronconeumología (English Edition) 2014;50:129-34. [DOI: 10.1016/j.arbr.2014.03.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
157 Yang B, Han K, Kim SH, Lee DH, Park SH, Yoo JE, Shin DW, Choi H, Lee H. Being Underweight Increases the Risk of Non-Cystic Fibrosis Bronchiectasis in the Young Population: A Nationwide Population-Based Study. Nutrients 2021;13:3206. [PMID: 34579084 DOI: 10.3390/nu13093206] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
158 Pérez de Llano L, Miravitlles M, Golpe R, Alvarez-Gutiérrez FJ, Cisneros C, Almonacid C, Martinez-Moragon E, Gonzalez-Barcala FJ, Ramos-Barbón D, Plaza V, Lopez-Campos JL, de-Torres JP, Casanova C, Garcia Rivero JL, Rodriguez Hermosa J, Calle Rubio M, Soler-Cataluña JJ, Cosio BG. A Proposed Approach to Chronic Airway Disease (CAD) Using Therapeutic Goals and Treatable Traits: A Look to the Future. Int J Chron Obstruct Pulmon Dis 2020;15:2091-100. [PMID: 32943862 DOI: 10.2147/COPD.S263430] [Cited by in Crossref: 10] [Cited by in F6Publishing: 1] [Article Influence: 5.0] [Reference Citation Analysis]
159 Cabello B, Borrás X, Carreras F, Thomas B, Leta R, Pons-Lladó G. [Improvement in the measurement technique of pulmonary artery pressure by Doppler echocardiography with contrast in chronic obstructive pulmonary disease]. Med Intensiva 2010;34:506-12. [PMID: 20598397 DOI: 10.1016/j.medin.2010.05.004] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
160 Labaki WW, Gu T, Murray S, Curtis JL, Yeomans L, Bowler RP, Barr RG, Comellas AP, Hansel NN, Cooper CB, Barjaktarevic I, Kanner RE, Paine R 3rd, McDonald MN, Krishnan JA, Peters SP, Woodruff PG, O'Neal WK, Diao W, He B, Martinez FJ, Standiford TJ, Stringer KA, Han MK. Serum amino acid concentrations and clinical outcomes in smokers: SPIROMICS metabolomics study. Sci Rep 2019;9:11367. [PMID: 31388056 DOI: 10.1038/s41598-019-47761-w] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
161 Jung EJ, Kim YK, Lee YM, Kim K, Uh S, Kim YH, Kim DJ, Park CS, Hwang JH. The Correlation of Dyspnea and Radiologic Quantity in Patients with COPD. Tuberc Respir Dis 2009;66:288. [DOI: 10.4046/trd.2009.66.4.288] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
162 Nonato NL, Díaz O, Nascimento OA, Dreyse J, Jardim JR, Lisboa C. Behavior of Quality of Life (SGRQ) in COPD Patients According to BODE Scores. Archivos de Bronconeumología (English Edition) 2015;51:315-21. [DOI: 10.1016/j.arbr.2015.04.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 0.9] [Reference Citation Analysis]
163 Pinto-Plata V, Casanova C, Divo M, Tesfaigzi Y, Calhoun V, Sui J, Polverino F, Priolo C, Petersen H, de Torres JP, Marin JM, Owen CA, Baz R, Cordova E, Celli B. Plasma metabolomics and clinical predictors of survival differences in COPD patients. Respir Res 2019;20:219. [PMID: 31615518 DOI: 10.1186/s12931-019-1167-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
164 Hersh CP, Demeo DL, Lazarus R, Celedón JC, Raby BA, Benditt JO, Criner G, Make B, Martinez FJ, Scanlon PD, Sciurba FC, Utz JP, Reilly JJ, Silverman EK. Genetic association analysis of functional impairment in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2006;173:977-84. [PMID: 16456143 DOI: 10.1164/rccm.200509-1452OC] [Cited by in Crossref: 80] [Cited by in F6Publishing: 47] [Article Influence: 5.0] [Reference Citation Analysis]
165 Lari SM, Attaran D, Tohidi M. Improving communication between the physician and the COPD patient: an evaluation of the utility of the COPD Assessment Test in primary care. Patient Relat Outcome Meas 2014;5:145-52. [PMID: 25422591 DOI: 10.2147/PROM.S54484] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
166 Wirtz HR. [Chronic bronchitis, COPD]. Internist (Berl) 2005;46:175-91; quiz 192-3. [PMID: 15655681 DOI: 10.1007/s00108-004-1335-z] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
167 Maekura R, Hiraga T, Miki K, Kitada S, Miki M, Yoshimura K, Yamamoto H, Kawabe T, Mori M. Personalized pulmonary rehabilitation and occupational therapy based on cardiopulmonary exercise testing for patients with advanced chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 2015;10:1787-800. [PMID: 26366071 DOI: 10.2147/COPD.S86455] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
168 Tetikkurt C, Ozdemir I, Tetikkurt S, Yılmaz N, Ertan T, Bayar N. Anxiety and depression in COPD patients and correlation with sputum and BAL cytology. Multidiscip Respir Med 2011;6:226-31. [PMID: 22958450 DOI: 10.1186/2049-6958-6-4-226] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
169 Seymour JM, Spruit MA, Hopkinson NS, Natanek SA, Man WD, Jackson A, Gosker HR, Schols AM, Moxham J, Polkey MI, Wouters EF. The prevalence of quadriceps weakness in COPD and the relationship with disease severity. Eur Respir J 2010;36:81-8. [PMID: 19897554 DOI: 10.1183/09031936.00104909] [Cited by in Crossref: 278] [Cited by in F6Publishing: 257] [Article Influence: 21.4] [Reference Citation Analysis]
170 Kim V, Goel N, Gangar J, Zhao H, Ciccolella DE, Silverman EK, Crapo JD, Criner GJ; and the COPD Gene Investigators. Risk Factors for Venous Thromboembolism in Chronic Obstructive Pulmonary Disease. Chronic Obstr Pulm Dis 2014;1:239-49. [PMID: 25844397 DOI: 10.15326/jcopdf.1.2.2014.0133#sthash.pvwPnxaI.dpuf] [Cited by in F6Publishing: 12] [Reference Citation Analysis]
171 Couillard A. Les facteurs pronostiques dans la BPCO : la tête, les jambes et le souffle ! Revue des Maladies Respiratoires 2011;28:174-86. [DOI: 10.1016/j.rmr.2010.09.026] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
172 Ban WH, Lee JM, Ha JH, Yeo CD, Kang HH, Rhee CK, Moon HS, Lee SH. Dyspnea as a Prognostic Factor in Patients with Non-Small Cell Lung Cancer. Yonsei Med J 2016;57:1063-9. [PMID: 27401635 DOI: 10.3349/ymj.2016.57.5.1063] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
173 Tényi Á, Cano I, Marabita F, Kiani N, Kalko SG, Barreiro E, de Atauri P, Cascante M, Gomez-Cabrero D, Roca J. Network modules uncover mechanisms of skeletal muscle dysfunction in COPD patients. J Transl Med 2018;16:34. [PMID: 29463285 DOI: 10.1186/s12967-018-1405-y] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.8] [Reference Citation Analysis]
174 Wang J, Guo S, Zeng M, Yu P, Mo W. Observation of the curative effect of device-guided rehabilitation on respiratory function in stable patients with chronic obstructive pulmonary disease. Medicine (Baltimore) 2019;98:e14034. [PMID: 30813125 DOI: 10.1097/MD.0000000000014034] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
175 van Buul AR, Derksen C, Hoedemaker O, van Dijk O, Chavannes NH, Kasteleyn MJ. eHealth Program to Reduce Hospitalizations Due to Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Retrospective Study. JMIR Form Res 2021;5:e24726. [PMID: 33734091 DOI: 10.2196/24726] [Reference Citation Analysis]
176 Hobbs BD, Hersh CP. Integrative genomics of chronic obstructive pulmonary disease. Biochem Biophys Res Commun 2014;452:276-86. [PMID: 25078622 DOI: 10.1016/j.bbrc.2014.07.086] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 4.0] [Reference Citation Analysis]
177 Khan MA, Khan N, Walley JD, Khan MA, Hicks J, Ahmed M, Sheikh FI, Ali M, Manzoor F, Khan HJ. Effectiveness of delivering integrated COPD care at public healthcare facilities: a cluster randomised trial in Pakistan. BJGP Open 2019;3:bjgpopen18X101634. [PMID: 31049414 DOI: 10.3399/bjgpopen18X101634] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
178 Han MK, Agusti A, Celli BR, Criner GJ, Halpin DMG, Roche N, Papi A, Stockley RA, Wedzicha J, Vogelmeier CF. From GOLD 0 to Pre-COPD. Am J Respir Crit Care Med 2021;203:414-23. [PMID: 33211970 DOI: 10.1164/rccm.202008-3328PP] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 8.0] [Reference Citation Analysis]
179 Naik D, Joshi A, Paul TV, Thomas N. Chronic obstructive pulmonary disease and the metabolic syndrome: Consequences of a dual threat. Indian J Endocrinol Metab 2014;18:608-16. [PMID: 25285275 DOI: 10.4103/2230-8210.139212] [Cited by in F6Publishing: 13] [Reference Citation Analysis]
180 Yamauchi Y, Hasegawa W, Yasunaga H, Sunohara M, Jo T, Takami K, Matsui H, Fushimi K, Nagase T. Paradoxical association between body mass index and in-hospital mortality in elderly patients with chronic obstructive pulmonary disease in Japan. Int J Chron Obstruct Pulmon Dis 2014;9:1337-46. [PMID: 25525351 DOI: 10.2147/COPD.S75175] [Cited by in Crossref: 48] [Cited by in F6Publishing: 24] [Article Influence: 6.0] [Reference Citation Analysis]
181 Sørensen AK, Holmgaard DB, Mygind LH, Johansen J, Pedersen C. Neutrophil-to-lymphocyte ratio, calprotectin and YKL-40 in patients with chronic obstructive pulmonary disease: correlations and 5-year mortality - a cohort study. J Inflamm (Lond) 2015;12:20. [PMID: 25908927 DOI: 10.1186/s12950-015-0064-5] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 3.4] [Reference Citation Analysis]
182 Lopez-Campos JL, Cejudo P, Marquez E, Ortega F, Quintana E, Carmona C, Barrot E. Modified BODE indexes: Agreement between multidimensional prognostic systems based on oxygen uptake. Int J Chron Obstruct Pulmon Dis 2010;5:133-40. [PMID: 20461145 DOI: 10.2147/copd.s8827] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
183 Divo MJ, Cabrera C, Casanova C, Marin JM, Pinto-Plata VM, de-Torres JP, Zulueta J, Zagaceta J, Sanchez-Salcedo P, Berto J, Cote C, Celli BR. Comorbidity Distribution, Clinical Expression and Survival in COPD Patients with Different Body Mass Index. Chronic Obstr Pulm Dis 2014;1:229-38. [PMID: 28848824 DOI: 10.15326/jcopdf.1.2.2014.0117] [Cited by in Crossref: 17] [Cited by in F6Publishing: 23] [Article Influence: 2.1] [Reference Citation Analysis]
184 O'Brien JM Jr, Phillips GS, Ali NA, Lucarelli M, Marsh CB, Lemeshow S. Body mass index is independently associated with hospital mortality in mechanically ventilated adults with acute lung injury. Crit Care Med 2006;34:738-44. [PMID: 16521268 DOI: 10.1097/01.ccm.0000202207.87891.fc] [Cited by in Crossref: 190] [Cited by in F6Publishing: 81] [Article Influence: 11.9] [Reference Citation Analysis]
185 Soler-Cataluña JJ, Alcázar-Navarrete B, Miravitlles M. The concept of control of COPD in clinical practice. Int J Chron Obstruct Pulmon Dis 2014;9:1397-405. [PMID: 25548521 DOI: 10.2147/COPD.S71370] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
186 Tickoo M, Ruthazer R, Bardia A, Doron S, Andujar-Vazquez GM, Gardiner BJ, Snydman DR, Kurz SG. The effect of respiratory viral assay panel on antibiotic prescription patterns at discharge in adults admitted with mild to moderate acute exacerbation of COPD: a retrospective before- after study. BMC Pulm Med 2019;19:118. [PMID: 31262278 DOI: 10.1186/s12890-019-0872-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
187 Greulich T, Altraja A, Barrecheguren M, Bals R, Chlumsky J, Chorostowska-Wynimko J, Clarenbach C, Corda L, Corsico AG, Ferrarotti I, Esquinas C, Gouder C, Hećimović A, Ilic A, Ivanov Y, Janciauskiene S, Janssens W, Kohler M, Krams A, Lara B, Mahadeva R, McElvaney G, Mornex JF, O'Hara K, Parr D, Piitulainen E, Schmid-Scherzer K, Seersholm N, Stockley RA, Stolk J, Sucena M, Tanash H, Turner A, Ulmeanu R, Wilkens M, Yorgancioğlu A, Zaharie A, Miravitlles M. Protocol for the EARCO Registry: a pan-European observational study in patients with α1-antitrypsin deficiency. ERJ Open Res 2020;6:00181-2019. [PMID: 32154291 DOI: 10.1183/23120541.00181-2019] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
188 Farkas J, Kosnik M, Zaletel-Kragelj L, Flezar M, Suskovic S, Lainscak M. Distribution of self-rated health and association with clinical parameters in patients with chronic obstructive pulmonary disease. Wien Klin Wochenschr 2009;121:297-302. [PMID: 19562290 DOI: 10.1007/s00508-009-1170-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
189 Vorrink SN, Kort HS, Troosters T, Lammers JW. Level of daily physical activity in individuals with COPD compared with healthy controls. Respir Res 2011;12:33. [PMID: 21426563 DOI: 10.1186/1465-9921-12-33] [Cited by in Crossref: 125] [Cited by in F6Publishing: 120] [Article Influence: 11.4] [Reference Citation Analysis]
190 Luqman Z, Arora RC. "It's not easy being wheezy". J Thorac Cardiovasc Surg 2018;156:1552-3. [PMID: 30029788 DOI: 10.1016/j.jtcvs.2018.05.115] [Reference Citation Analysis]
191 Loh LC, Ong CK, Koo HJ, Lee SM, Lee JS, Oh YM, Seo JB, Lee SD. A novel CT-emphysema index/FEV1 approach of phenotyping COPD to predict mortality. Int J Chron Obstruct Pulmon Dis 2018;13:2543-50. [PMID: 30174423 DOI: 10.2147/COPD.S165898] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
192 Brigham EP, Anderson JA, Brook RD, Calverley PMA, Celli BR, Cowans NJ, Crim C, Diserens JE, Martinez FJ, McCormack MC, Newby DE, Yates J, Vestbo J, Wu TD, Wise RA. Challenging the obesity paradox: extreme obesity and COPD mortality in the SUMMIT trial. ERJ Open Res 2021;7:00902-2020. [PMID: 34322545 DOI: 10.1183/23120541.00902-2020] [Reference Citation Analysis]
193 Wacker ME, Jörres RA, Karch A, Wilke S, Heinrich J, Karrasch S, Koch A, Schulz H, Watz H, Leidl R, Vogelmeier C, Holle R; COSYCONET-Consortium. Assessing health-related quality of life in COPD: comparing generic and disease-specific instruments with focus on comorbidities. BMC Pulm Med 2016;16:70. [PMID: 27160582 DOI: 10.1186/s12890-016-0238-9] [Cited by in Crossref: 40] [Cited by in F6Publishing: 45] [Article Influence: 6.7] [Reference Citation Analysis]
194 Pleguezuelos E, Casarramona P, Guirao L, Samitier B, Ortega P, Vila X, Carmen AD, Ovejero L, Moreno E, Serra N, Gomís M, Garnacho-Castaño MV, Miravitlles M. How whole-body vibration can help our COPD patients. Physiological changes at different vibration frequencies. Int J Chron Obstruct Pulmon Dis 2018;13:3373-80. [PMID: 30425467 DOI: 10.2147/COPD.S165058] [Cited by in Crossref: 4] [Article Influence: 1.0] [Reference Citation Analysis]
195 Aksu F, Capan N, Aksu K, Ofluoğlu R, Canbakan S, Yavuz B, Akin KO. C-reactive protein levels are raised in stable Chronic obstructive pulmonary disease patients independent of smoking behavior and biomass exposure. J Thorac Dis 2013;5:414-21. [PMID: 23991296 DOI: 10.3978/j.issn.2072-1439.2013.06.27] [Cited by in F6Publishing: 13] [Reference Citation Analysis]
196 Cosio BG, Soriano JB, López-Campos JL, Calle M, Soler JJ, de-Torres JP, Marín JM, Martínez C, de Lucas P, Mir I, Peces-Barba G, Feu-Collado N, Solanes I, Alfageme I; CHAIN study. Distribution and Outcomes of a Phenotype-Based Approach to Guide COPD Management: Results from the CHAIN Cohort. PLoS One 2016;11:e0160770. [PMID: 27684372 DOI: 10.1371/journal.pone.0160770] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 5.5] [Reference Citation Analysis]
197 Varraso R, Fung TT, Barr RG, Hu FB, Willett W, Camargo CA Jr. Prospective study of dietary patterns and chronic obstructive pulmonary disease among US women. Am J Clin Nutr 2007;86:488-95. [PMID: 17684223 DOI: 10.1093/ajcn/86.2.488] [Cited by in Crossref: 98] [Cited by in F6Publishing: 96] [Article Influence: 6.5] [Reference Citation Analysis]
198 Xu L, Chen Y, Xie Z, He Q, Chen S, Wang W, Liu G, Liao Y, Lu C, Hao L, Sun J, Shi W, Liang X; China collaborative study on AKI (CCS-AKI). High hemoglobin is associated with increased in-hospital death in patients with chronic obstructive pulmonary disease and chronic kidney disease: a retrospective multicenter population-based study. BMC Pulm Med 2019;19:174. [PMID: 31533673 DOI: 10.1186/s12890-019-0933-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
199 Andresen E, Lange C, Strodthoff D, Goldmann T, Fischer N, Sahly H, Branscheid D, Heine H. S100A7/psoriasin expression in the human lung: unchanged in patients with COPD, but upregulated upon positive S. aureus detection. BMC Pulm Med 2011;11:10. [PMID: 21324122 DOI: 10.1186/1471-2466-11-10] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
200 Donner CF, ZuWallack R, Nici L. The Role of Telemedicine in Extending and Enhancing Medical Management of the Patient with Chronic Obstructive Pulmonary Disease. Medicina (Kaunas) 2021;57:726. [PMID: 34357007 DOI: 10.3390/medicina57070726] [Reference Citation Analysis]
201 Grogono JC, Butler C, Izadi H, Moosavi SH. Inhaled furosemide for relief of air hunger versus sense of breathing effort: a randomized controlled trial. Respir Res 2018;19:181. [PMID: 30236110 DOI: 10.1186/s12931-018-0886-9] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
202 Dal Negro RW. COPD: The Annual Cost-Of-Illness during the Last Two Decades in Italy, and Its Mortality Predictivity Power. Healthcare (Basel) 2019;7:E35. [PMID: 30832210 DOI: 10.3390/healthcare7010035] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
203 Knaut C, Mesquita CB, Caram LM, Ferrari R, Dourado VZ, de Godoy I, Tanni SE. Assessment of Aerobic Exercise Adverse Effects during COPD Exacerbation Hospitalization. Can Respir J 2017;2017:5937908. [PMID: 28265180 DOI: 10.1155/2017/5937908] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
204 McDonald VM, Osadnik CR, Gibson PG. Treatable traits in acute exacerbations of chronic airway diseases. Chron Respir Dis 2019;16:1479973119867954. [PMID: 31409129 DOI: 10.1177/1479973119867954] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 8.0] [Reference Citation Analysis]
205 Segreti A, Stirpe E, Rogliani P, Cazzola M. Defining phenotypes in COPD: an aid to personalized healthcare. Mol Diagn Ther 2014;18:381-8. [PMID: 24781789 DOI: 10.1007/s40291-014-0100-9] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 5.1] [Reference Citation Analysis]
206 MacNee W. Guidelines for chronic obstructive pulmonary disease. BMJ 2004;329:361-3. [PMID: 15310589 DOI: 10.1136/bmj.329.7462.361] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
207 Birch J, Sunny SS, Hester KLM, Parry G, Kate Gould F, Dark JH, Clark SC, Meachery G, Lordan J, Fisher AJ, Corris PA, De Soyza A. Outcomes of lung transplantation in adults with bronchiectasis. BMC Pulm Med 2018;18:82. [PMID: 29789006 DOI: 10.1186/s12890-018-0634-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
208 Lou P, Zhu Y, Chen P, Zhang P, Yu J, Zhang N, Chen N, Zhang L, Wu H, Zhao J. Prevalence and correlations with depression, anxiety, and other features in outpatients with chronic obstructive pulmonary disease in China: a cross-sectional case control study. BMC Pulm Med 2012;12:53. [PMID: 22958576 DOI: 10.1186/1471-2466-12-53] [Cited by in Crossref: 48] [Cited by in F6Publishing: 50] [Article Influence: 4.8] [Reference Citation Analysis]
209 Singla S, Gong M, Riley C, Sciurba F, Batmanghelich K. Improving clinical disease subtyping and future events prediction through a chest CT-based deep learning approach. Med Phys 2021;48:1168-81. [PMID: 33340116 DOI: 10.1002/mp.14673] [Reference Citation Analysis]
210 Zeren M, Karci M, Demir R, Gurses HN, Oktay V, Uzunhasan I, Yigit Z. Cut-off values of 6-min walk test and sit-to-stand test for determining symptom burden in atrial fibrillation. Ir J Med Sci. [DOI: 10.1007/s11845-021-02901-y] [Reference Citation Analysis]
211 Toft-Petersen AP, Torp-Pedersen C, Weinreich UM, Rasmussen BS. Association between hemoglobin and prognosis in patients admitted to hospital for COPD. Int J Chron Obstruct Pulmon Dis 2016;11:2813-20. [PMID: 27877035 DOI: 10.2147/COPD.S116269] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
212 Han MK, Kazerooni EA, Lynch DA, Liu LX, Murray S, Curtis JL, Criner GJ, Kim V, Bowler RP, Hanania NA. Chronic obstructive pulmonary disease exacerbations in the COPDGene study: associated radiologic phenotypes. Radiology. 2011;261:274-282. [PMID: 21788524 DOI: 10.1148/radiol.11110173] [Cited by in Crossref: 251] [Cited by in F6Publishing: 243] [Article Influence: 22.8] [Reference Citation Analysis]
213 Al-Shair K, Kolsum U, Singh D, Vestbo J. The Effect of Fatigue and Fatigue Intensity on Exercise Tolerance in Moderate COPD. Lung 2016;194:889-95. [PMID: 27549363 DOI: 10.1007/s00408-016-9931-y] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
214 Burkhardt R, Pankow W. The diagnosis of chronic obstructive pulmonary disease. Dtsch Arztebl Int 2014;111:834-45, quiz 846. [PMID: 25556602 DOI: 10.3238/arztebl.2014.0834] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
215 Naya IP, Tombs L, Muellerova H, Compton C, Jones PW. Long-term outcomes following first short-term clinically important deterioration in COPD. Respir Res 2018;19:222. [PMID: 30453972 DOI: 10.1186/s12931-018-0928-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
216 Siebeling L, ter Riet G, van der Wal WM, Geskus RB, Zoller M, Muggensturm P, Joleska I, Puhan MA. ICE COLD ERIC--International collaborative effort on chronic obstructive lung disease: exacerbation risk index cohorts--study protocol for an international COPD cohort study. BMC Pulm Med 2009;9:15. [PMID: 19419546 DOI: 10.1186/1471-2466-9-15] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 1.6] [Reference Citation Analysis]
217 Formiga MF, Dosbaba F, Hartman M, Batalik L, Plutinsky M, Brat K, Ludka O, Cahalin LP. Novel versus Traditional Inspiratory Muscle Training Regimens as Home-Based, Stand-Alone Therapies in COPD: Protocol for a Randomized Controlled Trial. Int J Chron Obstruct Pulmon Dis 2020;15:2147-55. [PMID: 32982207 DOI: 10.2147/COPD.S266234] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
218 Abe Y, Suzuki M, Shima H, Shiraishi Y, Tanabe N, Sato S, Shimizu K, Kimura H, Makita H, Hirai T, Konno S, Nishimura M. Annual Body Weight Change and Prognosis in Chronic Obstructive Pulmonary Disease. Int J Chron Obstruct Pulmon Dis 2021;16:3243-53. [PMID: 34876811 DOI: 10.2147/COPD.S338908] [Reference Citation Analysis]
219 Chen X, Xu X, Xiao F. Heterogeneity of chronic obstructive pulmonary disease: from phenotype to genotype. Front Med 2013;7:425-32. [PMID: 24234678 DOI: 10.1007/s11684-013-0295-x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
220 Kim SH, Shin MJ, Shin YB, Kim KU. Sarcopenia Associated with Chronic Obstructive Pulmonary Disease. J Bone Metab 2019;26:65-74. [PMID: 31223602 DOI: 10.11005/jbm.2019.26.2.65] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
221 Bastos HN, Neves I, Redondo M, Cunha R, Pereira JM, Magalhães A, Fernandes G. Influence of emphysema distribution on pulmonary function parameters in COPD patients. J Bras Pneumol 2015;41:489-95. [PMID: 26785956 DOI: 10.1590/S1806-37562015000000136] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
222 Storgaard LH, Hockey HU, Laursen BS, Weinreich UM. Long-term effects of oxygen-enriched high-flow nasal cannula treatment in COPD patients with chronic hypoxemic respiratory failure. Int J Chron Obstruct Pulmon Dis 2018;13:1195-205. [PMID: 29713153 DOI: 10.2147/COPD.S159666] [Cited by in Crossref: 46] [Cited by in F6Publishing: 20] [Article Influence: 11.5] [Reference Citation Analysis]
223 Costa TM, Costa FM, Moreira CA, Rabelo LM, Boguszewski CL, Borba VZ. Sarcopenia in COPD: relationship with COPD severity and prognosis. J Bras Pneumol 2015;41:415-21. [PMID: 26578132 DOI: 10.1590/S1806-37132015000000040] [Cited by in Crossref: 50] [Cited by in F6Publishing: 22] [Article Influence: 8.3] [Reference Citation Analysis]
224 Pullen R, Miravitlles M, Sharma A, Singh D, Martinez F, Hurst JR, Alves L, Dransfield M, Chen R, Muro S, Winders T, Blango C, Muellerova H, Trudo F, Dorinsky P, Alacqua M, Morris T, Carter V, Couper A, Jones R, Kostikas K, Murray R, Price DB. CONQUEST Quality Standards: For the Collaboration on Quality Improvement Initiative for Achieving Excellence in Standards of COPD Care. Int J Chron Obstruct Pulmon Dis 2021;16:2301-22. [PMID: 34413639 DOI: 10.2147/COPD.S313498] [Reference Citation Analysis]
225 Chan HP, Mukhopadhyay A, Chong PL, Chin S, Wong XY, Ong V, Chan YH, Lim TK, Phua J. Prognostic utility of the 2011 GOLD classification and other multidimensional tools in Asian COPD patients: a prospective cohort study. Int J Chron Obstruct Pulmon Dis 2016;11:823-9. [PMID: 27217739 DOI: 10.2147/COPD.S96790] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
226 Bak SH, Kwon SO, Han SS, Kim WJ. Computed tomography-derived area and density of pectoralis muscle associated disease severity and longitudinal changes in chronic obstructive pulmonary disease: a case control study. Respir Res 2019;20:226. [PMID: 31638996 DOI: 10.1186/s12931-019-1191-y] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
227 Yohannes AM. Palliative care provision for patients with chronic obstructive pulmonary disease. Health Qual Life Outcomes 2007;5:17. [PMID: 17407591 DOI: 10.1186/1477-7525-5-17] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 2.4] [Reference Citation Analysis]
228 Lee SJ, Lee SH, Kim YE, Cho YJ, Jeong YY, Kim HC, Kim JH, You JJ, Yoon CH, Lee JD, Hwang YS. Clinical Features according to the Frequency of Acute Exacerbation in COPD. Tuberc Respir Dis (Seoul) 2012;72:367-73. [PMID: 23227078 DOI: 10.4046/trd.2012.72.4.367] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
229 Herth FJ, Ernst A, Baker KM, Egan JJ, Gotfried MH, Hopkins P, Stanzel F, Valipour A, Wagner M, Witt C, Kesten S, Snell G. Characterization of outcomes 1 year after endoscopic thermal vapor ablation for patients with heterogeneous emphysema. Int J Chron Obstruct Pulmon Dis 2012;7:397-405. [PMID: 22927751 DOI: 10.2147/COPD.S31082] [Cited by in Crossref: 3] [Cited by in F6Publishing: 15] [Article Influence: 0.3] [Reference Citation Analysis]
230 Delay JM, Jaber S. [Respiratory preparation before surgery in patients with chronic respiratory failure]. Presse Med 2012;41:225-33. [PMID: 22004791 DOI: 10.1016/j.lpm.2011.08.007] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
231 Yazar EE, Aydin S, Gunluoglu G, Kamat S, Gungen AC, Yildiz P. Clinical effects of cognitive impairment in patients with chronic obstructive pulmonary disease. Chron Respir Dis 2018;15:306-14. [PMID: 29169250 DOI: 10.1177/1479972317743757] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
232 Saito H, Nomura K, Abe S, Motegi T, Ishii T, Hattori K, Kusunoki Y, Gemma A, Kida K. Long-term effects of gastrectomy in patients with spirometry-defined COPD and patients at risk of COPD: a case-control study. Int J Chron Obstruct Pulmon Dis 2015;10:2311-8. [PMID: 26604730 DOI: 10.2147/COPD.S87135] [Reference Citation Analysis]
233 Xu L, Ye T, Li J, Hu Y, Xu W, Wang K, Ou C, Chen X. Identification of relevant variables and construction of a multidimensional index for predicting mortality in COPD patients. Int J Chron Obstruct Pulmon Dis 2019;14:1703-11. [PMID: 31534324 DOI: 10.2147/COPD.S215219] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
234 Karlsson N, Atkinson MJ, Müllerová H, Alacqua M, Keen C, Hughes R, Janson C, Make B, Price D, Reddel HK. Validation of a diagnosis-agnostic symptom questionnaire for asthma and/or COPD. ERJ Open Res 2021;7:00828-2020. [PMID: 33569501 DOI: 10.1183/23120541.00828-2020] [Reference Citation Analysis]
235 Oudkerk SF, Mohamed Hoesein FAA, Öner FC, Verlaan JJ, de Jong PA, Kuperus JS, Cho M, McDonald ML, Lynch DA, Silverman EK, Crapo JD, Make BJ, Lowe KE, Regan EA. Diffuse Idiopathic Skeletal Hyperostosis in Smokers and Restrictive Spirometry Pattern: An Analysis of the COPDGene Cohort. J Rheumatol 2020;47:531-8. [PMID: 31043539 DOI: 10.3899/jrheum.181357] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
236 Veerapaneni VV, Upadhyay S, Thimraj TA, Siddaiah JB, Krishnarao CS, Lokesh KS, Thimmulappa R, Palmberg L, Ganguly K, Anand MP. Circulating Secretoglobin Family 1A Member 1 (SCGB1A1) Levels as a Marker of Biomass Smoke Induced Chronic Obstructive Pulmonary Disease. Toxics 2021;9:208. [PMID: 34564359 DOI: 10.3390/toxics9090208] [Reference Citation Analysis]
237 Bowler R, Allinder M, Jacobson S, Miller A, Miller B, Tal-Singer R, Locantore N. Real-world use of rescue inhaler sensors, electronic symptom questionnaires and physical activity monitors in COPD. BMJ Open Respir Res 2019;6:e000350. [PMID: 30956796 DOI: 10.1136/bmjresp-2018-000350] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
238 Seaman J, Leonard AC, Panos RJ. Health care utilization history, GOLD guidelines, and respiratory medication prescriptions in patients with COPD. Int J Chron Obstruct Pulmon Dis 2010;5:89-97. [PMID: 20463890 DOI: 10.2147/copd.s8822] [Cited by in F6Publishing: 13] [Reference Citation Analysis]
239 Gallego M, Pomares X, Espasa M, Castañer E, Solé M, Suárez D, Monsó E, Montón C. Pseudomonas aeruginosa isolates in severe chronic obstructive pulmonary disease: characterization and risk factors. BMC Pulm Med 2014;14:103. [PMID: 24964956 DOI: 10.1186/1471-2466-14-103] [Cited by in Crossref: 45] [Cited by in F6Publishing: 50] [Article Influence: 5.6] [Reference Citation Analysis]
240 Hakamy A, Bolton CE, McKeever TM. The effect of pulmonary rehabilitation on mortality, balance, and risk of fall in stable patients with chronic obstructive pulmonary disease. Chron Respir Dis 2017;14:54-62. [PMID: 27515520 DOI: 10.1177/1479972316661925] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
241 Pessoa BV, Arcuri JF, Labadessa IG, Costa JN, Sentanin AC, Di Lorenzo VA. Validity of the six-minute step test of free cadence in patients with chronic obstructive pulmonary disease. Braz J Phys Ther 2014;18:228-36. [PMID: 25003275 DOI: 10.1590/bjpt-rbf.2014.0041] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 5.3] [Reference Citation Analysis]
242 Minai OA, Benditt J, Martinez FJ. Natural history of emphysema. Proc Am Thorac Soc 2008;5:468-74. [PMID: 18453357 DOI: 10.1513/pats.200802-018ET] [Cited by in Crossref: 24] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
243 Criner GJ, Sternberg AL; National Emphysema Treatment Trial Research Group. A clinician's guide to the use of lung volume reduction surgery. Proc Am Thorac Soc 2008;5:461-7. [PMID: 18453356 DOI: 10.1513/pats.200709-151ET] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
244 Yu L, De Mazancourt M, Hess A, Ashadi FR, Klein I, Mal H, Courbage M, Mangin L. Functional connectivity and information flow of the respiratory neural network in chronic obstructive pulmonary disease. Hum Brain Mapp 2016;37:2736-54. [PMID: 27059277 DOI: 10.1002/hbm.23205] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 4.2] [Reference Citation Analysis]
245 Santer P, McGahey A, Frise MC, Petousi N, Talbot NP, Baskerville R, Bafadhel M, Nickol AH, Robbins PA. Intravenous iron and chronic obstructive pulmonary disease: a randomised controlled trial. BMJ Open Respir Res 2020;7:e000577. [PMID: 32565444 DOI: 10.1136/bmjresp-2020-000577] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
246 Montserrat-Capdevila J, Godoy P, Marsal JR, Barbé-Illa F. [Risk factors for mortality in patients with chronic obstructive pulmonary disease]. Aten Primaria 2015;47:498-504. [PMID: 25778409 DOI: 10.1016/j.aprim.2014.11.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
247 Hecht A, Ma S, Porszasz J, Casaburi R; COPD Clinical Research Network. Methodology for using long-term accelerometry monitoring to describe daily activity patterns in COPD. COPD 2009;6:121-9. [PMID: 19378225 DOI: 10.1080/15412550902755044] [Cited by in Crossref: 49] [Cited by in F6Publishing: 42] [Article Influence: 3.8] [Reference Citation Analysis]
248 Bhatt SP, Wells JM, Kim V, Criner GJ, Hersh CP, Hardin M, Bailey WC, Nath H, Kim YI, Foreman MG, Stinson DS, Wilson CG, Rennard SI, Silverman EK, Make BJ, Dransfield MT; COPDGene Investigators. Radiological correlates and clinical implications of the paradoxical lung function response to β₂ agonists: an observational study. Lancet Respir Med 2014;2:911-8. [PMID: 25217076 DOI: 10.1016/S2213-2600(14)70185-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
249 Meunier I, Bocquet B, Labesse G, Zeitz C, Defoort-Dhellemmes S, Lacroux A, Mauget-Faysse M, Drumare I, Gamez AS, Mathieu C, Marquette V, Sagot L, Dhaenens CM, Arndt C, Carroll P, Remy-Jardin M, Cohen SY, Sahel JA, Puech B, Audo I, Mrejen S, Hamel CP. A new autosomal dominant eye and lung syndrome linked to mutations in TIMP3 gene. Sci Rep 2016;6:32544. [PMID: 27601084 DOI: 10.1038/srep32544] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
250 Gosker HR, Zeegers MP, Wouters EF, Schols AM. Muscle fibre type shifting in the vastus lateralis of patients with COPD is associated with disease severity: a systematic review and meta-analysis. Thorax 2007;62:944-9. [PMID: 17526675 DOI: 10.1136/thx.2007.078980] [Cited by in Crossref: 149] [Cited by in F6Publishing: 140] [Article Influence: 9.9] [Reference Citation Analysis]
251 Albert RK, Au DH, Blackford AL, Casaburi R, Cooper JA Jr, Criner GJ, Diaz P, Fuhlbrigge AL, Gay SE, Kanner RE, MacIntyre N, Martinez FJ, Panos RJ, Piantadosi S, Sciurba F, Shade D, Stibolt T, Stoller JK, Wise R, Yusen RD, Tonascia J, Sternberg AL, Bailey W; Long-Term Oxygen Treatment Trial Research Group. A Randomized Trial of Long-Term Oxygen for COPD with Moderate Desaturation. N Engl J Med 2016;375:1617-27. [PMID: 27783918 DOI: 10.1056/NEJMoa1604344] [Cited by in Crossref: 196] [Cited by in F6Publishing: 60] [Article Influence: 39.2] [Reference Citation Analysis]
252 Huang Y, Wang J, Shen J, Ma J, Miao X, Ding K, Jiang B, Hu B, Fu F, Huang L, Cao M, Zhang X. Relationship of Red Cell Index with the Severity of Chronic Obstructive Pulmonary Disease. Int J Chron Obstruct Pulmon Dis 2021;16:825-34. [PMID: 33814906 DOI: 10.2147/COPD.S292666] [Reference Citation Analysis]
253 Zhou XM, Hou G, Gu DX, Wang QY, Zhao L. Peroxisome proliferator-activated receptor-γ in induced sputum is correlated with MMP-9/TIMP-1 imbalance and formation of emphysema in COPD patients. J Thorac Dis 2017;9:3703-10. [PMID: 29268377 DOI: 10.21037/jtd.2017.09.10] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
254 Haja Mydin H, Murphy S, Clague H, Sridharan K, Taylor IK. Anemia and performance status as prognostic markers in acute hypercapnic respiratory failure due to chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 2013;8:151-7. [PMID: 23658480 DOI: 10.2147/COPD.S39403] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
255 Sun D, Liu H, Ouyang Y, Liu X, Xu Y. Serum Levels of Gamma-Glutamyltransferase During Stable and Acute Exacerbations of Chronic Obstructive Pulmonary Disease. Med Sci Monit 2020;26:e927771. [PMID: 33087693 DOI: 10.12659/MSM.927771] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
256 Sharma BB, Singh V. Pulmonary rehabilitation: An overview. Lung India 2011;28:276-84. [PMID: 22084542 DOI: 10.4103/0970-2113.85690] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
257 Martinez FJ, Curtis JL, Sciurba F, Mumford J, Giardino ND, Weinmann G, Kazerooni E, Murray S, Criner GJ, Sin DD, Hogg J, Ries AL, Han M, Fishman AP, Make B, Hoffman EA, Mohsenifar Z, Wise R; National Emphysema Treatment Trial Research Group. Sex differences in severe pulmonary emphysema. Am J Respir Crit Care Med 2007;176:243-52. [PMID: 17431226 DOI: 10.1164/rccm.200606-828OC] [Cited by in Crossref: 209] [Cited by in F6Publishing: 93] [Article Influence: 13.9] [Reference Citation Analysis]
258 White SM, Moppett IK, Griffiths R. A reply. Anaesthesia 2014;69:1057-8. [PMID: 25117019 DOI: 10.1111/anae.12815] [Reference Citation Analysis]
259 Siebeling L, Puhan MA, Muggensturm P, Zoller M, Ter Riet G. Characteristics of Dutch and Swiss primary care COPD patients - baseline data of the ICE COLD ERIC study. Clin Epidemiol 2011;3:273-83. [PMID: 22135502 DOI: 10.2147/CLEP.S24818] [Cited by in Crossref: 21] [Cited by in F6Publishing: 7] [Article Influence: 1.9] [Reference Citation Analysis]
260 Chen Z, Fan VS, Belza B, Pike K, Nguyen HQ. Association between Social Support and Self-Care Behaviors in Adults with Chronic Obstructive Pulmonary Disease. Ann Am Thorac Soc 2017;14:1419-27. [PMID: 28719225 DOI: 10.1513/AnnalsATS.201701-026OC] [Cited by in Crossref: 36] [Cited by in F6Publishing: 15] [Article Influence: 9.0] [Reference Citation Analysis]
261 Wouters EFM, Breyer MK, Breyer-Kohansal R, Hartl S. COPD Diagnosis: Time for Disruption. J Clin Med 2021;10:4660. [PMID: 34682780 DOI: 10.3390/jcm10204660] [Reference Citation Analysis]
262 Martinot JB, Chambellan A, Kays C, Silkoff PE, Guenard H. Partial versus maximal forced exhalations in COPD: enhanced signal detection for novel therapies. Pulm Pharmacol Ther 2014;29:58-65. [PMID: 24661905 DOI: 10.1016/j.pupt.2014.03.004] [Reference Citation Analysis]
263 Formiga MF, Vital I, Urdaneta G, Balestrini K, Cahalin LP, Campos MA. The BODE index and inspiratory muscle performance in COPD: Clinical findings and implications. SAGE Open Med 2018;6:2050312118819015. [PMID: 30574307 DOI: 10.1177/2050312118819015] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
264 Hersh CP, DeMeo DL, Reilly JJ, Silverman EK. Xenobiotic metabolizing enzyme gene polymorphisms predict response to lung volume reduction surgery. Respir Res 2007;8:59. [PMID: 17686149 DOI: 10.1186/1465-9921-8-59] [Cited by in Crossref: 9] [Cited by in F6Publishing: 13] [Article Influence: 0.6] [Reference Citation Analysis]
265 Poulain M, Doucet M, Major GC, Drapeau V, Sériès F, Boulet LP, Tremblay A, Maltais F. The effect of obesity on chronic respiratory diseases: pathophysiology and therapeutic strategies. CMAJ 2006;174:1293-9. [PMID: 16636330 DOI: 10.1503/cmaj.051299] [Cited by in Crossref: 215] [Cited by in F6Publishing: 172] [Article Influence: 13.4] [Reference Citation Analysis]
266 Chen C, Shen Y, Ni CJ, Zhu YH, Huang JA. Imbalance of circulating T-lymphocyte subpopulation in COPD and its relationship with CAT performance. J Clin Lab Anal 2012;26:109-14. [PMID: 22467326 DOI: 10.1002/jcla.21490] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
267 Menn P, Leidl R, Holle R. A lifetime Markov model for the economic evaluation of chronic obstructive pulmonary disease. Pharmacoeconomics 2012;30:825-40. [PMID: 22799876 DOI: 10.2165/11591340-000000000-00000] [Cited by in Crossref: 28] [Cited by in F6Publishing: 20] [Article Influence: 3.1] [Reference Citation Analysis]
268 Zhang J, Li G, Laukkanen JA, Liu C, Song X, Zhu Y. Low body mass is associated with reduced left ventricular mass in Chinese elderly with severe COPD. Sci Rep 2021;11:13074. [PMID: 34158542 DOI: 10.1038/s41598-021-92212-0] [Reference Citation Analysis]
269 Nazir SA, Erbland ML. Chronic obstructive pulmonary disease: an update on diagnosis and management issues in older adults. Drugs Aging 2009;26:813-31. [PMID: 19761275 DOI: 10.2165/11316760-000000000-00000] [Cited by in Crossref: 38] [Cited by in F6Publishing: 27] [Article Influence: 3.2] [Reference Citation Analysis]
270 Yuan R, Hogg JC, Paré PD, Sin DD, Wong JC, Nakano Y, McWilliams AM, Lam S, Coxson HO. Prediction of the rate of decline in FEV(1) in smokers using quantitative Computed Tomography. Thorax 2009;64:944-9. [PMID: 19734130 DOI: 10.1136/thx.2008.112433] [Cited by in Crossref: 54] [Cited by in F6Publishing: 59] [Article Influence: 4.2] [Reference Citation Analysis]
271 Tung NT, Ho SC, Lu YH, Chen TT, Lee KY, Chen KY, Wu CD, Chung KF, Kuo HP, Thao HNX, Dung HB, Thuy TPC, Wu SM, Kou HY, Lee YL, Chuang HC. Association Between Air Pollution and Lung Lobar Emphysema in COPD. Front Med (Lausanne) 2021;8:705792. [PMID: 34621758 DOI: 10.3389/fmed.2021.705792] [Reference Citation Analysis]
272 Sabino PG, Silva BM, Brunetto AF. Nutritional status is related to fat-free mass, exercise capacity and inspiratory strength in severe chronic obstructive pulmonary disease patients. Clinics (Sao Paulo) 2010;65:599-605. [PMID: 20613936 DOI: 10.1590/S1807-59322010000600007] [Cited by in Crossref: 36] [Cited by in F6Publishing: 14] [Article Influence: 3.6] [Reference Citation Analysis]
273 Esteban C, Castro-Acosta A, Alvarez-Martínez CJ, Capelastegui A, López-Campos JL, Pozo-Rodriguez F. Predictors of one-year mortality after hospitalization for an exacerbation of COPD. BMC Pulm Med 2018;18:18. [PMID: 29370849 DOI: 10.1186/s12890-018-0574-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
274 Shah T, Press VG, Huisingh-Scheetz M, White SR. COPD Readmissions: Addressing COPD in the Era of Value-based Health Care. Chest 2016;150:916-26. [PMID: 27167208 DOI: 10.1016/j.chest.2016.05.002] [Cited by in F6Publishing: 61] [Reference Citation Analysis]
275 Wickerson L, Rozenberg D, Janaudis-Ferreira T, Deliva R, Lo V, Beauchamp G, Helm D, Gottesman C, Mendes P, Vieira L, Herridge M, Singer LG, Mathur S. Physical rehabilitation for lung transplant candidates and recipients: An evidence-informed clinical approach. World J Transplant 2016; 6(3): 517-531 [PMID: 27683630 DOI: 10.5500/wjt.v6.i3.517] [Cited by in CrossRef: 43] [Cited by in F6Publishing: 34] [Article Influence: 7.2] [Reference Citation Analysis]
276 Mehta AC, Avasarala SK, Criner GJ. What's in a Name: Introduction to the BART Index. Am J Respir Crit Care Med 2020;201:1160-1. [PMID: 31951473 DOI: 10.1164/rccm.201912-2443LE] [Reference Citation Analysis]
277 Martinez Rivera C, Costan Galicia J, Alcázar Navarrete B, Garcia-Polo C, Ruiz Iturriaga LA, Herrejón A, Ros Lucas JA, García-Sidro P, Tirado-Conde G, López-Campos JL, Mayoralas Alises S, de Miguel-Díez J, Esquinas C, Miravitlles M. Factors Associated with Depression in COPD: A Multicenter Study. Lung 2016;194:335-43. [PMID: 26932809 DOI: 10.1007/s00408-016-9862-7] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 4.3] [Reference Citation Analysis]
278 Laporta R, Ussetti P, Mora G, López C, Gómez D, De Pablo A, Teresa Lázaro M, Cruz Carreño M, José Ferreiro M. Características clínicas y funcionales antes del trasplante pulmonar. Experiencia en la Clínica Puerta de Hierro. Archivos de Bronconeumología 2008;44:424-7. [DOI: 10.1016/s0300-2896(08)72106-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
279 Bhatia S, Qualls C, Crowell TA, Arynchyn A, Thyagarajan B, Smith LJ, Kalhan R, Jacobs DR, Kramer H, Duprez D, Celli B, Sood A. Rapid decline in lung function in healthy adults predicts incident excess urinary albumin excretion later in life. BMJ Open Respir Res 2017;4:e000194. [PMID: 29071073 DOI: 10.1136/bmjresp-2017-000194] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
280 An L, Lin Y, Yang T, Hua L. Exploring the interaction among EPHX1, GSTP1, SERPINE2, and TGFB1 contributing to the quantitative traits of chronic obstructive pulmonary disease in Chinese Han population. Hum Genomics 2016;10:13. [PMID: 27193053 DOI: 10.1186/s40246-016-0076-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
281 Xie Y, Xue Q, Jiao W, Wu J, Yu Y, Zhao L, Xu Y, Deng X, Fang G, Zheng Y, Gao Z. Associations Between Sputum Torque Teno Virus Load and Lung Function and Disease Severity in Patients With Chronic Obstructive Pulmonary Disease. Front Med (Lausanne) 2021;8:618757. [PMID: 33968949 DOI: 10.3389/fmed.2021.618757] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
282 Bikov A, Lange P, Anderson JA, Brook RD, Calverley PMA, Celli BR, Cowans NJ, Crim C, Dixon IJ, Martinez FJ, Newby DE, Yates JC, Vestbo J. FEV1 is a stronger mortality predictor than FVC in patients with moderate COPD and with an increased risk for cardiovascular disease. Int J Chron Obstruct Pulmon Dis 2020;15:1135-42. [PMID: 32547001 DOI: 10.2147/COPD.S242809] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
283 Eisner MD, Omachi TA, Katz PP, Yelin EH, Iribarren C, Blanc PD. Measurement of COPD severity using a survey-based score: validation in a clinically and physiologically characterized cohort. Chest 2010;137:846-51. [PMID: 20040611 DOI: 10.1378/chest.09-1855] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
284 Choi SM, Lee J, Park YS, Lee CH, Lee SM, Yim JJ, Kim YW, Han SK, Yoo CG. Prevalence and global initiative for chronic obstructive lung disease group distribution of chronic obstructive pulmonary disease detected by preoperative pulmonary function test. PLoS One 2015;10:e0115787. [PMID: 25625286 DOI: 10.1371/journal.pone.0115787] [Cited by in Crossref: 3] [Cited by in F6Publishing: 11] [Article Influence: 0.4] [Reference Citation Analysis]
285 Izquierdo JL, Barcina C, Jiménez J, Muñoz M, Leal M. Study of the burden on patients with chronic obstructive pulmonary disease. Int J Clin Pract 2009;63:87-97. [PMID: 19125996 DOI: 10.1111/j.1742-1241.2008.01936.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 2.2] [Reference Citation Analysis]
286 Singer JP, Singer LG. Quality of life in lung transplantation. Semin Respir Crit Care Med 2013;34:421-30. [PMID: 23821515 DOI: 10.1055/s-0033-1348470] [Cited by in Crossref: 40] [Cited by in F6Publishing: 34] [Article Influence: 4.4] [Reference Citation Analysis]
287 Roberts MH, Mapel DW, Bruse S, Petersen H, Nyunoya T. Development of a modified BODE index as a mortality risk measure among older adults with and without chronic obstructive pulmonary disease. Am J Epidemiol 2013;178:1150-60. [PMID: 23928262 DOI: 10.1093/aje/kwt087] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
288 Raskin J, Janssens A, Van Meerbeeck JP. Treatment recommendations by clinicians in stage I non-small cell lung cancer: better work-up leads to less discussion. Ann Transl Med 2017;5:427. [PMID: 29201879 DOI: 10.21037/atm.2017.08.17] [Reference Citation Analysis]
289 McAllister DA, Maclay JD, Mills NL, Mair G, Miller J, Anderson D, Newby DE, Murchison JT, Macnee W. Arterial stiffness is independently associated with emphysema severity in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2007;176:1208-14. [PMID: 17885263 DOI: 10.1164/rccm.200707-1080OC] [Cited by in Crossref: 176] [Cited by in F6Publishing: 77] [Article Influence: 11.7] [Reference Citation Analysis]
290 Oga T, Tsukino M, Hajiro T, Ikeda A, Nishimura K. Predictive properties of different multidimensional staging systems in patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 2011;6:521-6. [PMID: 22069363 DOI: 10.2147/COPD.S24420] [Cited by in Crossref: 32] [Cited by in F6Publishing: 13] [Article Influence: 2.9] [Reference Citation Analysis]
291 Dal Negro RW, Celli BR. The BODECOST Index (BCI): a composite index for assessing the impact of COPD in real life. Multidiscip Respir Med 2016;11:10. [PMID: 26941954 DOI: 10.1186/s40248-016-0045-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
292 Anzueto AR, Kostikas K, Mezzi K, Shen S, Larbig M, Patalano F, Fogel R, Banerji D, Wedzicha JA. Indacaterol/glycopyrronium versus salmeterol/fluticasone in the prevention of clinically important deterioration in COPD: results from the FLAME study. Respir Res 2018;19:121. [PMID: 29925383 DOI: 10.1186/s12931-018-0830-z] [Cited by in Crossref: 16] [Cited by in F6Publishing: 20] [Article Influence: 4.0] [Reference Citation Analysis]
293 Alupo P, Wosu AC, Mahofa A, Mugenyi L, Semakula D, Katagira W, Kirenga B. Incidence and predictors of COPD mortality in Uganda: A 2-year prospective cohort study. PLoS One 2021;16:e0246850. [PMID: 33571315 DOI: 10.1371/journal.pone.0246850] [Reference Citation Analysis]
294 Bektas S, Franssen FME, van Empel V, Uszko-Lencer N, Boyne J, Knackstedt C, Brunner-La Rocca HP. Impact of airflow limitation in chronic heart failure. Neth Heart J 2017;25:335-42. [PMID: 28244013 DOI: 10.1007/s12471-017-0965-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.6] [Reference Citation Analysis]
295 Roca J, Vargas C, Cano I, Selivanov V, Barreiro E, Maier D, Falciani F, Wagner P, Cascante M, Garcia-Aymerich J, Kalko S, De Mas I, Tegnér J, Escarrabill J, Agustí A, Gomez-Cabrero D; Synergy-COPD consortium. Chronic Obstructive Pulmonary Disease heterogeneity: challenges for health risk assessment, stratification and management. J Transl Med 2014;12 Suppl 2:S3. [PMID: 25472887 DOI: 10.1186/1479-5876-12-S2-S3] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 2.4] [Reference Citation Analysis]
296 Diniz OHG, Pereira MC, da Silva SMD, Koenigkam-santos M, Paschoal IA, Moreira MM. Correlations between Volumetric Capnography and Automated Quantitative Computed Tomography Analysis in Patients with Severe COPD. JoR 2022;2:13-24. [DOI: 10.3390/jor2010002] [Reference Citation Analysis]
297 Enfield K, Gammon S, Floyd J, Falt C, Patrie J, Platts-Mills TA, Truwit JD, Shim YM. Six-minute walk distance in patients with severe end-stage COPD: association with survival after inpatient pulmonary rehabilitation. J Cardiopulm Rehabil Prev 2010;30:195-202. [PMID: 20040883 DOI: 10.1097/HCR.0b013e3181c565e4] [Cited by in Crossref: 29] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
298 Hersh CP, Make BJ, Lynch DA, Barr RG, Bowler RP, Calverley PM, Castaldi PJ, Cho MH, Coxson HO, DeMeo DL, Foreman MG, Han MK, Harshfield BJ, Hokanson JE, Lutz S, Ramsdell JW, Regan EA, Rennard SI, Schroeder JD, Sciurba FC, Steiner RM, Tal-Singer R, van Beek E Jr, Silverman EK, Crapo JD; COPDGene and ECLIPSE Investigators. Non-emphysematous chronic obstructive pulmonary disease is associated with diabetes mellitus. BMC Pulm Med 2014;14:164. [PMID: 25341556 DOI: 10.1186/1471-2466-14-164] [Cited by in Crossref: 34] [Cited by in F6Publishing: 37] [Article Influence: 4.3] [Reference Citation Analysis]
299 Lee SJ, Yun SS, Ju S, You JW, Cho YJ, Jeong YY, Kim JY, Kim HC, Lee JD. Validity of the GOLD 2017 classification in the prediction of mortality and respiratory hospitalization in patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 2019;14:911-9. [PMID: 31118600 DOI: 10.2147/COPD.S191362] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
300 Masson Silva JB, Tannus Silva DGS, Furtado RG, da Silva Júnior CG, Araújo FA, Costa SA, Marra da Madeira Freitas E, Rassi DDC, Rabahi MF, Rassi S. Correlation Between 2D Strain and Classic Echocardiographic Indices in the Diagnosis of Right Ventricular Dysfunction in COPD. Int J Chron Obstruct Pulmon Dis 2021;16:1967-76. [PMID: 34234427 DOI: 10.2147/COPD.S290957] [Reference Citation Analysis]
301 DeCamp MM Jr, Lipson D, Krasna M, Minai OA, McKenna RJ Jr, Thomashow BM. The evaluation and preparation of the patient for lung volume reduction surgery. Proc Am Thorac Soc 2008;5:427-31. [PMID: 18453350 DOI: 10.1513/pats.200707-087ET] [Cited by in Crossref: 20] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
302 Chang KY, Wu PC, Lee CH, Lee YC, Chen HC, Huang WC, Wu MF. Clinical Features and Antimicrobial Susceptibility of Pseudomonas aeruginosa and Acinetobacter baumannii Complex Isolates in Intensive Care Patients with Chronic Obstructive Pulmonary Disease and Community-Acquired Pneumonia in Taiwan. Int J Chron Obstruct Pulmon Dis 2021;16:1801-11. [PMID: 34168441 DOI: 10.2147/COPD.S311714] [Reference Citation Analysis]
303 Chuang ML, Wu TC, Wang YT, Wang YC, Tsao TC, Wei JC, Chen CY, Lin IF. Adjunctive Treatment with Rhodiola Crenulata in Patients with Chronic Obstructive Pulmonary Disease--A Randomized Placebo Controlled Double Blind Clinical Trial. PLoS One 2015;10:e0128142. [PMID: 26098419 DOI: 10.1371/journal.pone.0128142] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
304 Moll M, Lutz SM, Ghosh AJ, Sakornsakolpat P, Hersh CP, Beaty TH, Dudbridge F, Tobin MD, Mittleman MA, Silverman EK, Hobbs BD, Cho MH. Relative contributions of family history and a polygenic risk score on COPD and related outcomes: COPDGene and ECLIPSE studies. BMJ Open Respir Res 2020;7:e000755. [PMID: 33239407 DOI: 10.1136/bmjresp-2020-000755] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
305 Patel N, DeCamp M, Criner GJ. Lung transplantation and lung volume reduction surgery versus transplantation in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2008;5:447-53. [PMID: 18453354 DOI: 10.1513/pats.200707-107ET] [Cited by in Crossref: 23] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
306 Marrone O, Salvaggio A, Insalaco G. Respiratory disorders during sleep in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 2006;1:363-72. [PMID: 18044093 DOI: 10.2147/copd.2006.1.4.363] [Cited by in Crossref: 6] [Cited by in F6Publishing: 13] [Article Influence: 0.4] [Reference Citation Analysis]
307 Perez T, Burgel PR, Paillasseur JL, Caillaud D, Deslée G, Chanez P, Roche N; INITIATIVES BPCO Scientific Committee. Modified Medical Research Council scale vs Baseline Dyspnea Index to evaluate dyspnea in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 2015;10:1663-72. [PMID: 26316740 DOI: 10.2147/COPD.S82408] [Cited by in Crossref: 36] [Cited by in F6Publishing: 21] [Article Influence: 5.1] [Reference Citation Analysis]
308 Manian P. Chronic obstructive pulmonary disease classification, phenotypes and risk assessment. J Thorac Dis 2019;11:S1761-6. [PMID: 31632753 DOI: 10.21037/jtd.2019.05.10] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
309 de Voogd JN, Wempe JB, Postema K, van Sonderen E, Ranchor AV, Coyne JC, Sanderman R. More evidence that depressive symptoms predict mortality in COPD patients: is type D personality an alternative explanation? Ann Behav Med 2009;38:86-93. [PMID: 19513800 DOI: 10.1007/s12160-009-9105-8] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 2.3] [Reference Citation Analysis]
310 Yee N, Locke ER, Pike KC, Chen Z, Lee J, Huang JC, Nguyen HQ, Fan VS. Frailty in Chronic Obstructive Pulmonary Disease and Risk of Exacerbations and Hospitalizations. Int J Chron Obstruct Pulmon Dis 2020;15:1967-76. [PMID: 32848382 DOI: 10.2147/COPD.S245505] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
311 McNamara RJ, Kearns R, Dennis SM, F Harris M, Gardner K, McDonald J. Knowledge, Skill, and Confidence in People Attending Pulmonary Rehabilitation: A Cross-Sectional Analysis of the Effects and Determinants of Patient Activation. J Patient Exp 2019;6:117-25. [PMID: 31218257 DOI: 10.1177/2374373518778864] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
312 Fisk M, McEniery CM, Gale N, Mäki-Petäjä K, Forman JR, Munnery M, Woodcock-Smith J, Cheriyan J, Mohan D, Fuld J, Tal-Singer R, Polkey MI, Cockcroft JR, Wilkinson IB; ERICA Consortium and ACCT Investigators. Surrogate Markers of Cardiovascular Risk and Chronic Obstructive Pulmonary Disease: A Large Case-Controlled Study. Hypertension 2018;71:499-506. [PMID: 29358458 DOI: 10.1161/HYPERTENSIONAHA.117.10151] [Cited by in Crossref: 22] [Cited by in F6Publishing: 4] [Article Influence: 5.5] [Reference Citation Analysis]
313 Jouneau S, Crestani B, Thibault R, Lederlin M, Vernhet L, Yang M, Morgenthien E, Kirchgaessler KU, Cottin V. Post hoc Analysis of Clinical Outcomes in Placebo- and Pirfenidone-Treated Patients with IPF Stratified by BMI and Weight Loss. Respiration 2021;:1-13. [PMID: 34610600 DOI: 10.1159/000518855] [Reference Citation Analysis]
314 Meriem M, Cherif J, Toujani S, Ouahchi Y, Hmida AB, Beji M. Sit-to-stand test and 6-min walking test correlation in patients with chronic obstructive pulmonary disease. Ann Thorac Med 2015;10:269-73. [PMID: 26664565 DOI: 10.4103/1817-1737.165289] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 0.3] [Reference Citation Analysis]
315 Hwang J, Oh YM, Lee M, Choi S, Seo JB, Lee SM, Kim N. Low morphometric complexity of emphysematous lesions predicts survival in chronic obstructive pulmonary disease patients. Eur Radiol 2019;29:176-85. [PMID: 29959456 DOI: 10.1007/s00330-018-5551-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
316 Tsimogianni AM, Papiris SA, Stathopoulos GT, Manali ED, Roussos C, Kotanidou A. Predictors of outcome after exacerbation of chronic obstructive pulmonary disease. J Gen Intern Med 2009;24:1043-8. [PMID: 19597892 DOI: 10.1007/s11606-009-1061-2] [Cited by in Crossref: 29] [Cited by in F6Publishing: 33] [Article Influence: 2.2] [Reference Citation Analysis]
317 Unnewehr M, Schlesinger A, Stieglitz S, Köhler D. Greulich T, Fähndrich S, Clarenbach C et al. Alpha-1-Antitrypsin-Mangel (AATM) – Ein Expertenstatement. Pneumologie 2020; 74: 436-442, doi:10.1055/a-1143-8186. Pneumologie 2021;75:69-71. [PMID: 33461236 DOI: 10.1055/a-1251-6424] [Reference Citation Analysis]
318 Martin SA, Celli BR, DiFranza JR, Krinzman SJ, Clarke JG, Beam H, Howard S, Foster M, Goldberg RJ. Health effects of the Federal Bureau of Prisons tobacco ban. BMC Pulm Med 2012;12:64. [PMID: 23067295 DOI: 10.1186/1471-2466-12-64] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
319 Lindenauer PK, Stefan MS, Pekow PS, Mazor KM, Priya A, Spitzer KA, Lagu TC, Pack QR, Pinto-Plata VM, ZuWallack R. Association Between Initiation of Pulmonary Rehabilitation After Hospitalization for COPD and 1-Year Survival Among Medicare Beneficiaries. JAMA 2020;323:1813-23. [PMID: 32396181 DOI: 10.1001/jama.2020.4437] [Cited by in Crossref: 38] [Cited by in F6Publishing: 30] [Article Influence: 19.0] [Reference Citation Analysis]
320 Sonetti DA, Hospenthal AC, Adams SG. Integrated management strategies for chronic obstructive pulmonary disease. J Multidiscip Healthc 2010;3:181-8. [PMID: 21197367 DOI: 10.2147/JMDH.S8173] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
321 Sadaka AS, Montgomery AJ, Mourad SM, Polkey MI, Hopkinson NS. Exercise response to oxygen supplementation is not associated with survival in hypoxemic patients with obstructive lung disease. Int J Chron Obstruct Pulmon Dis 2018;13:1607-12. [PMID: 29844666 DOI: 10.2147/COPD.S163119] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
322 van Ranst D, Otten H, Meijer JW, van 't Hul AJ. Outcome of pulmonary rehabilitation in COPD patients with severely impaired health status. Int J Chron Obstruct Pulmon Dis 2011;6:647-57. [PMID: 22162650 DOI: 10.2147/COPD.S24579] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 0.7] [Reference Citation Analysis]
323 Kwan HY, Maddocks M, Nolan CM, Jones SE, Patel S, Barker RE, Kon SSC, Polkey MI, Cullinan P, Man WD. The prognostic significance of weight loss in chronic obstructive pulmonary disease-related cachexia: a prospective cohort study. J Cachexia Sarcopenia Muscle 2019;10:1330-8. [PMID: 31207189 DOI: 10.1002/jcsm.12463] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
324 Nyssen SM, Santos JG, Barusso MS, Oliveira AD Jr, Lorenzo VA, Jamami M. Levels of physical activity and predictors of mortality in COPD. J Bras Pneumol 2013;39:659-66. [PMID: 24473759 DOI: 10.1590/S1806-37132013000600004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.9] [Reference Citation Analysis]
325 Benzo RP, Kirsch JL, Dulohery MM, Abascal-Bolado B. Emotional Intelligence: A Novel Outcome Associated with Wellbeing and Self-Management in Chronic Obstructive Pulmonary Disease. Ann Am Thorac Soc 2016;13:10-6. [PMID: 26501370 DOI: 10.1513/AnnalsATS.201508-490OC] [Cited by in Crossref: 17] [Cited by in F6Publishing: 7] [Article Influence: 2.8] [Reference Citation Analysis]
326 Hahm CR, Lim MN, Kim HY, Hong SH, Han SS, Lee SJ, Kim WJ, Hong Y. Implications of the pulmonary artery to ascending aortic ratio in patients with relatively mild chronic obstructive pulmonary disease. J Thorac Dis 2016;8:1524-31. [PMID: 27499939 DOI: 10.21037/jtd.2016.05.79] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
327 Amjad E, Asnaashari S, Sokouti B. The role of associated genes of Wnt signaling pathway in chronic obstructive pulmonary disease (COPD). Gene Reports 2020;18:100582. [DOI: 10.1016/j.genrep.2019.100582] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
328 Ranucci M, Ballotta A, La Rovere MT, Castelvecchio S; Surgical and Clinical Outcome Research (SCORE) Group. Postoperative hypoxia and length of intensive care unit stay after cardiac surgery: the underweight paradox? PLoS One 2014;9:e93992. [PMID: 24709952 DOI: 10.1371/journal.pone.0093992] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 3.6] [Reference Citation Analysis]
329 Yoshikawa M, Kimura H. 1. Nutritional Impairment in Patients with COPD. J Jpn Soc Intern Med 2012;101:1562-70. [DOI: 10.2169/naika.101.1562] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
330 Ddungu A, Semitala FC, Castelnuovo B, Sekaggya-Wiltshire C, Worodria W, Kirenga BJ. Chronic obstructive pulmonary disease prevalence and associated factors in an urban HIV clinic in a low income country. PLoS One 2021;16:e0256121. [PMID: 34388209 DOI: 10.1371/journal.pone.0256121] [Reference Citation Analysis]
331 Benavides-córdoba V, Guerrero-jaramillo D, Betancourt-peña J. Pulmonary Rehabilitation in COVID-19: The Contribution of other Chronic Lung Syndromes for the Intervention of a Novel Disease. CRMR 2021;16:207-12. [DOI: 10.2174/1573398x17666210129124433] [Reference Citation Analysis]
332 Gulart AA, Munari AB, Klein SR, Venâncio RS, Alexandre HF, Mayer AF. The London Chest Activity of Daily Living scale cut-off point to discriminate functional status in patients with chronic obstructive pulmonary disease. Braz J Phys Ther 2020;24:264-72. [PMID: 30948247 DOI: 10.1016/j.bjpt.2019.03.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
333 Matsunaga K, Harada M, Suizu J, Oishi K, Asami-Noyama M, Hirano T. Comorbid Conditions in Chronic Obstructive Pulmonary Disease: Potential Therapeutic Targets for Unmet Needs. J Clin Med 2020;9:E3078. [PMID: 32987778 DOI: 10.3390/jcm9103078] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
334 Caram LM, Ferrari R, Naves CR, Tanni SE, Coelho LS, Zanati SG, Minicucci MF, Godoy I. Association between left ventricular diastolic dysfunction and severity of chronic obstructive pulmonary disease. Clinics (Sao Paulo) 2013;68:772-6. [PMID: 23778477 DOI: 10.6061/clinics/2013(06)08] [Cited by in Crossref: 18] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
335 Isaac M, Curtis JR. Improving quality of life for patients with terminal respiratory disease. Expert Review of Respiratory Medicine 2014;3:597-605. [DOI: 10.1586/ers.09.47] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
336 McNamara RJ, McKeough ZJ, Mo LR, Dallimore JT, Dennis SM. Community-based exercise training for people with chronic respiratory and chronic cardiac disease: a mixed-methods evaluation. Int J Chron Obstruct Pulmon Dis 2016;11:2839-50. [PMID: 27895476 DOI: 10.2147/COPD.S118724] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
337 Black-Shinn JL, Kinney GL, Wise AL, Regan EA, Make B, Krantz MJ, Barr RG, Murphy JR, Lynch D, Silverman EK, Crapo JD, Hokanson JE; COPDGene Investigators. Cardiovascular disease is associated with COPD severity and reduced functional status and quality of life. COPD 2014;11:546-51. [PMID: 24831864 DOI: 10.3109/15412555.2014.898029] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
338 Allwood BW, Stolbrink M, Baines N, Louw E, Wademan DT, Lupton-Smith A, Nel S, Maree D, Mpagama S, Osman M, Marx FM, Hoddinott G, Lesosky M, Rylance J, Mortimer K. Persistent chronic respiratory symptoms despite TB cure is poorly correlated with lung function. Int J Tuberc Lung Dis 2021;25:262-70. [PMID: 33762069 DOI: 10.5588/ijtld.20.0906] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
339 Santus P, Radovanovic D, Di Marco S, Valenti V, Raccanelli R, Blasi F, Centanni S, Bussotti M. Effect of indacaterol on lung deflation improves cardiac performance in hyperinflated COPD patients: an interventional, randomized, double-blind clinical trial. Int J Chron Obstruct Pulmon Dis 2015;10:1917-23. [PMID: 26392766 DOI: 10.2147/COPD.S91684] [Cited by in Crossref: 21] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
340 Lüthje L, Raupach T, Michels H, Unsöld B, Hasenfuss G, Kögler H, Andreas S. Exercise intolerance and systemic manifestations of pulmonary emphysema in a mouse model. Respir Res 2009;10:7. [PMID: 19175913 DOI: 10.1186/1465-9921-10-7] [Cited by in Crossref: 45] [Cited by in F6Publishing: 43] [Article Influence: 3.5] [Reference Citation Analysis]
341 Sandberg J, Ekström M, Börjesson M, Bergström G, Rosengren A, Angerås O, Toren K. Underlying contributing conditions to breathlessness among middle-aged individuals in the general population: a cross-sectional study. BMJ Open Respir Res 2020;7:e000643. [PMID: 32978243 DOI: 10.1136/bmjresp-2020-000643] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
342 Sand JM, Leeming DJ, Byrjalsen I, Bihlet AR, Lange P, Tal-Singer R, Miller BE, Karsdal MA, Vestbo J. High levels of biomarkers of collagen remodeling are associated with increased mortality in COPD - results from the ECLIPSE study. Respir Res 2016;17:125. [PMID: 27716343 DOI: 10.1186/s12931-016-0440-6] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 6.2] [Reference Citation Analysis]
343 Lashari BH, Myers C, Brown J, Galli J, Sehgal S. Recipient selection, timing of referral, and listing for lung transplantation. Indian J Thorac Cardiovasc Surg. [DOI: 10.1007/s12055-022-01330-5] [Reference Citation Analysis]
344 Puhan MA, Schünemann HJ, Frey M, Scharplatz M, Bachmann LM. How should COPD patients exercise during respiratory rehabilitation? Comparison of exercise modalities and intensities to treat skeletal muscle dysfunction. Thorax 2005;60:367-75. [PMID: 15860711 DOI: 10.1136/thx.2004.033274] [Cited by in Crossref: 78] [Cited by in F6Publishing: 52] [Article Influence: 4.6] [Reference Citation Analysis]
345 Paneroni M, Ambrosino N, Simonelli C, Bertacchini L, Venturelli M, Vitacca M. Physical Activity in Patients with Chronic Obstructive Pulmonary Disease on Long-Term Oxygen Therapy: A Cross-Sectional Study. Int J Chron Obstruct Pulmon Dis 2019;14:2815-23. [PMID: 31824146 DOI: 10.2147/COPD.S228465] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
346 Mannino DM. Spirometric screening: Does it work? Thorax 2006;61:834-5. [PMID: 17008480 DOI: 10.1136/thx.2006.061317] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
347 Tsai SH, Shih CY, Kuo CW, Liao XM, Lin PC, Chen CW, Hsiue TR, Chen CZ. Development and validation of a prediction index for recent mortality in advanced COPD patients. NPJ Prim Care Respir Med 2022;32:2. [PMID: 35027570 DOI: 10.1038/s41533-021-00263-7] [Reference Citation Analysis]
348 Stokes NR, Dietz BW, Liang JJ. Cardiopulmonary laboratory biomarkers in the evaluation of acute dyspnea. Open Access Emerg Med 2016;8:35-45. [PMID: 27307771 DOI: 10.2147/OAEM.S71446] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
349 Shin TR, Oh YM, Park JH, Lee KS, Oh S, Kang DR, Sheen S, Seo JB, Yoo KH, Lee JH, Kim TH, Lim SY, Yoon HI, Rhee CK, Choe KH, Lee JS, Lee SD. The Prognostic Value of Residual Volume/Total Lung Capacity in Patients with Chronic Obstructive Pulmonary Disease. J Korean Med Sci 2015;30:1459-65. [PMID: 26425043 DOI: 10.3346/jkms.2015.30.10.1459] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 2.6] [Reference Citation Analysis]
350 Gallego M, Pomares X, Capilla S, Marcos MA, Suárez D, Monsó E, Montón C. C-reactive protein in outpatients with acute exacerbation of COPD: its relationship with microbial etiology and severity. Int J Chron Obstruct Pulmon Dis 2016;11:2633-40. [PMID: 27799762 DOI: 10.2147/COPD.S117129] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 2.2] [Reference Citation Analysis]
351 McGinn J, Herbert B, Maloney A, Patton B, Lazzaro R. Quality of life outcomes in tracheobronchomalacia surgery. J Thorac Dis 2020;12:6925-30. [PMID: 33282396 DOI: 10.21037/jtd.2020.03.08] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
352 Negewo NA, Gibson PG, Wark PA, Simpson JL, McDonald VM. Treatment burden, clinical outcomes, and comorbidities in COPD: an examination of the utility of medication regimen complexity index in COPD. Int J Chron Obstruct Pulmon Dis 2017;12:2929-42. [PMID: 29062230 DOI: 10.2147/COPD.S136256] [Cited by in Crossref: 20] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
353 Benzo R, Wigle D, Novotny P, Wetzstein M, Nichols F, Shen RK, Cassivi S, Deschamps C. Preoperative pulmonary rehabilitation before lung cancer resection: results from two randomized studies. Lung Cancer 2011;74:441-5. [PMID: 21663994 DOI: 10.1016/j.lungcan.2011.05.011] [Cited by in Crossref: 132] [Cited by in F6Publishing: 118] [Article Influence: 12.0] [Reference Citation Analysis]
354 Ong KC, Lu SJ, Soh CS. Does the multidimensional grading system (BODE) correspond to differences in health status of patients with COPD? Int J Chron Obstruct Pulmon Dis 2006;1:91-6. [PMID: 18046907 DOI: 10.2147/copd.2006.1.1.91] [Cited by in Crossref: 8] [Cited by in F6Publishing: 14] [Article Influence: 0.5] [Reference Citation Analysis]
355 Siebeling L, Musoro JZ, Geskus RB, Zoller M, Muggensturm P, Frei A, Puhan MA, ter Riet G. Prediction of COPD-specific health-related quality of life in primary care COPD patients: a prospective cohort study. NPJ Prim Care Respir Med 2014;24:14060. [PMID: 25164146 DOI: 10.1038/npjpcrm.2014.60] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
356 Osadnik CR, Loeckx M, Louvaris Z, Demeyer H, Langer D, Rodrigues FM, Janssens W, Vogiatzis I, Troosters T. The likelihood of improving physical activity after pulmonary rehabilitation is increased in patients with COPD who have better exercise tolerance. Int J Chron Obstruct Pulmon Dis 2018;13:3515-27. [PMID: 30498342 DOI: 10.2147/COPD.S174827] [Cited by in Crossref: 25] [Cited by in F6Publishing: 7] [Article Influence: 6.3] [Reference Citation Analysis]
357 Mahboub BH, Vats MG, Al Zaabi A, Iqbal MN, Safwat T, Al-Hurish F, Miravitlles M, Singh D, Asad K, Zeineldine S, Al-Hajjaj MS. Joint statement for the diagnosis, management, and prevention of chronic obstructive pulmonary disease for Gulf Cooperation Council countries and Middle East-North Africa region, 2017. Int J Chron Obstruct Pulmon Dis 2017;12:2869-90. [PMID: 29070946 DOI: 10.2147/COPD.S136245] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 2.4] [Reference Citation Analysis]
358 Yeh GY, Wayne PM, Litrownik D, Roberts DH, Davis RB, Moy ML. Tai chi mind-body exercise in patients with COPD: study protocol for a randomized controlled trial. Trials 2014;15:337. [PMID: 25168853 DOI: 10.1186/1745-6215-15-337] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
359 Funk GC, Kirchheiner K, Burghuber OC, Hartl S. BODE index versus GOLD classification for explaining anxious and depressive symptoms in patients with COPD - a cross-sectional study. Respir Res 2009;10:1. [PMID: 19134192 DOI: 10.1186/1465-9921-10-1] [Cited by in Crossref: 53] [Cited by in F6Publishing: 48] [Article Influence: 4.1] [Reference Citation Analysis]
360 Machado FVC, Spruit MA, Groenen MTJ, Houben-Wilke S, van Melick PP, Hernandes NA, Schols AMWJ, Pitta F, Wouters EFM, Franssen FME. Frequency and functional translation of low muscle mass in overweight and obese patients with COPD. Respir Res 2021;22:93. [PMID: 33766023 DOI: 10.1186/s12931-021-01689-w] [Reference Citation Analysis]
361 António C, Gonçalves AP, Tavares A. Doença pulmonar obstrutiva crónica e exercício físico. Revista Portuguesa de Pneumologia 2010;16:649-58. [DOI: 10.1016/s0873-2159(15)30059-3] [Reference Citation Analysis]
362 Berraho M, Nejjari C, El Rhazi K, Tessier JF, Dartigues JF, Barberger-Gateau P, Raherison C. Dyspnea: a strong independent factor for long-term mortality in the elderly. J Nutr Health Aging 2013;17:908-12. [PMID: 24257576 DOI: 10.1007/s12603-013-0347-6] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
363 Román A, Ussetti P, Solé A, Zurbano F, Borro JM, Vaquero JM, de Pablo A, Morales P, Blanco M, Bravo C, Cifrian J, de la Torre M, Gámez P, Laporta R, Monforte V, Mons R, Salvatierra Á, Santos F, Solé J, Varela A. Guidelines for the Selection of Lung Transplantation Candidates. Archivos de Bronconeumología (English Edition) 2011;47:303-9. [DOI: 10.1016/j.arbr.2011.03.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
364 Fermont JM, Fisk M, Bolton CE, MacNee W, Cockcroft JR, Fuld J, Cheriyan J, Mohan D, Mäki-Petäjä KM, Al-Hadithi AB, Tal-Singer R, Müllerova H, Polkey MI, Wood AM, McEniery CM, Wilkinson IB; ERICA consortium. Cardiovascular risk prediction using physical performance measures in COPD: results from a multicentre observational study. BMJ Open 2020;10:e038360. [PMID: 33372069 DOI: 10.1136/bmjopen-2020-038360] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
365 Stamm JA, Belloli EA, Zhang Y, Bon J, Sciurba FC, Gladwin MT. Elevated N-terminal pro-brain natriuretic peptide is associated with mortality in tobacco smokers independent of airflow obstruction. PLoS One 2011;6:e27416. [PMID: 22087311 DOI: 10.1371/journal.pone.0027416] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
366 Burney PG, Hooper RL. The use of ethnically specific norms for ventilatory function in African-American and white populations. Int J Epidemiol 2012;41:782-90. [PMID: 22434864 DOI: 10.1093/ije/dys011] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 2.8] [Reference Citation Analysis]
367 Haile SR, Guerra B, Soriano JB, Puhan MA; 3CIA collaboration. Multiple Score Comparison: a network meta-analysis approach to comparison and external validation of prognostic scores. BMC Med Res Methodol 2017;17:172. [PMID: 29268701 DOI: 10.1186/s12874-017-0433-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
368 Citgez E, van der Palen J, Koehorst-Ter Huurne K, Movig K, van der Valk P, Brusse-Keizer M. Statins and morbidity and mortality in COPD in the COMIC study: a prospective COPD cohort study. BMJ Open Respir Res 2016;3:e000142. [PMID: 27403321 DOI: 10.1136/bmjresp-2016-000142] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
369 Altinoz H, Adiguzel N, Salturk C, Gungor G, Mocin O, Berk Takir H, Kargin F, Balci M, Dikensoy O, Karakurt Z. Obesity might be a good prognosis factor for COPD patients using domiciliary noninvasive mechanical ventilation. Int J Chron Obstruct Pulmon Dis 2016;11:1895-901. [PMID: 27578969 DOI: 10.2147/COPD.S108813] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
370 Richens JL, Urbanowicz RA, Lunt EA, Metcalf R, Corne J, Fairclough L, O'Shea P. Systems biology coupled with label-free high-throughput detection as a novel approach for diagnosis of chronic obstructive pulmonary disease. Respir Res 2009;10:29. [PMID: 19386108 DOI: 10.1186/1465-9921-10-29] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
371 Perez T, Deslée G, Burgel PR, Caillaud D, Le Rouzic O, Zysman M, Escamilla R, Jebrak G, Chanez P, Court-Fortune I, Brinchault-Rabin G, Nesme-Meyer P, Paillasseur JL, Roche N; Initiatives BPCO Scientific Committee. Predictors in routine practice of 6-min walking distance and oxygen desaturation in patients with COPD: impact of comorbidities. Int J Chron Obstruct Pulmon Dis 2019;14:1399-410. [PMID: 31308646 DOI: 10.2147/COPD.S188412] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 2.3] [Reference Citation Analysis]
372 Donária L, Mesquita R, Martinez L, Sípoli L, Felcar JM, Probst VS, Hernandes NA, Pitta F. Relationship between sniff nasal inspiratory pressure and BODE index in patients with COPD. Lung 2014;192:897-903. [PMID: 25270517 DOI: 10.1007/s00408-014-9649-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
373 Morisse Pradier H, Sénéchal A, Philit F, Tronc F, Maury JM, Grima R, Flamens C, Paulus S, Neidecker J, Mornex JF. [Indications of lung transplantation: Patients selection, timing of listing, and choice of procedure]. Rev Pneumol Clin 2016;72:87-94. [PMID: 25727653 DOI: 10.1016/j.pneumo.2014.11.003] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
374 Péran L, Beaumont M, Le Ber C, Le Mevel P, Berriet AC, Nowak E, Consigny M, Couturaud F. Effect of neuromuscular electrical stimulation on exercise capacity in patients with severe chronic obstructive pulmonary disease: A randomised controlled trial. Clin Rehabil 2022;:2692155221091802. [PMID: 35404157 DOI: 10.1177/02692155221091802] [Reference Citation Analysis]
375 Despotes KA, Choate R, Addrizzo-Harris D, Aksamit TR, Barker A, Basavaraj A, Daley CL, Eden E, DiMango A, Fennelly K, Philley J, Johnson MM, McShane PJ, Metersky ML, O'Donnell AE, Olivier KN, Salathe MA, Schmid A, Thomashow B, Tino G, Winthrop KL, Knowles MR, Daniels MLA, Noone PG. Nutrition and Markers of Disease Severity in Patients With Bronchiectasis. Chronic Obstr Pulm Dis 2020;7:390-403. [PMID: 33108111 DOI: 10.15326/jcopdf.7.4.2020.0178] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
376 González G, Ash SY, San José Estépar R, Washko G. Reply to Mummadi et al.: Overfitting and Use of Mismatched Cohorts in Deep Learning Models: Preventable Design Limitations. Am J Respir Crit Care Med 2018;198:545. [PMID: 29641211 DOI: 10.1164/rccm.201803-0540LE] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
377 Raju SV, Kim H, Byzek SA, Tang LP, Trombley JE, Jackson P, Rasmussen L, Wells JM, Libby EF, Dohm E, Winter L, Samuel SL, Zinn KR, Blalock JE, Schoeb TR, Dransfield MT, Rowe SM. A ferret model of COPD-related chronic bronchitis. JCI Insight 2016;1:e87536. [PMID: 27699245 DOI: 10.1172/jci.insight.87536] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
378 Raghunath S, Rajagopalan S, Karwoski RA, Maldonado F, Peikert T, Moua T, Ryu JH, Bartholmai BJ, Robb RA. Quantitative stratification of diffuse parenchymal lung diseases. PLoS One 2014;9:e93229. [PMID: 24676019 DOI: 10.1371/journal.pone.0093229] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 2.0] [Reference Citation Analysis]
379 Alvarado Miranda M, Cumplí Gargallo C, Sancho Muñoz A, Admetlló Papiol M, Martínez Llorens J, Balañá Corberó A. ¿La función muscular inspiratoria podría ser un equivalente de la insuflación pulmonar en los pacientes con EPOC? Open Respiratory Archives 2021;3:100084. [DOI: 10.1016/j.opresp.2021.100084] [Reference Citation Analysis]
380 Houchen-Wolloff L, Williams JE, Green RH, Woltmann G, Steiner MC, Sewell L, Morgan MD, Singh SJ. Survival following pulmonary rehabilitation in patients with COPD: the effect of program completion and change in incremental shuttle walking test distance. Int J Chron Obstruct Pulmon Dis 2018;13:37-44. [PMID: 29302187 DOI: 10.2147/COPD.S143101] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 2.2] [Reference Citation Analysis]
381 Scott AS, Baltzan MA, Fox J, Wolkove N. Success in pulmonary rehabilitation in patients with chronic obstructive pulmonary disease. Can Respir J 2010;17:219-23. [PMID: 21037996 DOI: 10.1155/2010/203236] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 2.7] [Reference Citation Analysis]
382 Chen X, May B, Di YM, Zhang AL, Lu C, Xue CC, Lin L. Oral Chinese herbal medicine combined with pharmacotherapy for stable COPD: a systematic review of effect on BODE index and six minute walk test. PLoS One 2014;9:e91830. [PMID: 24622390 DOI: 10.1371/journal.pone.0091830] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
383 Tunsupon P, Mador MJ. The Influence of Body Composition on Pulmonary Rehabilitation Outcomes in Chronic Obstructive Pulmonary Disease Patients. Lung 2017;195:729-38. [PMID: 28993936 DOI: 10.1007/s00408-017-0053-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
384 Guerra S, Sherrill DL, Kurzius-Spencer M, Venker C, Halonen M, Quan SF, Martinez FD. The course of persistent airflow limitation in subjects with and without asthma. Respir Med 2008;102:1473-82. [PMID: 18684603 DOI: 10.1016/j.rmed.2008.04.011] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 2.6] [Reference Citation Analysis]
385 Borghi-Silva A, Beltrame T, Reis MS, Sampaio LM, Catai AM, Arena R, Costa D. Relationship between oxygen consumption kinetics and BODE Index in COPD patients. Int J Chron Obstruct Pulmon Dis 2012;7:711-8. [PMID: 23118534 DOI: 10.2147/COPD.S35637] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
386 Estépar RS, Kinney GL, Black-Shinn JL, Bowler RP, Kindlmann GL, Ross JC, Kikinis R, Han MK, Come CE, Diaz AA, Cho MH, Hersh CP, Schroeder JD, Reilly JJ, Lynch DA, Crapo JD, Wells JM, Dransfield MT, Hokanson JE, Washko GR; COPDGene Study. Computed tomographic measures of pulmonary vascular morphology in smokers and their clinical implications. Am J Respir Crit Care Med 2013;188:231-9. [PMID: 23656466 DOI: 10.1164/rccm.201301-0162OC] [Cited by in Crossref: 111] [Cited by in F6Publishing: 80] [Article Influence: 12.3] [Reference Citation Analysis]
387 Préfaut C. BPCO : maladie générale à point de départ respiratoire. Revue de Pneumologie Clinique 2005;61:23-6. [DOI: 10.1016/s0761-8417(05)84881-3] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
388 Bertens LC, Reitsma JB, Moons KG, van Mourik Y, Lammers JW, Broekhuizen BD, Hoes AW, Rutten FH. Development and validation of a model to predict the risk of exacerbations in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 2013;8:493-9. [PMID: 24143086 DOI: 10.2147/COPD.S49609] [Cited by in Crossref: 25] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
389 Miravitlles M, Soler-Cataluña JJ, Calle M, Molina J, Almagro P, Quintano JA, Trigueros JA, Piñera P, Simón A, Riesco JA, Ancochea J, Soriano JB. A new approach to grading and treating COPD based on clinical phenotypes: summary of the Spanish COPD guidelines (GesEPOC). Prim Care Respir J 2013;22:117-21. [PMID: 23443227 DOI: 10.4104/pcrj.2013.00016] [Cited by in Crossref: 45] [Cited by in F6Publishing: 55] [Article Influence: 5.0] [Reference Citation Analysis]
390 Ongel EA, Karakurt Z, Salturk C, Takir HB, Burunsuzoglu B, Kargin F, Ekinci GH, Mocin O, Gungor G, Adiguzel N, Yilmaz A. How do COPD comorbidities affect ICU outcomes? Int J Chron Obstruct Pulmon Dis 2014;9:1187-96. [PMID: 25378919 DOI: 10.2147/COPD.S70257] [Cited by in Crossref: 4] [Cited by in F6Publishing: 12] [Article Influence: 0.5] [Reference Citation Analysis]
391 Waked M, Khayat G, Salameh P. Chronic obstructive pulmonary disease prevalence in Lebanon: a cross-sectional descriptive study. Clin Epidemiol 2011;3:315-23. [PMID: 22253549 DOI: 10.2147/CLEP.S26350] [Cited by in Crossref: 42] [Cited by in F6Publishing: 29] [Article Influence: 3.8] [Reference Citation Analysis]
392 Inoue S, Shibata Y, Kishi H, Nitobe J, Iwayama T, Yashiro Y, Nemoto T, Sato K, Sato M, Kimura T, Igarashi A, Tokairin Y, Kubota I. Decreased left ventricular stroke volume is associated with low-grade exercise tolerance in patients with chronic obstructive pulmonary disease. BMJ Open Respir Res 2017;4:e000158. [PMID: 28176968 DOI: 10.1136/bmjresp-2016-000158] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
393 García-Rio F, Soriano JB, Miravitlles M, Muñoz L, Duran-Tauleria E, Sánchez G, Sobradillo V, Ancochea J. Impact of obesity on the clinical profile of a population-based sample with chronic obstructive pulmonary disease. PLoS One 2014;9:e105220. [PMID: 25153331 DOI: 10.1371/journal.pone.0105220] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 4.5] [Reference Citation Analysis]
394 Sergysels R. Question 3-1. L’évaluation fonctionnelle de repos. Revue des Maladies Respiratoires 2005;22:20-3. [DOI: 10.1016/s0761-8425(05)85698-0] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
395 White P, White S, Edmonds P, Gysels M, Moxham J, Seed P, Shipman C. Palliative care or end-of-life care in advanced chronic obstructive pulmonary disease: a prospective community survey. Br J Gen Pract 2011;61:e362-70. [PMID: 21801516 DOI: 10.3399/bjgp11X578043] [Cited by in Crossref: 32] [Cited by in F6Publishing: 14] [Article Influence: 2.9] [Reference Citation Analysis]
396 Hartman JE, Welling JB, Klooster K, Carpaij OA, Augustijn SW, Slebos D. Survival in COPD patients treated with bronchoscopic lung volume reduction. Respiratory Medicine 2022;196:106825. [DOI: 10.1016/j.rmed.2022.106825] [Reference Citation Analysis]
397 Nakano H, Shibata Y, Inoue S, Igarashi A, Yamauchi K, Abe S, Sato M, Aida Y, Nunomiya K, Kimura T, Nemoto T, Watanabe T, Konta T, Ueno Y, Kato T, Kayama T, Kubota I. Relationships between values of antibodies to several connective tissue disease autoantigens and pulmonary function in a Japanese general population: the Takahata study. PLoS One 2013;8:e81678. [PMID: 24312572 DOI: 10.1371/journal.pone.0081678] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
398 Agustí A, Celli B. Natural history of COPD: gaps and opportunities. ERJ Open Res 2017;3:00117-2017. [PMID: 29255718 DOI: 10.1183/23120541.00117-2017] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
399 Duffy S, Marchetti N, Criner GJ. Surgical Therapies for Chronic Obstructive Pulmonary Disease. Clin Chest Med 2020;41:559-66. [PMID: 32800206 DOI: 10.1016/j.ccm.2020.06.011] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
400 Puente-Maestu L, Stringer WW. Hyperinflation and its management in COPD. Int J Chron Obstruct Pulmon Dis 2006;1:381-400. [PMID: 18044095 DOI: 10.2147/copd.2006.1.4.381] [Cited by in Crossref: 5] [Cited by in F6Publishing: 12] [Article Influence: 0.4] [Reference Citation Analysis]
401 Abascal-Bolado B, Novotny PJ, Sloan JA, Karpman C, Dulohery MM, Benzo RP. Forecasting COPD hospitalization in the clinic: optimizing the chronic respiratory questionnaire. Int J Chron Obstruct Pulmon Dis 2015;10:2295-301. [PMID: 26543362 DOI: 10.2147/COPD.S87469] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
402 McKay AJ, Pa M, Patel RK, Majeed A. Management of chronic obstructive pulmonary disease in India: a systematic review. JRSM Short Rep 2012;3:85. [PMID: 23481100 DOI: 10.1258/shorts.2012.012029] [Reference Citation Analysis]
403 Martinelli B, Santos IPD, Barrile SR, Iwamoto HCT, Gimenes C, Rosa DMC. Estimulação elétrica transcutânea diafragmática pela corrente russa em portadores de DPOC. Fisioter Pesqui 2016;23:345-51. [DOI: 10.1590/1809-2950/14854823042016] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
404 Punturieri A, Croxton TL, Weinmann GG, Kiley JP. Chronic obstructive pulmonary disease: a view from the NHLBI. Am J Respir Crit Care Med 2008;178:441-3. [PMID: 18713849 DOI: 10.1164/rccm.200807-1128OE] [Cited by in Crossref: 26] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
405 Athlin Å, Giezeman M, Hasselgren M, Montgomery S, Lisspers K, Ställberg B, Janson C, Sundh J. Prediction of Mortality Using Different COPD Risk Assessments - A 12-Year Follow-Up. Int J Chron Obstruct Pulmon Dis 2021;16:665-75. [PMID: 33758503 DOI: 10.2147/COPD.S282694] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
406 Gainza Miranda D, Sanz Peces EM, Alonso Babarro A, Prados Sánchez MC, Varela Cerdeira M. HOLD study (Home care Obstructive Lung Disease): natural history of patients with advanced COPD. BMC Palliat Care 2016;15:35. [PMID: 27001552 DOI: 10.1186/s12904-016-0104-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
407 Zhan ZW, Chen YA, Dong YH. Comparative Performance of Comorbidity Measures in Predicting Health Outcomes in Patients with Chronic Obstructive Pulmonary Disease. Int J Chron Obstruct Pulmon Dis 2020;15:335-44. [PMID: 32103932 DOI: 10.2147/COPD.S229646] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
408 Agarwala P, Salzman SH. Six-Minute Walk Test: Clinical Role, Technique, Coding, and Reimbursement. Chest 2020;157:603-11. [PMID: 31689414 DOI: 10.1016/j.chest.2019.10.014] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 5.3] [Reference Citation Analysis]
409 Represas-Represas C, Leiro-Fernández V, Mallo-Alonso R, Botana-Rial MI, Tilve-Gómez A, Fernández-Villar A. Excessive dynamic airway collapse in a small cohort of chronic obstructive pulmonary disease patients. Ann Thorac Med 2015;10:118-22. [PMID: 25829963 DOI: 10.4103/1817-1737.150733] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
410 Mouchantaf FG, Shostak E, Lamb CR. Characteristics and financial costs of patients with respiratory failure at bronchoscopy. J Bronchology Interv Pulmonol 2012;19:188-94. [PMID: 23207459 DOI: 10.1097/LBR.0b013e31825aa467] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]
411 Lamonaca P, Prinzi G, Kisialiou A, Cardaci V, Fini M, Russo P. Metabolic Disorder in Chronic Obstructive Pulmonary Disease (COPD) Patients: Towards a Personalized Approach Using Marine Drug Derivatives. Mar Drugs 2017;15:E81. [PMID: 28335527 DOI: 10.3390/md15030081] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
412 Courville CA, Tidwell S, Liu B, Accurso FJ, Dransfield MT, Rowe SM. Acquired defects in CFTR-dependent β-adrenergic sweat secretion in chronic obstructive pulmonary disease. Respir Res 2014;15:25. [PMID: 24568560 DOI: 10.1186/1465-9921-15-25] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 3.3] [Reference Citation Analysis]
413 Venkateswaran S, Tee A. Overlap syndrome between chronic obstructive pulmonary disease and obstructive sleep apnoea in a Southeast Asian teaching hospital. Singapore Med J 2014;55:488-92. [PMID: 25273934 DOI: 10.11622/smedj.2014117] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
414 Deng ZC, Zhao P, Cao C, Sun SF, Zhao F, Lu CY, Ma HY. C-reactive protein as a prognostic marker in chronic obstructive pulmonary disease. Exp Ther Med 2014;7:443-6. [PMID: 24396422 DOI: 10.3892/etm.2013.1441] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
415 Lamprecht B, McBurnie MA, Vollmer WM, Gudmundsson G, Welte T, Nizankowska-Mogilnicka E, Studnicka M, Bateman E, Anto JM, Burney P, Mannino DM, Buist SA; BOLD Collaborative Research Group. COPD in never smokers: results from the population-based burden of obstructive lung disease study. Chest 2011;139:752-63. [PMID: 20884729 DOI: 10.1378/chest.10-1253] [Cited by in Crossref: 258] [Cited by in F6Publishing: 250] [Article Influence: 21.5] [Reference Citation Analysis]
416 Sangwan V, Chaudhry D, Malik R. Dyspnea, Eosinopenia, Consolidation, Acidemia and Atrial Fibrillation Score and BAP-65 Score, Tools for Prediction of Mortality in Acute Exacerbations of Chronic Obstructive Pulmonary Disease: A Comparative Pilot Study. Indian J Crit Care Med 2017;21:671-7. [PMID: 29142379 DOI: 10.4103/ijccm.IJCCM_148_17] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
417 Chochinov HM, Johnston W, McClement SE, Hack TF, Dufault B, Enns M, Thompson G, Harlos M, Damant RW, Ramsey CD, Davison S, Zacharias J, Milke D, Strang D, Campbell-Enns HJ, Kredentser MS. Dignity and Distress towards the End of Life across Four Non-Cancer Populations. PLoS One 2016;11:e0147607. [PMID: 26808530 DOI: 10.1371/journal.pone.0147607] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 6.3] [Reference Citation Analysis]
418 Ferrari R, Tanni SE, Caram LM, Naves CR, Godoy I. Predictors of health status do not change over three-year periods and exacerbation makes difference in chronic obstructive pulmonary disease. Health Qual Life Outcomes 2011;9:112. [PMID: 22152155 DOI: 10.1186/1477-7525-9-112] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
419 Malaguti C, Mourão-junior CA, Chebli JM. Reply to "Six-minute walking test performance is associated with survival in cirrhotic patients" to the editor. WJH 2022;14:1048-50. [DOI: 10.4254/wjh.v14.i5.1048] [Reference Citation Analysis]
420 Creutzberg EC. Factors associated with prognosis in COPD: influence of body composition and systemic corticosteroid use on morbidity and mortality. Chron Respir Dis 2004;1:79-81. [PMID: 16279262 DOI: 10.1191/1479972304cd029ed] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
421 Terashima T, Chubachi S, Matsuzaki T, Nakajima T, Satoh M, Iwami E, Yoshida K, Katakura A, Betsuyaku T. The association between dental health and nutritional status in chronic obstructive pulmonary disease. Chron Respir Dis 2017;14:334-41. [PMID: 27056058 DOI: 10.1177/1479972316643076] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
422 Advani S, Braithwaite D. Optimizing selection of candidates for lung cancer screening: role of comorbidity, frailty and life expectancy. Transl Lung Cancer Res 2019;8:S454-9. [PMID: 32038937 DOI: 10.21037/tlcr.2019.10.03] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
423 Cazorla-Rivero S, Mura-Escorche G, Gonzalvo-Hernández F, Mayato D, Córdoba-Lanús E, Casanova C. Circulating miR-1246 in the Progression of Chronic Obstructive Pulmonary Disease (COPD) in Patients from the BODE Cohort. Int J Chron Obstruct Pulmon Dis 2020;15:2727-37. [PMID: 33149570 DOI: 10.2147/COPD.S271864] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
424 Lévesque J, Antoniadis A, Li PZ, Herengt F, Brosson C, Grosbois JM, Bernady A, Bender A, Favre M, Guerder A, Surpas P, Similowski T, Aguilaniu B. Minimal clinically important difference of 3-minute chair rise test and the DIRECT questionnaire after pulmonary rehabilitation in COPD patients. Int J Chron Obstruct Pulmon Dis 2019;14:261-9. [PMID: 30774324 DOI: 10.2147/COPD.S187567] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
425 Hersh CP. Pharmacogenetics of chronic obstructive pulmonary disease: challenges and opportunities. Pharmacogenomics 2010;11:237-47. [PMID: 20136362 DOI: 10.2217/pgs.09.176] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
426 Zhang J, Miller A, Li Y, Lan Q, Zhang N, Chai Y, Hai B. Comparison of Multiple Chronic Obstructive Pulmonary Disease (COPD) Indices in Chinese COPD Patients. Tuberc Respir Dis (Seoul) 2018;81:116-22. [PMID: 29527841 DOI: 10.4046/trd.2017.0082] [Reference Citation Analysis]
427 Córdoba-Lanús E, Cazorla-Rivero S, Espinoza-Jiménez A, de-Torres JP, Pajares MJ, Aguirre-Jaime A, Celli B, Casanova C. Telomere shortening and accelerated aging in COPD: findings from the BODE cohort. Respir Res 2017;18:59. [PMID: 28407775 DOI: 10.1186/s12931-017-0547-4] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 5.2] [Reference Citation Analysis]
428 Barakat S, Michele G, George P, Nicole V, Guy A. Outpatient pulmonary rehabilitation in patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 2008;3:155-62. [PMID: 18488439 DOI: 10.2147/copd.s2126] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
429 de Torres JP, Casanova C, Hernández C, Abreu J, Montejo de Garcini A, Aguirre-Jaime A, Celli BR. Gender associated differences in determinants of quality of life in patients with COPD: a case series study. Health Qual Life Outcomes 2006;4:72. [PMID: 17007639 DOI: 10.1186/1477-7525-4-72] [Cited by in Crossref: 66] [Cited by in F6Publishing: 67] [Article Influence: 4.1] [Reference Citation Analysis]
430 Gu S, Li R, Leader JK, Zheng B, Bon J, Gur D, Sciurba F, Jin C, Pu J. Obesity and extent of emphysema depicted at CT. Clin Radiol 2015;70:e14-9. [PMID: 25703460 DOI: 10.1016/j.crad.2015.01.007] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
431 Tse HN, Tseng CZ, Wong KY, Ng LY, Lai TL, Yee KS. Frequent Exacerbator: The Phenotype at Risk of Depressive Symptoms in Geriatric COPD Patients. Lung 2016;194:665-73. [PMID: 27140193 DOI: 10.1007/s00408-016-9887-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
432 Zeng Y, Jiang F, Chen Y, Chen P, Cai S. Exercise assessments and trainings of pulmonary rehabilitation in COPD: a literature review. Int J Chron Obstruct Pulmon Dis 2018;13:2013-23. [PMID: 29983556 DOI: 10.2147/COPD.S167098] [Cited by in Crossref: 22] [Cited by in F6Publishing: 5] [Article Influence: 5.5] [Reference Citation Analysis]
433 Disdier C, Bollo E, Morales P, Montero C. [Annual review of Archivos de Neumología in interventional pneumology, interstitial diseases and lung transplantation]. Arch Bronconeumol 2009;45 Suppl 1:39-42. [PMID: 19303530 DOI: 10.1016/S0300-2896(09)70271-6] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
434 Martinez CH, Okajima Y, Murray S, Washko GR, Martinez FJ, Silverman EK, Lee JH, Regan EA, Crapo JD, Curtis JL. Impact of self-reported gastroesophageal reflux disease in subjects from COPDGene cohort. Respir Res. 2014;15:62. [PMID: 24894541 DOI: 10.1186/1465-9921-15-62] [Cited by in Crossref: 39] [Cited by in F6Publishing: 44] [Article Influence: 4.9] [Reference Citation Analysis]
435 Triantafillidou C, Manali E, Lyberopoulos P, Kolilekas L, Kagouridis K, Gyftopoulos S, Vougas K, Kotanidou A, Alchanatis M, Karakatsani A, Papiris SA. The Role of Cardiopulmonary Exercise Test in IPF Prognosis. Pulm Med 2013;2013:514817. [PMID: 24288606 DOI: 10.1155/2013/514817] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
436 Charbek E, Espiritu JR, Nayak R, Morley JE. Editorial: Frailty, Comorbidity, and COPD. J Nutr Health Aging 2018;22:876-9. [PMID: 30272086 DOI: 10.1007/s12603-018-1068-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
437 Gladysheva ES, Malhotra A, Owens RL. Influencing the decline of lung function in COPD: use of pharmacotherapy. Int J Chron Obstruct Pulmon Dis 2010;5:153-64. [PMID: 20631815 DOI: 10.2147/copd.s4577] [Cited by in Crossref: 3] [Cited by in F6Publishing: 10] [Article Influence: 0.3] [Reference Citation Analysis]
438 Lane CR, Tonelli AR. Lung transplantation in chronic obstructive pulmonary disease: patient selection and special considerations. Int J Chron Obstruct Pulmon Dis 2015;10:2137-46. [PMID: 26491282 DOI: 10.2147/COPD.S78677] [Cited by in Crossref: 1] [Cited by in F6Publishing: 10] [Article Influence: 0.1] [Reference Citation Analysis]
439 Guillien A, Laurent L, Soumagne T, Puyraveau M, Laplante JJ, Andujar P, Annesi-Maesano I, Roche N, Degano B, Dalphin JC. Anxiety and depression among dairy farmers: the impact of COPD. Int J Chron Obstruct Pulmon Dis. 2018;13:1-9. [PMID: 29296078 DOI: 10.2147/copd.s143883] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
440 Sarkar SK, Basuthakur S, Das SK, Das A, Das S, Choudhury S, Datta S. Evaluation of correlation of BODE index with health-related quality of life among patients with stable COPD attending a tertiary care hospital. Lung India 2015;32:24-8. [PMID: 25624592 DOI: 10.4103/0970-2113.148434] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
441 Zeskind JE, Lenburg ME, Spira A. Translating the COPD transcriptome: insights into pathogenesis and tools for clinical management. Proc Am Thorac Soc 2008;5:834-41. [PMID: 19017738 DOI: 10.1513/pats.200807-074TH] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 2.2] [Reference Citation Analysis]
442 Kiszałkiewicz JM, Majewski S, Piotrowski WJ, Górski P, Pastuszak-Lewandoska D, Migdalska-Sęk M, Brzeziańska-Lasota E. Evaluation of selected IL6/STAT3 pathway molecules and miRNA expression in chronic obstructive pulmonary disease. Sci Rep 2021;11:22756. [PMID: 34815425 DOI: 10.1038/s41598-021-01950-8] [Reference Citation Analysis]
443 Hasegawa W, Yamauchi Y, Yasunaga H, Sunohara M, Jo T, Matsui H, Fushimi K, Takami K, Nagase T. Factors affecting mortality following emergency admission for chronic obstructive pulmonary disease. BMC Pulm Med 2014;14:151. [PMID: 25253449 DOI: 10.1186/1471-2466-14-151] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 4.3] [Reference Citation Analysis]
444 Qi Q, Li T, Li JC, Li Y. Association of body mass index with disease severity and prognosis in patients with non-cystic fibrosis bronchiectasis. Braz J Med Biol Res 2015;48:715-24. [PMID: 26176309 DOI: 10.1590/1414-431X20154135] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.1] [Reference Citation Analysis]
445 Abdulai RM, Jensen TJ, Patel NR, Polkey MI, Jansson P, Celli BR, Rennard SI. Deterioration of Limb Muscle Function during Acute Exacerbation of Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med 2018;197:433-49. [PMID: 29064260 DOI: 10.1164/rccm.201703-0615CI] [Cited by in Crossref: 28] [Cited by in F6Publishing: 14] [Article Influence: 9.3] [Reference Citation Analysis]
446 Ainge-Allen HW, Glanville AR. Timing it right: the challenge of recipient selection for lung transplantation. Ann Transl Med 2020;8:408. [PMID: 32355852 DOI: 10.21037/atm.2019.11.61] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
447 Sergysels R. BPCO et distension : une simple gonflette pour les physiologistes respiratoires ? Revue des Maladies Respiratoires 2009;26:1032-3. [DOI: 10.1016/s0761-8425(09)73527-2] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
448 Leard LE, Holm AM, Valapour M, Glanville AR, Attawar S, Aversa M, Campos SV, Christon LM, Cypel M, Dellgren G, Hartwig MG, Kapnadak SG, Kolaitis NA, Kotloff RM, Patterson CM, Shlobin OA, Smith PJ, Solé A, Solomon M, Weill D, Wijsenbeek MS, Willemse BWM, Arcasoy SM, Ramos KJ. Consensus document for the selection of lung transplant candidates: An update from the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 2021;40:1349-79. [PMID: 34419372 DOI: 10.1016/j.healun.2021.07.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
449 Burgel PR, Paillasseur JL, Roche N. Identification of clinical phenotypes using cluster analyses in COPD patients with multiple comorbidities. Biomed Res Int 2014;2014:420134. [PMID: 24683548 DOI: 10.1155/2014/420134] [Cited by in Crossref: 44] [Cited by in F6Publishing: 43] [Article Influence: 5.5] [Reference Citation Analysis]
450 Oelsner EC, Hoffman EA, Folsom AR, Carr JJ, Enright PL, Kawut SM, Kronmal R, Lederer D, Lima JA, Lovasi GS, Shea S, Barr RG. Association between emphysema-like lung on cardiac computed tomography and mortality in persons without airflow obstruction: a cohort study. Ann Intern Med 2014;161:863-73. [PMID: 25506855 DOI: 10.7326/M13-2570] [Cited by in Crossref: 55] [Cited by in F6Publishing: 44] [Article Influence: 7.9] [Reference Citation Analysis]
451 Oprescu N, McCormack FX, Byrnes S, Kinder BW. Clinical predictors of mortality and cause of death in lymphangioleiomyomatosis: a population-based registry. Lung 2013;191:35-42. [PMID: 23007140 DOI: 10.1007/s00408-012-9419-3] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 3.6] [Reference Citation Analysis]
452 de Moraes MR, da Costa AC, Corrêa Kde S, Junqueira-Kipnis AP, Rabahi MF. Interleukin-6 and interleukin-8 blood levels' poor association with the severity and clinical profile of ex-smokers with COPD. Int J Chron Obstruct Pulmon Dis 2014;9:735-43. [PMID: 25114519 DOI: 10.2147/COPD.S64135] [Cited by in Crossref: 7] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
453 Lee SJ, Lee HR, Lee TW, Ju S, Lim S, Go SI, You JW, Cho YJ, Lee GW, Jeong YY, Kim HC, Lee JD. Usefulness of neutrophil to lymphocyte ratio in patients with chronic obstructive pulmonary disease: a prospective observational study. Korean J Intern Med 2016;31:891-8. [PMID: 27017385 DOI: 10.3904/kjim.2015.084] [Cited by in Crossref: 25] [Cited by in F6Publishing: 31] [Article Influence: 4.2] [Reference Citation Analysis]
454 Baines KJ, Negewo NA, Gibson PG, Fu JJ, Simpson JL, Wark PAB, Fricker M, McDonald VM. A Sputum 6 Gene Expression Signature Predicts Inflammatory Phenotypes and Future Exacerbations of COPD. Int J Chron Obstruct Pulmon Dis 2020;15:1577-90. [PMID: 32669843 DOI: 10.2147/COPD.S245519] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
455 Agusti A, Calverley PM, Celli B, Coxson HO, Edwards LD, Lomas DA, MacNee W, Miller BE, Rennard S, Silverman EK, Tal-Singer R, Wouters E, Yates JC, Vestbo J; Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) investigators. Characterisation of COPD heterogeneity in the ECLIPSE cohort. Respir Res 2010;11:122. [PMID: 20831787 DOI: 10.1186/1465-9921-11-122] [Cited by in Crossref: 620] [Cited by in F6Publishing: 642] [Article Influence: 51.7] [Reference Citation Analysis]
456 Chung KF. Salmeterol/fluticasone combination in the treatment of COPD. Int J Chron Obstruct Pulmon Dis 2006;1:235-42. [PMID: 18046860 DOI: 10.2147/copd.2006.1.3.235] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
457 Lin WY, Verma VK, Lee MY, Lin HC, Lai CS. Prediction of 30-Day Readmission for COPD Patients Using Accelerometer-Based Activity Monitoring. Sensors (Basel) 2019;20:E217. [PMID: 31905995 DOI: 10.3390/s20010217] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
458 Gao J, Prasad N. Chronic obstructive pulmonary disease in China: the potential role of indacaterol. J Thorac Dis 2013;5:549-58. [PMID: 23991315 DOI: 10.3978/j.issn.2072-1439.2013.08.04] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
459 Yang L, Zhu Y, Huang JA, Jin J, Zhang X. A Low Lean-to-Fat Ratio Reduces the Risk of Acute Exacerbation of Chronic Obstructive Pulmonary Disease in Patients with a Normal or Low Body Mass Index. Med Sci Monit 2019;25:5229-36. [PMID: 31302663 DOI: 10.12659/MSM.914783] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
460 Chaudhary N, Luettich K, Peck MJ, Pierri E, Felber-Medlin L, Vuillaume G, Leroy P, Hoeng J, Peitsch MC. Physiological and biological characterization of smokers with and without COPD. F1000Res 2017;6:877. [PMID: 29862011 DOI: 10.12688/f1000research.11698.2] [Reference Citation Analysis]
461 Strong M, Green A, Goyder E, Miles G, Lee AC, Basran G, Cooke J. Accuracy of diagnosis and classification of COPD in primary and specialist nurse-led respiratory care in Rotherham, UK: a cross-sectional study. Prim Care Respir J 2014;23:67-73. [PMID: 24477772 DOI: 10.4104/pcrj.2014.00005] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
462 Turner AM, Sen S, Steeley C, Khan Y, Sweeney P, Richards Y, Mukherjee R. Evaluation of oxygen prescription in relation to hospital admission rate in patients with chronic obstructive pulmonary disease. BMC Pulm Med 2014;14:127. [PMID: 25096821 DOI: 10.1186/1471-2466-14-127] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
463 Couillard A, Veale D, Muir JF. [Comorbidities in COPD: a new challenge in clinical practice]. Rev Pneumol Clin 2011;67:143-53. [PMID: 21665077 DOI: 10.1016/j.pneumo.2010.05.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
464 Putcha N, Drummond MB, Connett JE, Scanlon PD, Tashkin DP, Hansel NN, Wise RA. Chronic productive cough is associated with death in smokers with early COPD. COPD 2014;11:451-8. [PMID: 24127996 DOI: 10.3109/15412555.2013.837870] [Cited by in Crossref: 14] [Cited by in F6Publishing: 19] [Article Influence: 1.6] [Reference Citation Analysis]
465 de Torres JP, Casanova C, Montejo de Garcini A, Aguirre-Jaime A, Celli BR. Gender and respiratory factors associated with dyspnea in chronic obstructive pulmonary disease. Respir Res 2007;8:18. [PMID: 17341300 DOI: 10.1186/1465-9921-8-18] [Cited by in Crossref: 42] [Cited by in F6Publishing: 39] [Article Influence: 2.8] [Reference Citation Analysis]
466 Lee SA, Sun JS, Park JH, Park KJ, Lee SS, Choi H, Sheen SS, Chung WY, Lee KS, Park KJ, Hwang SC. Emphysema as a risk factor for the outcome of surgical resection of lung cancer. J Korean Med Sci 2010;25:1146-51. [PMID: 20676324 DOI: 10.3346/jkms.2010.25.8.1146] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
467 Cardoso J, Coelho R, Rocha C, Coelho C, Semedo L, Bugalho Almeida A. Prediction of severe exacerbations and mortality in COPD: the role of exacerbation history and inspiratory capacity/total lung capacity ratio. Int J Chron Obstruct Pulmon Dis 2018;13:1105-13. [PMID: 29670346 DOI: 10.2147/COPD.S155848] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
468 Ham HS, Lee HY, Lee SJ, Cho YJ, Jung YY, Kim HC, Hahm JR, Park CH, Lee JD, Sohn HJ, Youn HS, Hwang YS. Relationship between Systemic Inflammatory Marker, Oxidative Stress and Body Mass Index in Stable COPD Patient. Tuberc Respir Dis 2006;61:330. [DOI: 10.4046/trd.2006.61.4.330] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
469 Lim JU, Lee JH, Kim JS, Hwang YI, Kim TH, Lim SY, Yoo KH, Jung KS, Kim YK, Rhee CK. Comparison of World Health Organization and Asia-Pacific body mass index classifications in COPD patients.Int J Chron Obstruct Pulmon Dis. 2017;12:2465-2475. [PMID: 28860741 DOI: 10.2147/COPD.S141295] [Cited by in Crossref: 92] [Cited by in F6Publishing: 56] [Article Influence: 18.4] [Reference Citation Analysis]
470 Foreman MG, Wilson C, DeMeo DL, Hersh CP, Beaty TH, Cho MH, Ziniti J, Curran-Everett D, Criner G, Hokanson JE, Brantly M, Rouhani FN, Sandhaus RA, Crapo JD, Silverman EK; Genetic Epidemiology of COPD (COPDGene) Investigators * . Alpha-1 Antitrypsin PiMZ Genotype Is Associated with Chronic Obstructive Pulmonary Disease in Two Racial Groups. Ann Am Thorac Soc 2017;14:1280-7. [PMID: 28380308 DOI: 10.1513/AnnalsATS.201611-838OC] [Cited by in Crossref: 32] [Cited by in F6Publishing: 18] [Article Influence: 8.0] [Reference Citation Analysis]
471 Horne BD, Hegewald MJ, Crim C, Rea S, Bair TL, Blagev DP. The Summit Score Stratifies Mortality and Morbidity in Chronic Obstructive Pulmonary Disease. Int J Chron Obstruct Pulmon Dis 2020;15:1741-50. [PMID: 32764918 DOI: 10.2147/COPD.S254437] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
472 Mehrotra N, Freire AX, Bauer DC, Harris TB, Newman AB, Kritchevsky SB, Meibohm B; Health ABC Study. Predictors of mortality in elderly subjects with obstructive airway disease: the PILE score. Ann Epidemiol 2010;20:223-32. [PMID: 20159492 DOI: 10.1016/j.annepidem.2009.11.005] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 1.7] [Reference Citation Analysis]
473 Bhatt SP, Bodduluri S, Raghav V, Bhakta NR, Wilson CG, Kim YI, Eberlein M, Sciurba FC, Han MK, Dransfield MT, Nakhmani A. The Peak Index: Spirometry Metric for Airflow Obstruction Severity and Heterogeneity. Ann Am Thorac Soc 2019;16:982-9. [PMID: 30865842 DOI: 10.1513/AnnalsATS.201811-812OC] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
474 Baz-Dávila R, Espinoza-Jiménez A, Rodríguez-Pérez Mdel C, Zulueta J, Varo N, Montejo Á, Almeida-González D, Aguirre-Jaime A, Córdoba-Lanús E, Casanova C. Role of HIF1A, VEGFA and VEGFR2 SNPs in the Susceptibility and Progression of COPD in a Spanish Population. PLoS One 2016;11:e0154998. [PMID: 27163696 DOI: 10.1371/journal.pone.0154998] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
475 Leite Rodrigues S, Augusto Melo e Silva C, Ferreira Amorim C, Lima T, Almeida Ribeiro F, Alberto de Assis Viegas C. Correlação entre hipoxemia moderada e função muscular esquelética periférica na doença pulmonar obstrutiva crónica – Estudo-piloto. Revista Portuguesa de Pneumologia 2008;14:769-85. [DOI: 10.1016/s0873-2159(15)30286-5] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
476 Halpin D. Mortality in COPD: inevitable or preventable? Insights from the cardiovascular arena. COPD 2008;5:187-200. [PMID: 18568843 DOI: 10.1080/15412550802093041] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
477 Ge H, Jiang Z, Huang Q, Zhu M, Yang J. [Correlation between pulmonary function indexes and survival time in patients with advanced lung cancer]. Zhongguo Fei Ai Za Zhi 2013;16:359-63. [PMID: 23866666 DOI: 10.3779/j.issn.1009-3419.2013.07.05] [Reference Citation Analysis]
478 Lee JS, Rhee CK, Yoo KH, Lee JH, Yoon HI, Kim TH, Kim WJ, Lee J, Lim SY, Park TS, Lee JS, Lee SW, Lee SD, Oh YM. Three-month treatment response and exacerbation in chronic obstructive pulmonary disease. J Korean Med Sci 2015;30:54-9. [PMID: 25552883 DOI: 10.3346/jkms.2015.30.1.54] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
479 Shah A, Ng X, Shah R, Solem C, Wang P, Obradovic M. Psychometric Validation of the EQ-5D-3L in Patients with Nontuberculous Mycobacterial (NTM) Lung Disease Caused by Mycobacterium avium Complex (MAC). Patient Relat Outcome Meas 2021;12:45-54. [PMID: 33658880 DOI: 10.2147/PROM.S272075] [Reference Citation Analysis]
480 Fathy EM, Shafiek H, Morsi TS, El Sabaa B, Elnekidy A, Elhoffy M, Atta MS. Image-enhanced bronchoscopic evaluation of bronchial mucosal microvasculature in COPD. Int J Chron Obstruct Pulmon Dis 2016;11:2447-55. [PMID: 27729785 DOI: 10.2147/COPD.S109788] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
481 Sundh J, Montgomery S, Hasselgren M, Kämpe M, Janson C, Ställberg B, Lisspers K. Change in health status in COPD: a seven-year follow-up cohort study. NPJ Prim Care Respir Med 2016;26:16073. [PMID: 27763623 DOI: 10.1038/npjpcrm.2016.73] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
482 Nardini S, Camiciottoli G, Locicero S, Maselli R, Pasqua F, Passalacqua G, Pela R, Pesci A, Sebastiani A, Vatrella A. COPD: maximization of bronchodilation. Multidiscip Respir Med 2014;9:50. [PMID: 25364503 DOI: 10.1186/2049-6958-9-50] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
483 Estrada-Alvarez JM, Orozco-Hernández JP, Aristizabal-Franco LE. Validation of chronic obstructive pulmonary disease severity score (COPDSS) for primary care in a Colombian population. Biomedica 2020;40:664-72. [PMID: 33275345 DOI: 10.7705/biomedica.5123] [Reference Citation Analysis]
484 Celli B, Locantore N, Yates JC, Bakke P, Calverley PMA, Crim C, Coxson HO, Lomas DA, MacNee W, Miller BE, Mullerova H, Rennard SI, Silverman EK, Wouters E, Tal-Singer R, Agusti A, Vestbo J; Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) Investigators. Markers of disease activity in COPD: an 8-year mortality study in the ECLIPSE cohort. Eur Respir J 2021;57:2001339. [PMID: 33303557 DOI: 10.1183/13993003.01339-2020] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
485 Make BJ, Martinez FJ. Assessment of patients with chronic obstructive pulmonary disease. Proc Am Thorac Soc 2008;5:884-90. [PMID: 19056711 DOI: 10.1513/pats.200808-093QC] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
486 Gompelmann D, Eberhardt R, Herth F. Endoscopic volume reduction in COPD- a critical review. Dtsch Arztebl Int 2014;111:827-33. [PMID: 25556601 DOI: 10.3238/arztebl.2014.0827] [Cited by in Crossref: 3] [Cited by in F6Publishing: 9] [Article Influence: 0.4] [Reference Citation Analysis]
487 van Ranst D, Stoop WA, Meijer JW, Otten HJ, van de Port IG. Reduction of exacerbation frequency in patients with COPD after participation in a comprehensive pulmonary rehabilitation program. Int J Chron Obstruct Pulmon Dis 2014;9:1059-67. [PMID: 25336938 DOI: 10.2147/COPD.S69574] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
488 Kuniaki H, Akihiko T, Tetsuya H, Hatsuko M, Tomoko K, Shin O, Sojiro K, Mayumi Y, Fumihiro Y, Shintaro S, Tsukasa O, Hironori S. Improvement in Frailty in a Patient With Severe Chronic Obstructive Pulmonary Disease After Ninjin'yoeito Therapy: A Case Report. Front Nutr 2018;5:71. [PMID: 30234120 DOI: 10.3389/fnut.2018.00071] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
489 Sarioglu N, Alpaydin AO, Coskun AS, Celik P, Ozyurt BC, Yorgancioglu A. Relationship between BODE index, quality of life and inflammatory cytokines in COPD patients. Multidiscip Respir Med 2010;5:84-91. [PMID: 22958780 DOI: 10.1186/2049-6958-5-2-84] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
490 Dijk WD, Bemt Lv, Haak-Rongen Sv, Bischoff E, Weel Cv, Veen JC, Schermer TR. Multidimensional prognostic indices for use in COPD patient care. A systematic review. Respir Res 2011;12:151. [PMID: 22082049 DOI: 10.1186/1465-9921-12-151] [Cited by in Crossref: 46] [Cited by in F6Publishing: 46] [Article Influence: 4.2] [Reference Citation Analysis]
491 Guler SA, Hur SA, Lear SA, Camp PG, Ryerson CJ. Body composition, muscle function, and physical performance in fibrotic interstitial lung disease: a prospective cohort study. Respir Res 2019;20:56. [PMID: 30866948 DOI: 10.1186/s12931-019-1019-9] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 4.7] [Reference Citation Analysis]
492 O'Donnell DE, Aaron S, Bourbeau J, Hernandez P, Marciniuk DD, Balter M, Ford G, Gervais A, Goldstein R, Hodder R, Kaplan A, Keenan S, Lacasse Y, Maltais F, Road J, Rocker G, Sin D, Sinuff T, Voduc N. Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease - 2007 update. Can Respir J 2007;14 Suppl B:5B-32B. [PMID: 17885691 DOI: 10.1155/2007/830570] [Cited by in Crossref: 210] [Cited by in F6Publishing: 210] [Article Influence: 15.0] [Reference Citation Analysis]
493 Osman S, Ziegler C, Gibson R, Mahmood R, Moraros J. The Association between Risk Factors and Chronic Obstructive Pulmonary Disease in Canada: A Cross-sectional Study Using the 2014 Canadian Community Health Survey. Int J Prev Med 2017;8:86. [PMID: 29142652 DOI: 10.4103/ijpvm.IJPVM_330_17] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
494 Bausewein C, Jolley C, Reilly C, Lobo P, Kelly J, Bellas H, Madan P, Panell C, Brink E, De Biase C, Gao W, Murphy C, McCrone P, Moxham J, Higginson IJ. Development, effectiveness and cost-effectiveness of a new out-patient Breathlessness Support Service: study protocol of a phase III fast-track randomised controlled trial. BMC Pulm Med 2012;12:58. [PMID: 22992240 DOI: 10.1186/1471-2466-12-58] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 2.6] [Reference Citation Analysis]
495 Zhang X, Ding K, Miao X, Wang J, Hu B, Shen J, Hu X, Xu Y, Yu B, Tu T, Lin A, Chen X, Huang Y. Associations between bone mineral density and chronic obstructive pulmonary disease. J Int Med Res 2022;50:3000605221094644. [PMID: 35579181 DOI: 10.1177/03000605221094644] [Reference Citation Analysis]
496 Pinto-Plata VM, Müllerova H, Toso JF, Feudjo-Tepie M, Soriano JB, Vessey RS, Celli BR. C-reactive protein in patients with COPD, control smokers and non-smokers. Thorax 2006;61:23-8. [PMID: 16143583 DOI: 10.1136/thx.2005.042200] [Cited by in Crossref: 208] [Cited by in F6Publishing: 225] [Article Influence: 12.2] [Reference Citation Analysis]
497 Kikuchi H, Shiozawa N, Takata S, Ashida K, Mitsunobu F. Effect of repeated Waon therapy on exercise tolerance and pulmonary function in patients with chronic obstructive pulmonary disease: a pilot controlled clinical trial. Int J Chron Obstruct Pulmon Dis 2014;9:9-15. [PMID: 24363555 DOI: 10.2147/COPD.S50860] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
498 Lin SH, Kuo PH, Kuo SH, Yang PC. Severity staging of chronic obstructive pulmonary disease: differences in pre- and post-bronchodilator spirometry. Yonsei Med J 2009;50:672-6. [PMID: 19881971 DOI: 10.3349/ymj.2009.50.5.672] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
499 Lee YK, Oh YM, Lee JH, Kim EK, Lee JH, Kim N, Seo JB, Lee SD; KOLD Study Group. Quantitative assessment of emphysema, air trapping, and airway thickening on computed tomography. Lung 2008;186:157-65. [PMID: 18351420 DOI: 10.1007/s00408-008-9071-0] [Cited by in Crossref: 130] [Cited by in F6Publishing: 136] [Article Influence: 9.3] [Reference Citation Analysis]
500 Suzuki M, Muro S, Fukui M, Ishizaki N, Sato S, Shiota T, Endo K, Suzuki T, Mitsuma T, Mishima M, Hirai T. Effects of acupuncture on nutritional state of patients with stable chronic obstructive pulmonary disease (COPD): re-analysis of COPD acupuncture trial, a randomized controlled trial. BMC Complement Altern Med 2018;18:287. [PMID: 30355325 DOI: 10.1186/s12906-018-2341-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
501 Albertson TE, Schivo M, Zeki AA, Louie S, Sutter ME, Avdalovic M, Chan AL. The pharmacological approach to the elderly COPD patient. Drugs Aging 2013;30:479-502. [PMID: 23580319 DOI: 10.1007/s40266-013-0080-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
502 Ramos D, Bertolini GN, Leite MR, Carvalho Junior LC, da Silva Pestana PR, dos Santos VR, Fortaleza AC, Rodrigues FM, Ramos EM. Is dynamometry able to infer the risk of muscle mass loss in patients with COPD? Int J Chron Obstruct Pulmon Dis 2015;10:1403-7. [PMID: 26229459 DOI: 10.2147/COPD.S69829] [Reference Citation Analysis]
503 Kim V, Goel N, Gangar J, Zhao H, Ciccolella DE, Silverman EK, Crapo JD, Criner GJ; and the COPD Gene Investigators. Risk Factors for Venous Thromboembolism in Chronic Obstructive Pulmonary Disease. Chronic Obstr Pulm Dis 2014;1:239-49. [PMID: 25844397 DOI: 10.15326/jcopdf.1.2.2014.0133#sthash.pvwPnxaI.dpuf] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 1.1] [Reference Citation Analysis]
504 Serrano-Mollar A. [Alveolar epithelial cell injury as an etiopathogenic factor in pulmonary fibrosis]. Arch Bronconeumol 2012;48 Suppl 2:2-6. [PMID: 23116901 DOI: 10.1016/S0300-2896(12)70044-3] [Cited by in Crossref: 23] [Article Influence: 2.6] [Reference Citation Analysis]
505 Drwal KR, Hurst D, Wakefield BJ. Effectiveness of a Home-Based Pulmonary Rehabilitation Program in Veterans. Telemed J E Health 2022. [PMID: 35584256 DOI: 10.1089/tmj.2022.0050] [Reference Citation Analysis]
506 Putman RK, Hatabu H, Araki T, Gudmundsson G, Gao W, Nishino M, Okajima Y, Dupuis J, Latourelle JC, Cho MH, El-Chemaly S, Coxson HO, Celli BR, Fernandez IE, Zazueta OE, Ross JC, Harmouche R, Estépar RS, Diaz AA, Sigurdsson S, Gudmundsson EF, Eiríksdottír G, Aspelund T, Budoff MJ, Kinney GL, Hokanson JE, Williams MC, Murchison JT, MacNee W, Hoffmann U, O'Donnell CJ, Launer LJ, Harrris TB, Gudnason V, Silverman EK, O'Connor GT, Washko GR, Rosas IO, Hunninghake GM; Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) Investigators., COPDGene Investigators. Association Between Interstitial Lung Abnormalities and All-Cause Mortality. JAMA 2016;315:672-81. [PMID: 26881370 DOI: 10.1001/jama.2016.0518] [Cited by in Crossref: 203] [Cited by in F6Publishing: 174] [Article Influence: 33.8] [Reference Citation Analysis]
507 Baldi S, Jose PE, Bruschi C, Pinna GD, Maestri R, Rezzani A, Bellinzona E, Fracchia C, Dacosto E, Crotti P, Montemartini S. The mediating role of cytokine IL-6 on the relationship of FEV₁ upon 6-minute walk distance in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 2014;9:1091-9. [PMID: 25336940 DOI: 10.2147/COPD.S57845] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
508 Dreher M, Neuzeret PC, Windisch W, Martens D, Hoheisel G, Gröschel A, Woehrle H, Fetsch T, Graml A, Köhnlein T. Prevalence Of Chronic Hypercapnia In Severe Chronic Obstructive Pulmonary Disease: Data From The HOmeVent Registry. Int J Chron Obstruct Pulmon Dis 2019;14:2377-84. [PMID: 31695357 DOI: 10.2147/COPD.S222803] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
509 Nielsen M, Bårnes CB, Ulrik CS. Clinical characteristics of the asthma-COPD overlap syndrome--a systematic review. Int J Chron Obstruct Pulmon Dis 2015;10:1443-54. [PMID: 26251584 DOI: 10.2147/COPD.S85363] [Cited by in Crossref: 6] [Cited by in F6Publishing: 40] [Article Influence: 0.9] [Reference Citation Analysis]
510 Tudorache V, Oancea C, Mlădinescu OF. Clinical relevance of maximal inspiratory pressure: determination in COPD exacerbation. Int J Chron Obstruct Pulmon Dis 2010;5:119-23. [PMID: 20461143 DOI: 10.2147/copd.s9194] [Cited by in Crossref: 2] [Cited by in F6Publishing: 8] [Article Influence: 0.2] [Reference Citation Analysis]
511 Lacedonia D, Carpagnano GE, Trotta T, Palladino GP, Panaro MA, Zoppo LD, Foschino Barbaro MP, Porro C. Microparticles in sputum of COPD patients: a potential biomarker of the disease? Int J Chron Obstruct Pulmon Dis 2016;11:527-33. [PMID: 27042041 DOI: 10.2147/COPD.S99547] [Cited by in Crossref: 7] [Cited by in F6Publishing: 17] [Article Influence: 1.2] [Reference Citation Analysis]
512 Ulubay G, Ulasli SS, Bozbas SS, Ozdemirel T, Karatas M. Effects of peripheral neuropathy on exercise capacity and quality of life in patients with chronic obstructive pulmonary diseases. Arch Med Sci 2012;8:296-302. [PMID: 22662003 DOI: 10.5114/aoms.2012.28557] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
513 Fathima M, Bawa Z, Mitchell B, Foster J, Armour C, Saini B. COPD Management in Community Pharmacy Results in Improved Inhaler Use, Immunization Rate, COPD Action Plan Ownership, COPD Knowledge, and Reductions in Exacerbation Rates. Int J Chron Obstruct Pulmon Dis 2021;16:519-33. [PMID: 33688177 DOI: 10.2147/COPD.S288792] [Reference Citation Analysis]
514 Mieczkowski B, Ezzie ME. Update on obstructive sleep apnea and its relation to COPD. Int J Chron Obstruct Pulmon Dis 2014;9:349-62. [PMID: 24748786 DOI: 10.2147/COPD.S42394] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
515 Chen H, Song Z, Qian M, Bai C, Wang X. Selection of disease-specific biomarkers by integrating inflammatory mediators with clinical informatics in AECOPD patients: a preliminary study. J Cell Mol Med 2012;16:1286-97. [PMID: 21883889 DOI: 10.1111/j.1582-4934.2011.01416.x] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 3.6] [Reference Citation Analysis]
516 Gianjoppe-santos J, Nyssen SM, Pessoa BV, Basso-vanelli RP, Jamami M, Di Lorenzo VAP. Chronic obstructive pulmonary disease Assessment Test na avaliação de pacientes com doença pulmonar obstrutiva crônica em reabilitação pulmonar: há relação com nível de dispneia nas atividades de vida diária e com índice preditor de mortalidade? Estudo transversal. Fisioter Pesqui 2013;20:379-86. [DOI: 10.1590/s1809-29502013000400013] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
517 Jo YS, Kim SK, Park SJ, Um SJ, Park YB, Jung KS, Kim DK, Yoo KH. Longitudinal change of FEV1 and inspiratory capacity: clinical implication and relevance to exacerbation risk in patients with COPD. Int J Chron Obstruct Pulmon Dis 2019;14:361-9. [PMID: 30787605 DOI: 10.2147/COPD.S189384] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
518 Zhao Y, Xu M, Liu M, Zhang Q, Xiong W. Clinical Implications of LTA4H Genetic Polymorphism in Patients with Chronic Obstructive Pulmonary Disease. COPD 2021;:1-8. [PMID: 34694182 DOI: 10.1080/15412555.2021.1993168] [Reference Citation Analysis]
519 Esteban C, Arostegui I, Aramburu A, Moraza J, Aburto M, Aizpiri S, Chasco L, Quintana JM. Changes in health-related quality of life as a marker in the prognosis in COPD patients. ERJ Open Res 2022;8:00181-2021. [PMID: 35036422 DOI: 10.1183/23120541.00181-2021] [Reference Citation Analysis]
520 Adrion C, Weiss B, Paul N, Berger E, Busse R, Marschall U, Caumanns J, Rosseau S, Mansmann U, Spies C; ERIC study group. Enhanced Recovery after Intensive Care (ERIC): study protocol for a German stepped wedge cluster randomised controlled trial to evaluate the effectiveness of a critical care telehealth program on process quality and functional outcomes. BMJ Open 2020;10:e036096. [PMID: 32978185 DOI: 10.1136/bmjopen-2019-036096] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
521 Kovelis D, Gomes ARS, Mazzarin C, de Miranda A, Valderramas S. Association Between the Results of the Timed Up-and-Go Test Adjusted for Disease Severity and Sarcopenia in Patients with Chronic Obstructive Pulmonary Disease: a Pilot Study. Clinics (Sao Paulo) 2019;74:e930. [PMID: 31721937 DOI: 10.6061/clinics/2019/e930] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
522 Lewthwaite H, Olds T, Williams MT, Effing TW, Dumuid D. Use of time in chronic obstructive pulmonary disease: Longitudinal associations with symptoms and quality of life using a compositional analysis approach. PLoS One 2019;14:e0214058. [PMID: 30897134 DOI: 10.1371/journal.pone.0214058] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
523 Myc LA, Shim YM, Laubach VE, Dimastromatteo J. Role of medical and molecular imaging in COPD. Clin Transl Med 2019;8:12. [PMID: 30989390 DOI: 10.1186/s40169-019-0231-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
524 Hersh CP, Hokanson JE, Lynch DA, Washko GR, Make BJ, Crapo JD, Silverman EK; COPDGene Investigators. Family history is a risk factor for COPD. Chest 2011;140:343-50. [PMID: 21310839 DOI: 10.1378/chest.10-2761] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 2.5] [Reference Citation Analysis]
525 Park HJ, Leem AY, Lee SH, Song JH, Park MS, Kim YS, Kim SK, Chang J, Chung KS. Comorbidities in obstructive lung disease in Korea: data from the fourth and fifth Korean National Health and Nutrition Examination Survey. Int J Chron Obstruct Pulmon Dis 2015;10:1571-82. [PMID: 26300636 DOI: 10.2147/COPD.S85767] [Cited by in Crossref: 2] [Cited by in F6Publishing: 12] [Article Influence: 0.3] [Reference Citation Analysis]
526 McCormack MC, Belli AJ, Kaji DA, Matsui EC, Brigham EP, Peng RD, Sellers C, Williams DL, Diette GB, Breysse PN, Hansel NN. Obesity as a susceptibility factor to indoor particulate matter health effects in COPD. Eur Respir J 2015;45:1248-57. [PMID: 25573407 DOI: 10.1183/09031936.00081414] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 3.9] [Reference Citation Analysis]
527 Navarro A, Costa R, Rodriguez-carballeira M, Yun S, Lapuente A, Barrera A, Acosta E, Viñas C, Heredia J, Almagro P. Prognostic assessment of mortality and hospitalizations of outpatients with advanced chronic obstructive pulmonary disease. Usefulness of the CODEX index. Revista Clínica Española (English Edition) 2015;215:431-8. [DOI: 10.1016/j.rceng.2015.07.002] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
528 Brightling CE, Bleecker ER, Panettieri RA Jr, Bafadhel M, She D, Ward CK, Xu X, Birrell C, van der Merwe R. Benralizumab for chronic obstructive pulmonary disease and sputum eosinophilia: a randomised, double-blind, placebo-controlled, phase 2a study. Lancet Respir Med 2014;2:891-901. [PMID: 25208464 DOI: 10.1016/S2213-2600(14)70187-0] [Cited by in Crossref: 181] [Cited by in F6Publishing: 77] [Article Influence: 22.6] [Reference Citation Analysis]
529 Moll M, Qiao D, Regan EA, Hunninghake GM, Make BJ, Tal-Singer R, McGeachie MJ, Castaldi PJ, San Jose Estepar R, Washko GR, Wells JM, LaFon D, Strand M, Bowler RP, Han MK, Vestbo J, Celli B, Calverley P, Crapo J, Silverman EK, Hobbs BD, Cho MH. Machine Learning and Prediction of All-Cause Mortality in COPD. Chest 2020;158:952-64. [PMID: 32353417 DOI: 10.1016/j.chest.2020.02.079] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
530 Roberts MH, Mapel DW, Ganvir N, Dodd MA. Frailty Among Older Individuals with and without COPD: A Cohort Study of Prevalence and Association with Adverse Outcomes. COPD 2022;Volume 17:701-17. [DOI: 10.2147/copd.s348714] [Reference Citation Analysis]
531 Wortz K, Cade A, Menard JR, Lurie S, Lykens K, Bae S, Jackson B, Su F, Singh K, Coultas D. A qualitative study of patients' goals and expectations for self-management of COPD. Prim Care Respir J 2012;21:384-91. [PMID: 23138844 DOI: 10.4104/pcrj.2012.00070] [Cited by in Crossref: 43] [Cited by in F6Publishing: 43] [Article Influence: 4.8] [Reference Citation Analysis]
532 de Blasio F, de Blasio F, Miracco Berlingieri G, Bianco A, La Greca M, Franssen FM, Scalfi L. Evaluation of body composition in COPD patients using multifrequency bioelectrical impedance analysis. Int J Chron Obstruct Pulmon Dis 2016;11:2419-26. [PMID: 27757027 DOI: 10.2147/COPD.S110364] [Cited by in Crossref: 15] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
533 He M, Yu S, Wang L, Lv H, Qiu Z. Efficiency and safety of pulmonary rehabilitation in acute exacerbation of chronic obstructive pulmonary disease. Med Sci Monit 2015;21:806-12. [PMID: 25783889 DOI: 10.12659/MSM.892769] [Cited by in Crossref: 21] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
534 Nguyen HQ, Donesky-Cuenco D, Carrieri-Kohlman V. Associations between symptoms, functioning, and perceptions of mastery with global self-rated health in patients with COPD: a cross-sectional study. Int J Nurs Stud 2008;45:1355-65. [PMID: 17983617 DOI: 10.1016/j.ijnurstu.2007.09.012] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 1.5] [Reference Citation Analysis]
535 Soler X, Gaio E, Powell FL, Ramsdell JW, Loredo JS, Malhotra A, Ries AL. High Prevalence of Obstructive Sleep Apnea in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease. Ann Am Thorac Soc 2015;12:1219-25. [PMID: 25871443 DOI: 10.1513/AnnalsATS.201407-336OC] [Cited by in Crossref: 18] [Cited by in F6Publishing: 53] [Article Influence: 3.0] [Reference Citation Analysis]
536 O'Donnell DE, Gebke KB. Activity restriction in mild COPD: a challenging clinical problem. Int J Chron Obstruct Pulmon Dis 2014;9:577-88. [PMID: 24940054 DOI: 10.2147/COPD.S62766] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
537 Rehman AU, Shah S, Abbas G, Harun SN, Shakeel S, Hussain R, Hassali MAA, Rasool MF. Assessment of risk factors responsible for rapid deterioration of lung function over a period of one year in patients with chronic obstructive pulmonary disease. Sci Rep 2021;11:13578. [PMID: 34193949 DOI: 10.1038/s41598-021-92968-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
538 Makita H, Nasuhara Y, Nagai K, Ito Y, Hasegawa M, Betsuyaku T, Onodera Y, Hizawa N, Nishimura M; Hokkaido COPD Cohort Study Group. Characterisation of phenotypes based on severity of emphysema in chronic obstructive pulmonary disease. Thorax 2007;62:932-7. [PMID: 17573447 DOI: 10.1136/thx.2006.072777] [Cited by in Crossref: 147] [Cited by in F6Publishing: 144] [Article Influence: 9.8] [Reference Citation Analysis]
539 Kamal AH, Maguire JM, Wheeler JL, Currow DC, Abernethy AP. Dyspnea review for the palliative care professional: assessment, burdens, and etiologies. J Palliat Med 2011;14:1167-72. [PMID: 21895451 DOI: 10.1089/jpm.2011.0109] [Cited by in Crossref: 31] [Cited by in F6Publishing: 19] [Article Influence: 2.8] [Reference Citation Analysis]
540 Andresen E, Günther G, Bullwinkel J, Lange C, Heine H. Increased expression of beta-defensin 1 (DEFB1) in chronic obstructive pulmonary disease. PLoS One 2011;6:e21898. [PMID: 21818276 DOI: 10.1371/journal.pone.0021898] [Cited by in Crossref: 46] [Cited by in F6Publishing: 42] [Article Influence: 4.2] [Reference Citation Analysis]
541 Keene JD, Jacobson S, Kechris K, Kinney GL, Foreman MG, Doerschuk CM, Make BJ, Curtis JL, Rennard SI, Barr RG, Bleecker ER, Kanner RE, Kleerup EC, Hansel NN, Woodruff PG, Han MK, Paine R 3rd, Martinez FJ, Bowler RP, O'Neal WK; COPDGene and SPIROMICS Investigators ‡. Biomarkers Predictive of Exacerbations in the SPIROMICS and COPDGene Cohorts. Am J Respir Crit Care Med 2017;195:473-81. [PMID: 27579823 DOI: 10.1164/rccm.201607-1330OC] [Cited by in Crossref: 62] [Cited by in F6Publishing: 48] [Article Influence: 12.4] [Reference Citation Analysis]
542 Park HJ, Byun MK, Kim T, Rhee CK, Kim K, Kim BY, Ahn SI, Jo YU, Yoo KH. Frequent Outpatient Visits Prevent Exacerbation of Chronic Obstructive Pulmonary Disease. Sci Rep 2020;10:6049. [PMID: 32269274 DOI: 10.1038/s41598-020-63064-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
543 Ferrari R, Caram LM, Faganello MM, Sanchez FF, Tanni SE, Godoy I. Relation between systemic inflammatory markers, peripheral muscle mass, and strength in limb muscles in stable COPD patients. Int J Chron Obstruct Pulmon Dis 2015;10:1553-8. [PMID: 26345641 DOI: 10.2147/COPD.S85954] [Cited by in Crossref: 23] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
544 Cao C, Wang R, Wang J, Bunjhoo H, Xu Y, Xiong W. Body mass index and mortality in chronic obstructive pulmonary disease: a meta-analysis. PLoS One 2012;7:e43892. [PMID: 22937118 DOI: 10.1371/journal.pone.0043892] [Cited by in Crossref: 80] [Cited by in F6Publishing: 93] [Article Influence: 8.0] [Reference Citation Analysis]
545 Mahut B, Caumont-Prim A, Plantier L, Gillet-Juvin K, Callens E, Sanchez O, Chevalier-Bidaud B, Bokov P, Delclaux C. Relationships between respiratory and airway resistances and activity-related dyspnea in patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 2012;7:165-71. [PMID: 22500118 DOI: 10.2147/COPD.S29745] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
546 González-Costello J, Armstrong HF, Jorde UP, Bevelaqua AC, Letarte L, Thomashow BM, Bartels MN. Chronotropic incompetence predicts mortality in severe obstructive pulmonary disease. Respir Physiol Neurobiol 2013;188:113-8. [PMID: 23669496 DOI: 10.1016/j.resp.2013.05.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
547 Goossens LM, Leimer I, Metzdorf N, Becker K, Rutten-van Mölken MP. Does the 2013 GOLD classification improve the ability to predict lung function decline, exacerbations and mortality: a post-hoc analysis of the 4-year UPLIFT trial. BMC Pulm Med 2014;14:163. [PMID: 25326750 DOI: 10.1186/1471-2466-14-163] [Cited by in Crossref: 28] [Cited by in F6Publishing: 41] [Article Influence: 3.5] [Reference Citation Analysis]
548 Simon KM, Hass AP, Zimmermman JL, Carpes MF. Índice prognóstico de mortalidade BODE e atividade física em doentes pulmonares obstrutivos crônicos. Rev Bras Med Esporte 2009;15:19-22. [DOI: 10.1590/s1517-86922009000100004] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
549 Boixeda R, Rabella N, Sauca G, Delgado M, Martínez-Costa X, Mauri M, Vicente V, Palomera E, Serra-Prat M, Capdevila JA. Microbiological study of patients hospitalized for acute exacerbation of chronic obstructive pulmonary disease (AE-COPD) and the usefulness of analytical and clinical parameters in its identification (VIRAE study). Int J Chron Obstruct Pulmon Dis 2012;7:327-35. [PMID: 22745532 DOI: 10.2147/COPD.S30568] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
550 Landers A, Wiseman R, Pitama S, Beckert L. Severe COPD and the transition to a palliative approach. Breathe (Sheff) 2017;13:310-6. [PMID: 29209424 DOI: 10.1183/20734735.013917] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
551 Jithoo A, Enright PL, Burney P, Buist AS, Bateman ED, Tan WC, Studnicka M, Mejza F, Gillespie S, Vollmer WM; BOLD Collaborative Research Group. Case-finding options for COPD: results from the Burden of Obstructive Lung Disease study. Eur Respir J 2013;41:548-55. [PMID: 22743668 DOI: 10.1183/09031936.00132011] [Cited by in Crossref: 39] [Cited by in F6Publishing: 36] [Article Influence: 3.9] [Reference Citation Analysis]
552 Kulkarni T, Yuan K, Tran-Nguyen TK, Kim YI, de Andrade JA, Luckhardt T, Valentine VG, Kass DJ, Duncan SR. Decrements of body mass index are associated with poor outcomes of idiopathic pulmonary fibrosis patients. PLoS One 2019;14:e0221905. [PMID: 31584949 DOI: 10.1371/journal.pone.0221905] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
553 Damato S, Bonatti C, Frigo V, Pappagallo S, Raccanelli R, Rampoldi C, Rodi F. Validation of the Clinical COPD questionnaire in Italian language. Health Qual Life Outcomes 2005;3:9. [PMID: 15698477 DOI: 10.1186/1477-7525-3-9] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 1.2] [Reference Citation Analysis]
554 Zucchi JW, Franco EAT, Schreck T, Castro E Silva MH, Migliorini SRDS, Garcia T, Mota GAF, de Morais BEB, Machado LHS, Batista ANR, de Paiva SAR, de Godoy I, Tanni SE. Different Clusters in Patients with Chronic Obstructive Pulmonary Disease (COPD): A Two-Center Study in Brazil. Int J Chron Obstruct Pulmon Dis 2020;15:2847-56. [PMID: 33192058 DOI: 10.2147/COPD.S268332] [Reference Citation Analysis]
555 López-Sánchez M, Muñoz-Esquerre M, Huertas D, Gonzalez-Costello J, Ribas J, Manresa F, Dorca J, Santos S. High Prevalence of Left Ventricle Diastolic Dysfunction in Severe COPD Associated with A Low Exercise Capacity: A Cross-Sectional Study. PLoS One 2013;8:e68034. [PMID: 23826360 DOI: 10.1371/journal.pone.0068034] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 3.7] [Reference Citation Analysis]
556 Xin Y, Guo C, Qi X, Tian H, Li X, Dai Q, Wang S, Wang C. Wearable and unconstrained systems based on PVDF sensors in physiological signals monitoring: A brief review. Ferroelectrics 2016;500:291-300. [DOI: 10.1080/00150193.2016.1230440] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
557 Millares L, Pérez-Brocal V, Ferrari R, Gallego M, Pomares X, García-Núñez M, Montón C, Capilla S, Monsó E, Moya A. Functional Metagenomics of the Bronchial Microbiome in COPD. PLoS One 2015;10:e0144448. [PMID: 26632844 DOI: 10.1371/journal.pone.0144448] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 3.7] [Reference Citation Analysis]
558 Kim C, Park YB, Park SY, Park S, Kim CH, Park SM, Lee MG, Hyun IG, Jung KS, Kim DG. COPD patients with exertional desaturation are at a higher risk of rapid decline in lung function. Yonsei Med J 2014;55:732-8. [PMID: 24719141 DOI: 10.3349/ymj.2014.55.3.732] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
559 Durheim MT, Smith PJ, Babyak MA, Mabe SK, Martinu T, Welty-Wolf KE, Emery CF, Palmer SM, Blumenthal JA. Six-minute-walk distance and accelerometry predict outcomes in chronic obstructive pulmonary disease independent of Global Initiative for Chronic Obstructive Lung Disease 2011 Group. Ann Am Thorac Soc 2015;12:349-56. [PMID: 25568929 DOI: 10.1513/AnnalsATS.201408-365OC] [Cited by in Crossref: 31] [Cited by in F6Publishing: 23] [Article Influence: 4.4] [Reference Citation Analysis]
560 Drummond MB, Kirk GD, Astemborski J, Marshall MM, Mehta SH, McDyer JF, Brown RH, Wise RA, Merlo CA. Association between obstructive lung disease and markers of HIV infection in a high-risk cohort. Thorax 2012;67:309-14. [PMID: 22090038 DOI: 10.1136/thoraxjnl-2011-200702] [Cited by in Crossref: 67] [Cited by in F6Publishing: 63] [Article Influence: 6.1] [Reference Citation Analysis]
561 Çolak Y, Nordestgaard BG, Vestbo J, Afzal S, Lange P. Potential clinical implications of targeted spirometry for detection of COPD: A contemporary population-based cohort study. Respiratory Medicine 2022. [DOI: 10.1016/j.rmed.2022.106852] [Reference Citation Analysis]
562 Chen C, Shi L, Li Y, Wang X, Yang S. Disease-specific dynamic biomarkers selected by integrating inflammatory mediators with clinical informatics in ARDS patients with severe pneumonia. Cell Biol Toxicol 2016;32:169-84. [PMID: 27095254 DOI: 10.1007/s10565-016-9322-4] [Cited by in Crossref: 49] [Cited by in F6Publishing: 46] [Article Influence: 8.2] [Reference Citation Analysis]
563 Esteban C, Quintana JM, Aburto M, Moraza J, Egurrola M, España PP, Pérez-Izquierdo J, Capelastegui A. Predictors of mortality in patients with stable COPD. J Gen Intern Med 2008;23:1829-34. [PMID: 18795373 DOI: 10.1007/s11606-008-0783-x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 2.2] [Reference Citation Analysis]
564 Rossi A, Khirani S, Cazzola M. Long-acting beta2-agonists (LABA) in chronic obstructive pulmonary disease: efficacy and safety. Int J Chron Obstruct Pulmon Dis 2008;3:521-9. [PMID: 19281071 DOI: 10.2147/copd.s1353] [Cited by in Crossref: 22] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
565 Gungor S, Kargin F, Irmak I, Ciyiltepe F, Acartürk Tunçay E, Atagun Guney P, Aksoy E, Ocakli B, Adiguzel N, Karakurt Z. Severity of acidosis affects long-term survival in COPD patients with hypoxemia after intensive care unit discharge. Int J Chron Obstruct Pulmon Dis 2018;13:1495-506. [PMID: 29780244 DOI: 10.2147/COPD.S159504] [Cited by in Crossref: 4] [Article Influence: 1.0] [Reference Citation Analysis]
566 Wu X, Hu X, Hu W, Xiang G, Li S. Effects of neuromuscular electrical stimulation on exercise capacity and quality of life in COPD patients: a systematic review and meta-analysis. Biosci Rep 2020;40:BSR20191912. [PMID: 32368783 DOI: 10.1042/BSR20191912] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
567 Chang C, Zhu H, Shen N, Han X, Chen Y, He B. Utility of the combination of serum highly-sensitive C-reactive protein level at discharge and a risk index in predicting readmission for acute exacerbation of COPD. J Bras Pneumol 2014;40:495-503. [PMID: 25410837 DOI: 10.1590/s1806-37132014000500005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
568 Li CL, Lin MH, Chen PS, Tsai YC, Shen LS, Kuo HC, Liu SF. Using the BODE Index and Comorbidities to Predict Health Utilization Resources in Chronic Obstructive Pulmonary Disease. Int J Chron Obstruct Pulmon Dis 2020;15:389-95. [PMID: 32110007 DOI: 10.2147/COPD.S234363] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
569 Lee CH, Lee J, Park YS, Lee SM, Yim JJ, Kim YW, Han SK, Yoo CG. Chronic obstructive pulmonary disease (COPD) assessment test scores corresponding to modified Medical Research Council grades among COPD patients. Korean J Intern Med 2015;30:629-37. [PMID: 26354057 DOI: 10.3904/kjim.2015.30.5.629] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
570 Hansel NN, Washko GR, Foreman MG, Han MK, Hoffman EA, DeMeo DL, Barr RG, Van Beek EJ, Kazerooni EA, Wise RA, Brown RH, Black-Shinn J, Hokanson JE, Hanania NA, Make B, Silverman EK, Crapo JD, Dransfield MT; COPDGene Investigators. Racial differences in CT phenotypes in COPD. COPD 2013;10:20-7. [PMID: 23413893 DOI: 10.3109/15412555.2012.727921] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 2.3] [Reference Citation Analysis]
571 Man SF, Connett JE, Anthonisen NR, Wise RA, Tashkin DP, Sin DD. C-reactive protein and mortality in mild to moderate chronic obstructive pulmonary disease. Thorax 2006;61:849-53. [PMID: 16738034 DOI: 10.1136/thx.2006.059808] [Cited by in Crossref: 222] [Cited by in F6Publishing: 207] [Article Influence: 13.9] [Reference Citation Analysis]
572 Mahler DA, Ward J, Waterman LA, McCusker C, ZuWallack R, Baird JC. Patient-reported dyspnea in COPD reliability and association with stage of disease. Chest 2009;136:1473-9. [PMID: 19696126 DOI: 10.1378/chest.09-0934] [Cited by in Crossref: 54] [Cited by in F6Publishing: 53] [Article Influence: 4.2] [Reference Citation Analysis]
573 Tung LF, Shen SY, Shih HH, Chen YT, Yen CT, Ho SC. Effect of high-flow nasal therapy during early pulmonary rehabilitation in patients with severe AECOPD: a randomized controlled study. Respir Res 2020;21:84. [PMID: 32293463 DOI: 10.1186/s12931-020-1328-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
574 Prats E, Tejero E, Pardo P, Gavilán A, Galera R, Donado JR, Racionero MÁ, Casitas R, Zapatero A, García-Río F. Prognostic Value of the Six-Second Spirometry in Patients with Chronic Obstructive Pulmonary Disease: A Cohort Study. PLoS One 2015;10:e0140855. [PMID: 26489023 DOI: 10.1371/journal.pone.0140855] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
575 Furlanetto KC, Pinto IF, Sant'Anna T, Hernandes NA, Pitta F. Profile of patients with chronic obstructive pulmonary disease classified as physically active and inactive according to different thresholds of physical activity in daily life. Braz J Phys Ther 2016;20:517-24. [PMID: 27683835 DOI: 10.1590/bjpt-rbf.2014.0185] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
576 Bodduluri S, Reinhardt JM, Hoffman EA, Newell JD Jr, Nath H, Dransfield MT, Bhatt SP; COPDGene Investigators. Signs of Gas Trapping in Normal Lung Density Regions in Smokers. Am J Respir Crit Care Med 2017;196:1404-10. [PMID: 28707983 DOI: 10.1164/rccm.201705-0855OC] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 2.4] [Reference Citation Analysis]
577 Orme MW, Pina I, Singh SJ. The untapped potential of physical activity monitoring for quality assurance of field-based walking tests in clinical respiratory trials. Chron Respir Dis 2022;19:14799731221089318. [PMID: 35380873 DOI: 10.1177/14799731221089318] [Reference Citation Analysis]
578 Byun MK, Cho EN, Chang J, Ahn CM, Kim HJ. Sarcopenia correlates with systemic inflammation in COPD. Int J Chron Obstruct Pulmon Dis 2017;12:669-75. [PMID: 28255238 DOI: 10.2147/COPD.S130790] [Cited by in Crossref: 67] [Cited by in F6Publishing: 33] [Article Influence: 13.4] [Reference Citation Analysis]
579 Gupta D, Agarwal R, Aggarwal AN, Maturu VN, Dhooria S, Prasad KT, Sehgal IS, Yenge LB, Jindal A, Singh N, Ghoshal AG, Khilnani GC, Samaria JK, Gaur SN, Behera D; S. K. Jindal for the COPD Guidelines Working Group. Guidelines for diagnosis and management of chronic obstructive pulmonary disease: Joint ICS/NCCP (I) recommendations. Lung India 2013;30:228-67. [PMID: 24049265 DOI: 10.4103/0970-2113.116248] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 3.7] [Reference Citation Analysis]
580 Puhan MA, Scharplatz M, Troosters T, Steurer J. Respiratory rehabilitation after acute exacerbation of COPD may reduce risk for readmission and mortality -- a systematic review. Respir Res 2005;6:54. [PMID: 15943867 DOI: 10.1186/1465-9921-6-54] [Cited by in Crossref: 129] [Cited by in F6Publishing: 117] [Article Influence: 7.6] [Reference Citation Analysis]
581 Corlateanu A, Plahotniuc A, Corlateanu O, Botnaru V, Bikov A, Mathioudakis AG, Covantev S, Siafakas N. Multidimensional indices in the assessment of chronic obstructive pulmonary disease. Respiratory Medicine 2021;185:106519. [DOI: 10.1016/j.rmed.2021.106519] [Reference Citation Analysis]
582 Sherrill DM, Moy ML, Reilly JJ, Bonato P. Using hierarchical clustering methods to classify motor activities of COPD patients from wearable sensor data. J Neuroeng Rehabil 2005;2:16. [PMID: 15987518 DOI: 10.1186/1743-0003-2-16] [Cited by in Crossref: 27] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
583 Yanagisawa S, Papaioannou AI, Papaporfyriou A, Baker JR, Vuppusetty C, Loukides S, Barnes PJ, Ito K. Decreased Serum Sirtuin-1 in COPD. Chest 2017;152:343-52. [PMID: 28506610 DOI: 10.1016/j.chest.2017.05.004] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 5.6] [Reference Citation Analysis]
584 Barnes PJ. Chronic obstructive pulmonary disease: a growing but neglected global epidemic. PLoS Med 2007;4:e112. [PMID: 17503959 DOI: 10.1371/journal.pmed.0040112] [Cited by in Crossref: 94] [Cited by in F6Publishing: 84] [Article Influence: 6.3] [Reference Citation Analysis]
585 Betancourt-peña J, Ávila-valencia JC, Assis JK, Escobar-vidal DA. Clinical and Quality of Life Differences in Patients with COPD With and Without a Background of Hospitalization in the Last Year. CRMR 2021;16:228-33. [DOI: 10.2174/1573398x17666210209111111] [Reference Citation Analysis]
586 Færk G, Çolak Y, Afzal S, Nordestgaard BG. Low concentrations of 25-hydroxyvitamin D and long-term prognosis of COPD: a prospective cohort study. Eur J Epidemiol 2018;33:567-77. [PMID: 29691706 DOI: 10.1007/s10654-018-0393-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
587 Inal-Ince D, Savci S, Saglam M, Calik E, Arikan H, Bosnak-Guclu M, Vardar-Yagli N, Coplu L. Fatigue and multidimensional disease severity in chronic obstructive pulmonary disease. Multidiscip Respir Med 2010;5:162-7. [PMID: 22958301 DOI: 10.1186/2049-6958-5-3-162] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
588 Aguilaniu B, Gonzalez-Bermejo J, Regnault A, Barbosa CD, Arnould B, Mueser M, Granet G, Bonnefoy M, Similowski T. Disability related to COPD tool (DIRECT): towards an assessment of COPD-related disability in routine practice. Int J Chron Obstruct Pulmon Dis 2011;6:387-98. [PMID: 21760726 DOI: 10.2147/COPD.S20007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 10] [Article Influence: 0.2] [Reference Citation Analysis]
589 Fastenau A, van Schayck OC, Gosselink R, Aretz KC, Muris JW. Discrepancy between functional exercise capacity and daily physical activity: a cross-sectional study in patients with mild to moderate COPD. Prim Care Respir J 2013;22:425-30. [PMID: 24217860 DOI: 10.4104/pcrj.2013.00090] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
590 Savale L, Chaouat A, Bastuji-Garin S, Marcos E, Boyer L, Maitre B, Sarni M, Housset B, Weitzenblum E, Matrat M, Le Corvoisier P, Rideau D, Boczkowski J, Dubois-Randé JL, Chouaid C, Adnot S. Shortened telomeres in circulating leukocytes of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2009;179:566-71. [PMID: 19179485 DOI: 10.1164/rccm.200809-1398OC] [Cited by in Crossref: 198] [Cited by in F6Publishing: 84] [Article Influence: 15.2] [Reference Citation Analysis]
591 Choate R, Mannino DM, Holm KE, Beiko T, Boyd B, Sandhaus RA. Home-Based Multicomponent Intervention Increases Exercise Activity and Improves Body Mass Index: Results of a 5-Year Randomized Trial Among Individuals with Alpha-1 Antitrypsin Deficiency-Associated Lung Disease. Chronic Obstr Pulm Dis 2021;8. [PMID: 33135406 DOI: 10.15326/jcopdf.8.1.2020.0183] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
592 Ferreira SA, Guimarães M, Taveira N. Pulmonary rehabilitation in COPD: from exercise training to 'real life'. J Bras Pneumol 2009;35:1112-5. [PMID: 20011847 DOI: 10.1590/s1806-37132009001100009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
593 Moy ML, Matthess K, Stolzmann K, Reilly J, Garshick E. Free-living physical activity in COPD: assessment with accelerometer and activity checklist. J Rehabil Res Dev 2009;46:277-86. [PMID: 19533541 DOI: 10.1682/jrrd.2008.07.0083] [Cited by in Crossref: 46] [Cited by in F6Publishing: 21] [Article Influence: 3.5] [Reference Citation Analysis]
594 Pinto-Plata V, Toso J, Lee K, Park D, Bilello J, Mullerova H, De Souza MM, Vessey R, Celli B. Profiling serum biomarkers in patients with COPD: associations with clinical parameters. Thorax 2007;62:595-601. [PMID: 17356059 DOI: 10.1136/thx.2006.064428] [Cited by in Crossref: 132] [Cited by in F6Publishing: 128] [Article Influence: 8.8] [Reference Citation Analysis]
595 Welling JBA, Hartman JE, Augustijn SWS, Kerstjens HAM, Vanfleteren LEGW, Klooster K, Slebos DJ. Patient Selection for Bronchoscopic Lung Volume Reduction. Int J Chron Obstruct Pulmon Dis 2020;15:871-81. [PMID: 32368033 DOI: 10.2147/COPD.S240848] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
596 Meshram PL, Shinde SN, Ramraje NN, Hegde RR. Study of inflammatory markers and BODE index in chronic obstructive pulmonary disease. Lung India 2018;35:37-40. [PMID: 29319032 DOI: 10.4103/lungindia.lungindia_46_17] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
597 Walsh JR, McKeough ZJ, Morris NR, Yerkovich ST, Wood ME, Paratz JD. Seasonal variation and living alone are related to pulmonary rehabilitation non-completion. World J Respirol 2013; 3(2): 29-37 [DOI: 10.5320/wjr.v3.i2.29] [Cited by in CrossRef: 1] [Article Influence: 0.1] [Reference Citation Analysis]
598 Papaioannou AI, Kostikas K, Manali ED, Papadaki G, Roussou A, Spathis A, Mazioti A, Tomos I, Papanikolaou I, Loukides S, Chainis K, Karakitsos P, Griese M, Papiris S. Serum Levels of Surfactant Proteins in Patients with Combined Pulmonary Fibrosis and Emphysema (CPFE). PLoS One 2016;11:e0157789. [PMID: 27337142 DOI: 10.1371/journal.pone.0157789] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
599 Zhong H, Wang Y, Gu Y, Ni Y, Wang Y, Shen K, Shi Y, Su X. Clinical Features, Diagnostic Test Performance, and Prognosis in Different Subtypes of Chronic Pulmonary Aspergillosis. Front Med 2022;9:811807. [DOI: 10.3389/fmed.2022.811807] [Reference Citation Analysis]
600 Paly VF, Naya I, Gunsoy NB, Driessen MT, Risebrough N, Briggs A, Ismaila AS. Long-term cost and utility consequences of short-term clinically important deterioration in patients with chronic obstructive pulmonary disease: results from the TORCH study. Int J Chron Obstruct Pulmon Dis 2019;14:939-51. [PMID: 31190781 DOI: 10.2147/COPD.S188898] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
601 Bai P, Sun Y, Jin J, Hou J, Li R, Zhang Q, Wang Y. Disturbance of the OPG/RANK/RANKL pathway and systemic inflammation in COPD patients with emphysema and osteoporosis. Respir Res 2011;12:157. [PMID: 22176920 DOI: 10.1186/1465-9921-12-157] [Cited by in Crossref: 51] [Cited by in F6Publishing: 50] [Article Influence: 4.6] [Reference Citation Analysis]
602 Aguilaniu B, Roth H, Gonzalez-Bermejo J, Jondot M, Maitre J, Denis F, Similowski T. A simple semipaced 3-minute chair rise test for routine exercise tolerance testing in COPD. Int J Chron Obstruct Pulmon Dis 2014;9:1009-19. [PMID: 25285001 DOI: 10.2147/COPD.S59855] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
603 Córdoba-Lanús E, Cazorla-Rivero S, García-Bello MA, Mayato D, Gonzalvo F, Ayra-Plasencia J, Celli B, Casanova C. Telomere length dynamics over 10-years and related outcomes in patients with COPD. Respir Res 2021;22:56. [PMID: 33608013 DOI: 10.1186/s12931-021-01616-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
604 Ikeda M, Oga T, Chen-Yoshikawa TF, Tokuno J, Oto T, Okawa T, Okada Y, Akiba M, Tanaka S, Yamada Y, Yutaka Y, Ohsumi A, Nakajima D, Hamaji M, Isomi M, Chin K, Date H. Patient-reported dyspnea and health predict waitlist mortality in patients waiting for lung transplantation in Japan. Respir Res 2021;22:116. [PMID: 33882928 DOI: 10.1186/s12931-021-01715-x] [Reference Citation Analysis]
605 Parshall MB, Schwartzstein RM, Adams L, Banzett RB, Manning HL, Bourbeau J, Calverley PM, Gift AG, Harver A, Lareau SC. An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea. Am J Respir Crit Care Med. 2012;185:435-452. [PMID: 22336677 DOI: 10.1164/rccm.201111-2042ST] [Cited by in Crossref: 869] [Cited by in F6Publishing: 287] [Article Influence: 86.9] [Reference Citation Analysis]
606 Horie J, Takahashi K, Shiranita S, Anami K, Hayashi S. Validation of Clinical Characteristics and Effectiveness of Pulmonary Rehabilitation in a COPD Population with Discrepancy between Exercise Tolerance and FEV1. Healthcare (Basel) 2021;9:53. [PMID: 33419024 DOI: 10.3390/healthcare9010053] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
607 Varraso R, Fung TT, Hu FB, Willett W, Camargo CA. Prospective study of dietary patterns and chronic obstructive pulmonary disease among US men. Thorax 2007;62:786-91. [PMID: 17504819 DOI: 10.1136/thx.2006.074534] [Cited by in Crossref: 87] [Cited by in F6Publishing: 92] [Article Influence: 5.8] [Reference Citation Analysis]
608 Housset B. [Definition of low respiratory tract infections]. Med Mal Infect 2006;36:538-45. [PMID: 16837158 DOI: 10.1016/j.medmal.2006.05.014] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
609 Ross JC, Castaldi PJ, Cho MH, Hersh CP, Rahaghi FN, Sánchez-Ferrero GV, Parker MM, Litonjua AA, Sparrow D, Dy JG, Silverman EK, Washko GR, San José Estépar R. Longitudinal Modeling of Lung Function Trajectories in Smokers with and without Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med 2018;198:1033-42. [PMID: 29671603 DOI: 10.1164/rccm.201707-1405OC] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 5.3] [Reference Citation Analysis]
610 Morakami FK, Morita AA, Bisca GW, Felcar JM, Ribeiro M, Furlanetto KC, Hernandes NA, Pitta F. Can the six-minute walk distance predict the occurrence of acute exacerbations of COPD in patients in Brazil? J Bras Pneumol 2017;43:280-4. [PMID: 29365003 DOI: 10.1590/S1806-37562016000000197] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
611 Dai J, Yang P, Cox A, Jiang G. Lung cancer and chronic obstructive pulmonary disease: From a clinical perspective. Oncotarget 2017;8:18513-24. [PMID: 28061470 DOI: 10.18632/oncotarget.14505] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.6] [Reference Citation Analysis]
612 Puhan MA, Schünemann HJ, Frey M, Bachmann LM. Value of supplemental interventions to enhance the effectiveness of physical exercise during respiratory rehabilitation in COPD patients. A systematic review. Respir Res 2004;5:25. [PMID: 15575956 DOI: 10.1186/1465-9921-5-25] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
613 Kawamatawong T. Phosphodiesterase-4 Inhibitors for Non-COPD Respiratory Diseases. Front Pharmacol 2021;12:518345. [PMID: 34434103 DOI: 10.3389/fphar.2021.518345] [Reference Citation Analysis]
614 James BD, Jones AV, Trethewey RE, Evans RA. Obesity and metabolic syndrome in COPD: Is exercise the answer? Chron Respir Dis 2018;15:173-81. [PMID: 29117797 DOI: 10.1177/1479972317736294] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
615 Pimentel CFMG, Amaral ACC, Gonzalez AM, Lai M, Mota DO, Ferraz MLG, Junior WM, Kondo M. Six-minute walking test performance is associated with survival in cirrhotic patients. World J Hepatol 2021; 13(11): 1791-1801 [PMID: 34904046 DOI: 10.4254/wjh.v13.i11.1791] [Reference Citation Analysis]
616 Uronis HE, Currow DC, Abernethy AP. Palliative management of refractory dyspnea in COPD. Int J Chron Obstruct Pulmon Dis 2006;1:289-304. [PMID: 18046866 DOI: 10.2147/copd.2006.1.3.289] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 0.4] [Reference Citation Analysis]
617 Coultas DB, Jackson BE, Russo R, Peoples J, Singh KP, Sloan J, Uhm M, Ashmore JA, Blair SN, Bae S. Home-based Physical Activity Coaching, Physical Activity, and Health Care Utilization in Chronic Obstructive Pulmonary Disease. Chronic Obstructive Pulmonary Disease Self-Management Activation Research Trial Secondary Outcomes. Ann Am Thorac Soc 2018;15:470-8. [PMID: 29283670 DOI: 10.1513/AnnalsATS.201704-308OC] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 4.7] [Reference Citation Analysis]
618 Karpman C, DePew ZS, LeBrasseur NK, Novotny PJ, Benzo RP. Determinants of gait speed in COPD. Chest 2014;146:104-10. [PMID: 24522522 DOI: 10.1378/chest.13-2017] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 3.9] [Reference Citation Analysis]
619 Chan MC, Lin CH, Kou YR. Hyperlipidemia in COPD is associated with decreased incidence of pneumonia and mortality: a nationwide health insurance data-based retrospective cohort study. Int J Chron Obstruct Pulmon Dis 2016;11:1053-9. [PMID: 27274227 DOI: 10.2147/COPD.S102708] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
620 Aljazeeri J, Sakkat A, Makhdami N, Almusally R, Morfaw F, McIvor A. Blood Eosinophils and Pulmonary Rehabilitation in COPD. Can Respir J 2021;2021:7449527. [PMID: 34777651 DOI: 10.1155/2021/7449527] [Reference Citation Analysis]
621 Katsiki N, Stoian AP, Steiropoulos P, Papanas N, Suceveanu AI, Mikhailidis DP. Metabolic Syndrome and Abnormal Peri-Organ or Intra-Organ Fat (APIFat) Deposition in Chronic Obstructive Pulmonary Disease: An Overview. Metabolites 2020;10:E465. [PMID: 33203192 DOI: 10.3390/metabo10110465] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
622 Pompe E, Galbán CJ, Ross BD, Koenderman L, Ten Hacken NH, Postma DS, van den Berge M, de Jong PA, Lammers JJ, Mohamed Hoesein FA. Parametric response mapping on chest computed tomography associates with clinical and functional parameters in chronic obstructive pulmonary disease. Respir Med 2017;123:48-55. [PMID: 28137496 DOI: 10.1016/j.rmed.2016.11.021] [Cited by in Crossref: 21] [Cited by in F6Publishing: 25] [Article Influence: 3.5] [Reference Citation Analysis]
623 Gagné M, Lauzier S, Babineau-Therrien J, Hamel C, Penney SE, Bourbeau J, Moisan J, Boulet LP. COPD-Specific Self-Management Support Provided by Trained Educators in Everyday Practice is Associated with Improved Quality of Life, Health-Directed Behaviors, and Skill and Technique Acquisition: A Convergent Embedded Mixed-Methods Study. Patient 2020;13:103-19. [PMID: 31502238 DOI: 10.1007/s40271-019-00386-7] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
624 Kim YW, Lee CH, Hwang HG, Kim YI, Kim DK, Oh YM, Lee SH, Kim KU, Lee SD. Decline in Carbon Monoxide Transfer Coefficient in Chronic Obstructive Pulmonary Disease. J Clin Med 2020;9:E1512. [PMID: 32443426 DOI: 10.3390/jcm9051512] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
625 Liang J, Abramson MJ, Zwar N, Russell G, Holland AE, Bonevski B, Mahal A, Hecke BV, Phillips K, Eustace P, Paul E, Petrie K, Wilson S, George J. Interdisciplinary model of care (RADICALS) for early detection and management of chronic obstructive pulmonary disease (COPD) in Australian primary care: study protocol for a cluster randomised controlled trial. BMJ Open 2017;7:e016985. [PMID: 28928190 DOI: 10.1136/bmjopen-2017-016985] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
626 Lainscak M, von Haehling S, Doehner W, Sarc I, Jeric T, Ziherl K, Kosnik M, Anker SD, Suskovic S. Body mass index and prognosis in patients hospitalized with acute exacerbation of chronic obstructive pulmonary disease. J Cachexia Sarcopenia Muscle 2011;2:81-6. [PMID: 21766053 DOI: 10.1007/s13539-011-0023-9] [Cited by in Crossref: 97] [Cited by in F6Publishing: 95] [Article Influence: 8.8] [Reference Citation Analysis]
627 Dangour AD, Albala C, Allen E, Grundy E, Walker DG, Aedo C, Sanchez H, Fletcher O, Elbourne D, Uauy R. Effect of a nutrition supplement and physical activity program on pneumonia and walking capacity in Chilean older people: a factorial cluster randomized trial. PLoS Med 2011;8:e1001023. [PMID: 21526229 DOI: 10.1371/journal.pmed.1001023] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 2.6] [Reference Citation Analysis]
628 Flattet Y, Garin N, Serratrice J, Perrier A, Stirnemann J, Carballo S. Determining prognosis in acute exacerbation of COPD. Int J Chron Obstruct Pulmon Dis 2017;12:467-75. [PMID: 28203070 DOI: 10.2147/COPD.S122382] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 4.4] [Reference Citation Analysis]
629 Oh YM, Park JH, Kim EK, Hwang SC, Kim HJ, Kang DR, Yoo KH, Lee JH, Kim TH, Lim SY, Rhee CK, Yoon HK, Lee SY, Lee SD. Anemia as a clinical marker of stable chronic obstructive pulmonary disease in the Korean obstructive lung disease cohort. J Thorac Dis 2017;9:5008-16. [PMID: 29312705 DOI: 10.21037/jtd.2017.10.140] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
630 Huang HY, Chou PC, Joa WC, Chen LF, Sheng TF, Lin HC, Yang LY, Pan YB, Chung FT, Wang CH, Kuo HP. Pulmonary rehabilitation coupled with negative pressure ventilation decreases decline in lung function, hospitalizations, and medical cost in COPD: A 5-year study. Medicine (Baltimore) 2016;95:e5119. [PMID: 27741132 DOI: 10.1097/MD.0000000000005119] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
631 Echave-Sustaeta JM, Comeche Casanova L, Cosio BG, Soler-Cataluña JJ, Garcia-Lujan R, Ribera X. Comorbidity in chronic obstructive pulmonary disease. Related to disease severity? Int J Chron Obstruct Pulmon Dis 2014;9:1307-14. [PMID: 25429213 DOI: 10.2147/COPD.S71849] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
632 Annegarn J, Spruit MA, Savelberg HH, Willems PJ, van de Bool C, Schols AM, Wouters EF, Meijer K. Differences in walking pattern during 6-min walk test between patients with COPD and healthy subjects. PLoS One 2012;7:e37329. [PMID: 22624017 DOI: 10.1371/journal.pone.0037329] [Cited by in Crossref: 52] [Cited by in F6Publishing: 45] [Article Influence: 5.2] [Reference Citation Analysis]
633 Ekberg-Aronsson M, Pehrsson K, Nilsson JA, Nilsson PM, Löfdahl CG. Mortality in GOLD stages of COPD and its dependence on symptoms of chronic bronchitis. Respir Res 2005;6:98. [PMID: 16120227 DOI: 10.1186/1465-9921-6-98] [Cited by in Crossref: 98] [Cited by in F6Publishing: 97] [Article Influence: 5.8] [Reference Citation Analysis]
634 Kraemer KM, Litrownik D, Moy ML, Wayne PM, Beach D, Klings ES, Reyes Nieva H, Pinheiro A, Davis RB, Yeh GY. Exploring Tai Chi Exercise and Mind-Body Breathing in Patients with COPD in a Randomized Controlled Feasibility Trial. COPD 2021;18:288-98. [PMID: 34106027 DOI: 10.1080/15412555.2021.1928037] [Reference Citation Analysis]
635 Fumagalli G, Fabiani F, Forte S, Napolitano M, Balzano G, Bonini M, De Simone G, Fuschillo S, Pentassuglia A, Pasqua F, Alimonti P, Carlone S, Sanguinetti CM. INDACO project: COPD and link between comorbidities, lung function and inhalation therapy. Multidiscip Respir Med 2015;10:4. [PMID: 25973198 DOI: 10.1186/2049-6958-10-4] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
636 Criner RN, Yu D, Jacobs MR, Criner GJ. Effect of Lung Volume Reduction Surgery on Respiratory Muscle Strength in Advanced Emphysema. Chronic Obstr Pulm Dis 2018;6:40-50. [PMID: 30775423 DOI: 10.15326/jcopdf.6.1.2018.0188] [Reference Citation Analysis]
637 Sevenoaks MJ, Stockley RA. Chronic Obstructive Pulmonary Disease, inflammation and co-morbidity--a common inflammatory phenotype? Respir Res 2006;7:70. [PMID: 16669999 DOI: 10.1186/1465-9921-7-70] [Cited by in Crossref: 132] [Cited by in F6Publishing: 113] [Article Influence: 8.3] [Reference Citation Analysis]
638 Singh D, Criner GJ, Naya I, Jones PW, Tombs L, Lipson DA, Han MK. Measuring disease activity in COPD: is clinically important deterioration the answer? Respir Res 2020;21:134. [PMID: 32487202 DOI: 10.1186/s12931-020-01387-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
639 Kim KY, Miravitlles M, Sliwinski P, Costello R, Carter V, Tan J, Lapperre TS, Alcazar B, Gouder C, Esquinas C, García-Rivero JL, Kemppinen A, Tee A, Roman-Rodríguez M, Soler-Cataluña JJ, Price D, Rhee CK. Comparison of clinical baseline characteristics between Asian and Western COPD patients in a prospective, international, multicenter study. Int J Chron Obstruct Pulmon Dis 2019;14:1595-601. [PMID: 31440042 DOI: 10.2147/COPD.S208245] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
640 Arnaudis B, Lairez O, Escamilla R, Fouilloux A, Fournier P, Monteil B, Bouisset F, Arnal JF, Elbaz M, Carrié D, Roncalli J, Pathak A, Galinier M. Impact of chronic obstructive pulmonary disease severity on symptoms and prognosis in patients with systolic heart failure. Clin Res Cardiol 2012;101:717-26. [PMID: 22484345 DOI: 10.1007/s00392-012-0450-4] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
641 Díez-Manglano J, Cabrerizo García JL, García-Arilla Calvo E, Jimeno Saínz A, Calvo Beguería E, Martínez-Álvarez RM, Bejarano Tello E, Caudevilla Martínez A. External validation of the PROFUND index in polypathological patients from internal medicine and acute geriatrics departments in Aragón. Intern Emerg Med 2015;10:915-26. [PMID: 25986479 DOI: 10.1007/s11739-015-1252-2] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
642 Sánchez-Martínez MP, Bernabeu-Mora R, Martínez-González M, Gacto-Sánchez M, Martín San Agustín R, Medina-Mirapeix F. Stability and Predictors of Poor 6-min Walking Test Performance over 2 Years in Patients with COPD. J Clin Med 2020;9:E1155. [PMID: 32325637 DOI: 10.3390/jcm9041155] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
643 Georges T, Le Blanc C, Ferreol S, Menu P, Dauty M, Fouasson-Chailloux A. Effects of Altitude on Chronic Obstructive Pulmonary Disease Patients: Risks and Care. Life (Basel) 2021;11:798. [PMID: 34440542 DOI: 10.3390/life11080798] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
644 Reséndiz-Hernández JM, Ambrocio-Ortiz E, Pérez-Rubio G, López-Flores LA, Abarca-Rojano E, Pavón-Romero GF, Flores-Trujillo F, de Jesús Hernández-Zenteno R, Camarena Á, Pérez-Rodríguez M, Salazar AM, Ramírez-Venegas A, Falfán-Valencia R. TNF promoter polymorphisms are associated with genetic susceptibility in COPD secondary to tobacco smoking and biomass burning. Int J Chron Obstruct Pulmon Dis 2018;13:627-37. [PMID: 29497291 DOI: 10.2147/COPD.S147688] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
645 Lo Tam Loi AT, Hoonhorst SJ, Franciosi L, Bischoff R, Hoffmann RF, Heijink I, van Oosterhout AJ, Boezen HM, Timens W, Postma DS, Lammers JW, Koenderman L, Ten Hacken NH. Acute and chronic inflammatory responses induced by smoking in individuals susceptible and non-susceptible to development of COPD: from specific disease phenotyping towards novel therapy. Protocol of a cross-sectional study. BMJ Open 2013;3:e002178. [PMID: 23377993 DOI: 10.1136/bmjopen-2012-002178] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 3.3] [Reference Citation Analysis]
646 Pertzov B, Soliman M, Shostak Y, Heching M, Rosengarten D, Izbicki G, Kramer MR. Effect of Endobronchial Coils on Exercise Tolerance and Lung Functions in Patients with Severe Emphysema - A Retrospective Cohort Study of 48 Patients. Int J Chron Obstruct Pulmon Dis 2021;16:2809-15. [PMID: 34675505 DOI: 10.2147/COPD.S327048] [Reference Citation Analysis]
647 Farias CC, Resqueti V, Dias FA, Borghi-Silva A, Arena R, Fregonezi GA. Costs and benefits of pulmonary rehabilitation in chronic obstructive pulmonary disease: a randomized controlled trial. Braz J Phys Ther 2014;18:165-73. [PMID: 24838809 DOI: 10.1590/s1413-35552012005000151] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
648 Punekar YS, Riley JH, Lloyd E, Driessen M, Singh SJ. Systematic review of the association between exercise tests and patient-reported outcomes in patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 2017;12:2487-506. [PMID: 28860743 DOI: 10.2147/COPD.S100204] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 2.6] [Reference Citation Analysis]
649 Mansour W, El-shabrawy M, Khalil WA, Eldamanhory AS, Embarak S. Arterial stiffness can occur early in mild-to-moderate chronic obstructive pulmonary disease. Egypt J Bronchol 2020;14. [DOI: 10.1186/s43168-020-00014-1] [Reference Citation Analysis]
650 Bell M, Fotheringham I, Punekar YS, Riley JH, Cockle S, Singh SJ. Systematic Review of the Association Between Laboratory- and Field-Based Exercise Tests and Lung Function in Patients with Chronic Obstructive Pulmonary Disease. Chronic Obstr Pulm Dis 2015;2:321-42. [PMID: 28848854 DOI: 10.15326/jcopdf.2.4.2014.0157] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
651 Bhattacharya B, Prashant A, Vishwanath P, Suma MN, Nataraj B. Prediction of outcome and prognosis of patients on mechanical ventilation using body mass index, SOFA score, C-Reactive protein, and serum albumin. Indian J Crit Care Med 2011;15:82-7. [PMID: 21814371 DOI: 10.4103/0972-5229.83011] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
652 Nickler M, Ottiger M, Steuer C, Huber A, Anderson JB, Müller B, Schuetz P. Systematic review regarding metabolic profiling for improved pathophysiological understanding of disease and outcome prediction in respiratory infections. Respir Res 2015;16:125. [PMID: 26471192 DOI: 10.1186/s12931-015-0283-6] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 3.7] [Reference Citation Analysis]
653 Attaran D, Lari SM, Towhidi M, Marallu HG, Ayatollahi H, Khajehdaluee M, Ghanei M, Basiri R. Interleukin-6 and airflow limitation in chemical warfare patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 2010;5:335-40. [PMID: 21037957 DOI: 10.2147/COPD.S12545] [Cited by in Crossref: 3] [Cited by in F6Publishing: 16] [Article Influence: 0.3] [Reference Citation Analysis]
654 Stapleton RD, Curtis JR. End-of-life considerations in older patients who have lung disease. Clin Chest Med 2007;28:801-11, vii. [PMID: 17967296 DOI: 10.1016/j.ccm.2007.08.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
655 Puhan MA, Siebeling L, Zoller M, Muggensturm P, ter Riet G. Simple functional performance tests and mortality in COPD. Eur Respir J 2013;42:956-63. [PMID: 23520321 DOI: 10.1183/09031936.00131612] [Cited by in Crossref: 104] [Cited by in F6Publishing: 96] [Article Influence: 11.6] [Reference Citation Analysis]
656 Martinez CH, Mannino DM, Divo MJ. Defining COPD-Related Comorbidities, 2004-2014. Chronic Obstr Pulm Dis 2014;1:51-63. [PMID: 28848811 DOI: 10.15326/jcopdf.1.1.2014.0119] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
657 Hardin M, Silverman EK, Barr RG, Hansel NN, Schroeder JD, Make BJ, Crapo JD, Hersh CP; COPDGene Investigators. The clinical features of the overlap between COPD and asthma. Respir Res 2011;12:127. [PMID: 21951550 DOI: 10.1186/1465-9921-12-127] [Cited by in Crossref: 241] [Cited by in F6Publishing: 270] [Article Influence: 21.9] [Reference Citation Analysis]
658 Mouronte-Roibás C, Fernández-Villar A, Ruano-Raviña A, Ramos-Hernández C, Tilve-Gómez A, Rodríguez-Fernández P, Díaz ACC, Vázquez-Noguerol MG, Fernández-García S, Leiro-Fernández V. Influence of the type of emphysema in the relationship between COPD and lung cancer. Int J Chron Obstruct Pulmon Dis 2018;13:3563-70. [PMID: 30464438 DOI: 10.2147/COPD.S178109] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
659 Takiguchi Y, Sekine I, Iwasawa S, Kurimoto R, Tatsumi K. Chronic obstructive pulmonary disease as a risk factor for lung cancer. World J Clin Oncol 2014; 5(4): 660-666 [PMID: 25300704 DOI: 10.5306/wjco.v5.i4.660] [Cited by in CrossRef: 36] [Cited by in F6Publishing: 37] [Article Influence: 4.5] [Reference Citation Analysis]
660 Márquez-Martín E, Ramos PC, López-Campos JL, Serrano Gotarredona Mdel P, Herrero SN, Aguilar RT, Cortes EB, Ruiz FO. Components of physical capacity in patients with chronic obstructive pulmonary disease: relationship with phenotypic expression. Int J Chron Obstruct Pulmon Dis 2011;6:105-12. [PMID: 21407823 DOI: 10.2147/COPD.S16646] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
661 Belloli EA, Wang X, Murray S, Forrester G, Weyhing A, Lin J, Ojo T, Lama VN. Longitudinal Forced Vital Capacity Monitoring as a Prognostic Adjunct after Lung Transplantation. Am J Respir Crit Care Med 2015;192:209-18. [PMID: 25922973 DOI: 10.1164/rccm.201501-0174OC] [Cited by in Crossref: 38] [Cited by in F6Publishing: 14] [Article Influence: 5.4] [Reference Citation Analysis]
662 Sharabi K, Lecuona E, Helenius IT, Beitel GJ, Sznajder JI, Gruenbaum Y. Sensing, physiological effects and molecular response to elevated CO2 levels in eukaryotes. J Cell Mol Med 2009;13:4304-18. [PMID: 19863692 DOI: 10.1111/j.1582-4934.2009.00952.x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 2.4] [Reference Citation Analysis]
663 Roshanravan B, Gamboa J, Wilund K. Exercise and CKD: Skeletal Muscle Dysfunction and Practical Application of Exercise to Prevent and Treat Physical Impairments in CKD. Am J Kidney Dis 2017;69:837-52. [PMID: 28427790 DOI: 10.1053/j.ajkd.2017.01.051] [Cited by in Crossref: 67] [Cited by in F6Publishing: 58] [Article Influence: 13.4] [Reference Citation Analysis]
664 Ansari K, Keaney N, Kay A, Price M, Munby J, Billett A, Haggerty S, Taylor IK, Al Otaibi H. Body mass index, airflow obstruction and dyspnea and body mass index, airflow obstruction, dyspnea scores, age and pack years-predictive properties of new multidimensional prognostic indices of chronic obstructive pulmonary disease in primary care. Ann Thorac Med 2016;11:261-8. [PMID: 27803752 DOI: 10.4103/1817-1737.191866] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
665 Sanguinetti CM, De Benedetto F, Donner CF, Nardini S, Visconti A. Pneumocafé project: an inquiry on current COPD diagnosis and management among General Practitioners in Italy through a novel tool for professional education. Multidiscip Respir Med 2014;9:35. [PMID: 24944787 DOI: 10.1186/2049-6958-9-35] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
666 Williams M, De Palma L, Cafarella P, Petkov J. Fifteen-count breathlessness score in adults with COPD. Respirology 2006;11:627-32. [PMID: 16916337 DOI: 10.1111/j.1440-1843.2006.00895.x] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
667 Bhatt SP, Han MK. Developing and Implementing Biomarkers and Novel Imaging in COPD. Chronic Obstr Pulm Dis 2016;3:485-90. [PMID: 28848871 DOI: 10.15326/jcopdf.3.1.2015.0170] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
668 Kakavas S, Papanikolaou A, Kompogiorgas S, Stavrinoudakis E, Balis E, Bulbasakos G. Sit-to-stand tests in patients hospitalised for chronic obstructive pulmonary disease exacerbation: association with pulmonary function tests and risk of future exacerbations. International Journal of Therapy and Rehabilitation 2020;27:1-11. [DOI: 10.12968/ijtr.2019.0005] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
669 Dretzke J, Blissett D, Dave C, Mukherjee R, Price M, Bayliss S, Wu X, Jordan R, Jowett S, Turner AM, Moore D. The cost-effectiveness of domiciliary non-invasive ventilation in patients with end-stage chronic obstructive pulmonary disease: a systematic review and economic evaluation. Health Technol Assess 2015;19:1-246. [PMID: 26470875 DOI: 10.3310/hta19810] [Cited by in Crossref: 5] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
670 Anzueto AR, Vogelmeier CF, Kostikas K, Mezzi K, Fucile S, Bader G, Shen S, Banerji D, Fogel R. The effect of indacaterol/glycopyrronium versus tiotropium or salmeterol/fluticasone on the prevention of clinically important deterioration in COPD. Int J Chron Obstruct Pulmon Dis 2017;12:1325-37. [PMID: 28496316 DOI: 10.2147/COPD.S133307] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 5.4] [Reference Citation Analysis]
671 Pottecher J, Noll E, Borel M, Audibert G, Gette S, Meyer C, Gaertner E, Legros V, Carapito R, Uring-Lambert B, Sauleau E, Land WG, Bahram S, Meyer A, Geny B, Diemunsch P. Protocol for TRAUMADORNASE: a prospective, randomized, multicentre, double-blinded, placebo-controlled clinical trial of aerosolized dornase alfa to reduce the incidence of moderate-to-severe hypoxaemia in ventilated trauma patients. Trials 2020;21:274. [PMID: 32183886 DOI: 10.1186/s13063-020-4141-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
672 Barker BL, McKenna S, Mistry V, Pancholi M, Patel H, Haldar K, Barer MR, Pavord ID, Steiner MC, Brightling CE, Bafadhel M. Systemic and pulmonary inflammation is independent of skeletal muscle changes in patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 2014;9:975-81. [PMID: 25246784 DOI: 10.2147/COPD.S63568] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
673 Orooj M, Moiz JA, Mujaddadi A, Ali MS, Talwar D. Effect of Pulmonary Rehabilitation in Patients with Asthma COPD Overlap Syndrome: A Randomized Control Trial. Oman Med J 2020;35:e136. [PMID: 32704387 DOI: 10.5001/omj.2020.54] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
674 Arostegui I, Legarreta MJ, Barrio I, Esteban C, Garcia-Gutierrez S, Aguirre U, Quintana JM; IRYSS-COPD Group. A Computer Application to Predict Adverse Events in the Short-Term Evolution of Patients With Exacerbation of Chronic Obstructive Pulmonary Disease. JMIR Med Inform 2019;7:e10773. [PMID: 30994471 DOI: 10.2196/10773] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
675 Gargano LP, Zuppo IDF, Nascimento MMGD, Augusto VM, Godman B, Costa JDO, Acúrcio FA, Álvares-teodoro J, Guerra AA. Survival Analysis of COPD Patients in a 13-Year Nationwide Cohort Study of the Brazilian National Health System. Front Big Data 2022;4:788268. [DOI: 10.3389/fdata.2021.788268] [Reference Citation Analysis]
676 Criner GJ. Giants in Chest Medicine: Bartolome Celli, MD, FCCP. Chest 2016;150:995-7. [PMID: 27832893 DOI: 10.1016/j.chest.2016.08.1464] [Reference Citation Analysis]
677 Kwak MS, Kim E, Jang EJ, Kim HJ, Lee CH. The efficacy and safety of triple inhaled treatment in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis using Bayesian methods. Int J Chron Obstruct Pulmon Dis 2015;10:2365-76. [PMID: 26604734 DOI: 10.2147/COPD.S93191] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 0.1] [Reference Citation Analysis]
678 Cleutjens FA, Janssen DJ, Ponds RW, Dijkstra JB, Wouters EF. COgnitive-pulmonary disease. Biomed Res Int 2014;2014:697825. [PMID: 24738069 DOI: 10.1155/2014/697825] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 3.6] [Reference Citation Analysis]
679 Singh S, Maltais F, Tombs L, Fahy WA, Vahdati-Bolouri M, Locantore N, Riley JH. Relationship between exercise endurance and static hyperinflation in a post hoc analysis of two clinical trials in patients with COPD. Int J Chron Obstruct Pulmon Dis 2018;13:203-15. [PMID: 29386889 DOI: 10.2147/COPD.S145285] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
680 Tsiligianni IG, van der Molen T, Moraitaki D, Lopez I, Kocks JW, Karagiannis K, Siafakas N, Tzanakis N. Assessing health status in COPD. A head-to-head comparison between the COPD assessment test (CAT) and the clinical COPD questionnaire (CCQ). BMC Pulm Med 2012;12:20. [PMID: 22607459 DOI: 10.1186/1471-2466-12-20] [Cited by in Crossref: 82] [Cited by in F6Publishing: 98] [Article Influence: 8.2] [Reference Citation Analysis]
681 O'Reilly S. Chronic Obstructive Pulmonary Disease. Am J Lifestyle Med 2017;11:296-302. [PMID: 30202345 DOI: 10.1177/1559827616656593] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
682 Pomiès P, Rodriguez J, Blaquière M, Sedraoui S, Gouzi F, Carnac G, Laoudj-Chenivesse D, Mercier J, Préfaut C, Hayot M. Reduced myotube diameter, atrophic signalling and elevated oxidative stress in cultured satellite cells from COPD patients. J Cell Mol Med 2015;19:175-86. [PMID: 25339614 DOI: 10.1111/jcmm.12390] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 3.8] [Reference Citation Analysis]
683 Wise RA, Krishnan JA. Celebration of the 50-Year Anniversary of the National Heart, Lung, and Blood Institute Division of Lung Diseases: A Half-Century of Landmark Clinical Trials. Chronic Obstr Pulm Dis 2019;6. [PMID: 31647858 DOI: 10.15326/jcopdf.6.4.2019.0157] [Reference Citation Analysis]
684 Huang Q, He C, Xiong H, Shuai T, Zhang C, Zhang M, Wang Y, Zhu L, Lu J, Jian L. DECAF score as a mortality predictor for acute exacerbation of chronic obstructive pulmonary disease: a systematic review and meta-analysis. BMJ Open 2020;10:e037923. [PMID: 33127631 DOI: 10.1136/bmjopen-2020-037923] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
685 Knaut C, Bonfanti Mesquita C, Dourado VZ, de Godoy I, Tanni SE. Evaluation of Inflammatory Markers in Patients Undergoing a Short-Term Aerobic Exercise Program while Hospitalized due to Acute Exacerbation of COPD. Int J Inflam 2020;2020:6492720. [PMID: 32411343 DOI: 10.1155/2020/6492720] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
686 Strang P, Fürst P, Hedman C, Bergqvist J, Adlitzer H, Schultz T. Chronic obstructive pulmonary disease and lung cancer: access to palliative care, emergency room visits and hospital deaths. BMC Pulm Med 2021;21:170. [PMID: 34011344 DOI: 10.1186/s12890-021-01533-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
687 Tatsis N, Kakavas S, Metaxas E, Balis E, Tatsis G, Pantazis N, Bakakos P, Koulouris N, Hadjistavrou Κ. Spirometric Values of Greek People and Comparison with ECSC and GLI Values in COPD People. Open Respir Med J 2018;12:29-38. [PMID: 30159096 DOI: 10.2174/1874306401812010029] [Reference Citation Analysis]
688 Dusser D, Wise RA, Dahl R, Anzueto A, Carter K, Fowler A, Calverley PM. Differences in outcomes between GOLD groups in patients with COPD in the TIOSPIR(®) trial. Int J Chron Obstruct Pulmon Dis 2016;11:133-45. [PMID: 26855568 DOI: 10.2147/COPD.S97924] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
689 Kruis AL, van Adrichem J, Erkelens MR, Scheepers H, In 't Veen H, Muris JW, Chavannes NH. Sustained effects of integrated COPD management on health status and exercise capacity in primary care patients. Int J Chron Obstruct Pulmon Dis 2010;5:407-13. [PMID: 21191435 DOI: 10.2147/COPD.S9654] [Cited by in Crossref: 2] [Cited by in F6Publishing: 12] [Artic